terlipressin has been researched along with lypressin in 633 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 44 (6.95) | 18.7374 |
1990's | 99 (15.64) | 18.2507 |
2000's | 235 (37.12) | 29.6817 |
2010's | 224 (35.39) | 24.3611 |
2020's | 31 (4.90) | 2.80 |
Authors | Studies |
---|---|
Machová, A | 1 |
Bode, JC; Kreichgauer, HP; Walker, S | 3 |
Merican, MI | 1 |
Burroughs, AK | 2 |
Gaudin, C; Hadengue, A; Kleber, G; Lebrec, D; Moreau, R; Sogni, P; Soubrane, O | 1 |
Amodio, P; Bianco, S; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Rose, JD; Smith, PM | 1 |
Eriksson, LS; Söderlund, C | 1 |
Confalonieri, F; De Filippi, G; Foresti, V; Parisio, E; Ungaro, A | 1 |
Geller, LI | 1 |
Czejka, M; Jäger, W; Schüller, J | 1 |
Czejka, M; Jäger, W; Schernthaner, G; Schüller, J | 1 |
Walker, S | 4 |
Arentsen, J; Dupont, E; Matthiesen, T; Rittig, S; Sørensen, K | 1 |
Berling, R; Lindblom, P; Nilsson, G; Ohlin, M; Vernersson, E | 1 |
Beauchant, M; Fort, E; Ingrand, P; Pillegand, B; Sautereau, D; Silvain, C | 1 |
Chang, TT; Lay, CS; Lee, FY; Lee, SD; Lin, HC; Lo, KJ; Tsai, YT; Wang, SS | 2 |
Braga, M; Burroughs, AK; Cestari, R; Missale, G; Ravelli, P | 1 |
Lundell, L; Magnusson, I; Söderlund, C; Törngren, S | 1 |
Chang, WY; Chen, SC; Chuang, WL; Hsieh, MY; Lin, ZY; Lu, SN; Tsai, JF; Wang, LY | 1 |
Fort, E | 1 |
Bjelkengren, G | 1 |
Aichner, W; Cuan-Orozco, F; Gad, HA; Mercado, MA; Müting, D; Paquet, KJ | 1 |
Blanc-Jouvan, F; Bosseray, A; Brambilla, C | 1 |
Breuer, HW; Charchut, S; Glänzer, K; Trampisch, HJ; Worth, H | 1 |
Cobden, I; Freeman, JG; Record, CO | 1 |
Cervinka, J; Jedlicka, J; Kaláb, M; Kordac, V; Marecek, Z; Petrtýl, J; Srnský, J; Vrána, J | 1 |
D'Odemont, JP; Derollez, M; Ramon, P; Tonnel, AB; Wallaert, B | 1 |
McLaren, MI; Taylor, I | 1 |
Maier, KP | 1 |
Junge, U | 1 |
Gerunda, GE; Maffei Faccioli, A; Monti, G | 1 |
Söderlund, C | 3 |
Celle, G; Dagnino, F; Ghia, M; Grasso, A; Mereto, E; Testa, R | 1 |
Aberg, M; Lindblom, P; Nilsson, G; Palmer, B; Vernersson, E | 1 |
Barton, JR; Freeman, JG; Record, CO | 1 |
Allen, D; Larsson, G; Rundqvist, E | 1 |
Alkner, U; Ohlin, M | 1 |
Angeli, P; Battaglia, G; Bolognesi, M; Finucci, G; Gatta, A; Merkel, C; Zuin, R | 1 |
Lux, G; Schmitt, W; Wagner-Thiessen, E | 1 |
Meyer zum Büschenfelde, KH; Rambow, A; Staritz, M | 1 |
Schröder, R | 1 |
Irestedt, L; Thomassen, PA; Vilhardt, H | 1 |
Baer, R; Balldin, U; Eiken, O | 2 |
Hadengue, A; Lebrec, D; Lee, SS; Moreau, R; Sayegh, R; Valla, D | 1 |
Lindecken, KD; Rey, C; Schäfer, H; Schoenemann, J; Willems, MG | 1 |
Hussey, KP | 1 |
Aberg, M; Aronsen, KF; Vernersson, E | 1 |
Cobden, I; Freeman, JG; Lishman, AH; Record, CO | 1 |
Behrens, R; Dickinson, RJ; Hunter, JO | 1 |
Aprea, G; Casucci, R; Masciariello, S; Santini, M; Sodo, M | 1 |
Bartolucci, C; Brocchi, E; Caletti, GC; Guizzardi, G; Labo', G; Zani, L | 1 |
Aberg, M; Palmer, B; Vernersson, E | 1 |
Aberg, M; Jacobsson, S; Vernersson, E | 1 |
Kohaus, HM | 1 |
Dreiling, DA; Greenstein, RJ | 1 |
Douglas, JG; Forrest, JA; Forsling, ML; Prowse, CV | 1 |
Nádvorníková, H; Schück, O | 1 |
Horejsi, J | 1 |
Aziz, LA; Davies, R; Donovan, B; Forsling, ML; Miller, M | 1 |
Blei, AT; Conn, HO; Groszmann, RJ; Gusberg, R | 1 |
Akerlund, M; Laudański, T | 1 |
Cort, JH; John, EG; Rosenthal, IM; Schade, SG; Spigos, DG | 1 |
Binmoeller, KF; Soehendra, N | 1 |
Bretagne, JF; Gosselin, M; Heresbach, D | 1 |
Kitsenko, EA; Peresta, IuIu | 1 |
Groszmann, RJ; Lopez-Talavera, JC | 1 |
Blaise, M; Lapandry, C; Letoumelin, P; Levacher, S; Pateron, D; Pourriat, JL | 1 |
Danyi, P; Micera, G; Sanna, D; Schön, I; Sóvágó, I; Várnagy, K | 1 |
Aronsen, KF; Augustsson, NE; Bjelkengren, G; Borgström, S; Lindström, C; Nylander, G | 1 |
Armonis, A; Avgerinos, A | 1 |
Calzetti, C; Elia, G; Fiaccadori, F; Magnani, G; Pedretti, G | 1 |
Bernard, B; Valla, D | 1 |
Donovan, B | 1 |
Desaint, B; Florent, C; Guivarch, P; Levy, VG; Pauwels, A; Van, H | 1 |
D'Amico, G; Luca, A; Montalbano, L; Morabito, A; Pagliaro, L; Pasta, L; Politi, F; Tinè, F; Traina, M; Vizzini, G | 1 |
Andreoni, B; Arcidiacono, PG; Battaglia, G; Brunati, S; Carpinelli, L; Cestari, L; de Franchis, R; Mannucci, PM; Zambelli, A | 1 |
Birchall, MA; Donovan, B; Stafford, ND; Vinayak, BC | 1 |
Bordas, JM; Bosch, J; Llach, J; Panés, J; Piqué, JM; Rodés, J; Terés, J | 1 |
Biraghi, M; Boccardo, F; Campisi, C; Casaccia, M; Padula, P; Peressini, A | 1 |
Boyer, J; Carpentier, S; Czernichow, B; Doffël, M; Fort, E; Ingrand, P; Métreau, JM; Pillegand, B; Sautereau, D; Silvain, C | 1 |
Brosius, FC; Garner, WL; Rodriguez, JL; Smith, DJ; Thomson, PD | 1 |
Cailmail, S; Hadengue, A; Lebrec, D; Moreau, R; Oberti, F; Sogni, P | 1 |
Debackere, M; Vynckier, LJ | 1 |
Soederlund, C | 1 |
Fevery, J; Nevens, F; Van Steenbergen, W; Yap, SH | 1 |
Benhamou, JP; Durand, F; Erlinger, S; Ganne-Carrié, N; Hadengue, A; Mathurin, P | 1 |
Decaux, G; Gulbis, B; Namias, B; Soupart, A | 1 |
Burroughs, AK; Patch, D | 2 |
Cailmail, S; Gadano, A; Hadengue, A; Lebrec, D; Moreau, R; Sogni, P; Soupison, T; Vachiery, F; Yang, S | 1 |
Heinemann, A; Stauber, RE | 1 |
Bañares, R; Bosch, J; Feu, F; Planas, R; Ruiz del Arbol, L | 1 |
Nevens, F | 2 |
Bourlière, M; Camatte, R; Dupont, M; Lalanne, B; Lambot, G; Lèbre, P; Lepesan, D; Martelet, JP; Rosario, R | 1 |
Bandi, JC; Bosch, J; Escorsell, A; Feu, F; García-Pagan, JC; Moitinho, E; Rodés, J | 1 |
Blanc, P; Bories, JM; David, XR; Desprez, D; García-Compeán, D; Larrey, D; Michel, H; Michel, J; Pageaux, GP | 1 |
Cailmail, S; Durand, F; Gadano, A; Hadengue, A; Lebrec, D; Moreau, R; Sogni, P; Soupison, T; Vachiery, F; Valla, D; Yang, S | 1 |
Becker, PU; Bendtsen, F | 1 |
Cailmail, S; Lebrec, D; Moreau, R; Valla, D | 1 |
Auroux, J; Barbier, JP; Cellier, C; Cervoni, JP; Gadano, A; Landi, B; Lecomte, T; Simon, C | 1 |
Decaux, G; Namias, B; Prospert, F; Soupart, A | 1 |
Huvar, I; Jelínek, J; Pilka, L; Roztocil, A | 1 |
Renner, EL | 1 |
Bandi, JC; Bernadich, C; Bosch, J; Melin, P | 1 |
Bosch, J; Jenkins, SA; Lebrec, D | 1 |
Avgerinos, A | 1 |
Paillard, F; Stéphan, F | 1 |
Calès, P; Kaassis, M; Oberti, F; Pilette, C; Rifflet, H; Trouvé, R; Veal, N | 1 |
Chan, CC; Chang, FY; Chu, CJ; Hou, MC; Lee, FY; Lee, SD; Lin, HC; Tai, CC; Wang, SS; Wu, SL | 1 |
Decaux, G; Hannotier, P; Musch, W; Prospert, F; Soupart, A | 1 |
Durand, F; Erlinger, S; Gadano, A; Giostra, E; Hadengue, A; Lebrec, D; Moreau, R; Valla, D | 1 |
Lebrec, D | 5 |
Bosch, J; Escorsell, A | 1 |
de Franchis, R | 2 |
Becker, U; Bendtsen, F; Hansen, EF; Henriksen, JH; Højgaard, L; Madsen, J; Schroeder, TV; Strandberg, C | 1 |
Chern, JW; Hong, CY; Huang, YT; Lin, HC; Lin, LC | 1 |
Becker, U; Bendtsen, F; Hansen, EF; Henriksen, JH; Højgaard, L; Madsen, J; Rasmussen, A; Schroeder, TV; Strandberg, C | 1 |
Bertrand, M; Brabant, S; Coriat, P; Eyraud, D; Fléron, MH; Gilles, G; Nathalie, D | 1 |
Grace, ND; Nader, A | 1 |
Combier, E; de Pouvourville, G; Joseph, A; Letoumelin, P; Levacher, S; Pourriat, JL | 1 |
Landström, G; Lindblom, B; Lundmark, K; Norén, H; Wallin, A | 1 |
Chung, SC; Lee, YT; Sung, JJ; Yu, AL; Yung, MY | 1 |
Fernández, J; Hinojosa, J; Llorca, P; Molés, JR; Primo, J | 1 |
Bolondi, L; Donati, G; Gaiani, S; Masi, L; Piscaglia, F | 1 |
Bertrand, M; Brabant, SM; Coriat, P; Eyraud, D | 1 |
Cannella, G; Ravetti, JL; Rolla, D | 1 |
Chang, FC; Chen, KJ; Hong, CY; Huang, YT; Lin, HC; Lin, JG | 1 |
Krizko, M | 1 |
Jelínek, J; Koudelka, M; Sieglová, V | 1 |
Dimitrov, A; Gŭrchev, E; Karag'ozov, I; Krŭsteva, K; Lazarova, L; Nikolov, A | 1 |
Becker, U; Bendtsen, F; Brinch, K; Hansen, EF; Henriksen, JH; Møller, S | 2 |
Dimitrov, A | 1 |
Argonz, J; Bildozola, M; Kravetz, D; Romero, G; Suarez, A; Terg, R | 1 |
Bosch, J | 1 |
Burroughs, A; Dagher, L; Marley, R; Moore, K; Patch, D | 1 |
Chan, CC; Chang, FY; Chu, CJ; Lee, FY; Lee, SD; Lin, HC; Wang, SS; Wu, SL | 1 |
Arroyo, V; Bataller, R; Cárdenas, A; Ginès, P; Jiménez, W; Mas, A; Navasa, M; Rodés, J; Salmerón, JM; Sort, P; Uriz, J | 1 |
Arroyo, V; Cárdenas, A; Ginès, P; Uriz, J | 1 |
Albillos, A; Bañares, R; Bernard, B; Bosch, J; Calès, P; Escorsell, A; Pateron, D; Planas, R; Ruiz del Arbol, L; Vinel, JP | 1 |
Berkelmans, I; Bourienne, A; Duhamel, C; Mauillon, J; Tranvouez, JL | 1 |
Jalan, R; Kapoor, D | 1 |
Chan, CC; Chang, FY; Chen, CT; Chu, CJ; Hou, MC; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Wang, SS; Wu, SL | 2 |
Adamcová, P; Bartos, P; Popelka, P; Struppl, D | 1 |
Adkisson, W; Cello, JP; Corley, DA; Kerlikowske, K; Ko, WF | 1 |
Doust, J; Ioannou, G; Rockey, DC | 2 |
Chang, FY; Hou, MC; Lee, FY; Lee, SD; Lee, WC; Lin, HC; Yang, YY | 1 |
Vlavianos, P; Westaby, D | 1 |
Bertrand, M; Boccara, G; Coriat, P; Godet, G; Medel, J; Van de Steen, E | 1 |
Calès, P; Kaassis, M; Moal, F; Oberti, F; Roy, E; Saumet, JL; Trouvé, R; Veal, N; Vuillemin, E; Wang, J | 1 |
Sirakov, M | 1 |
Bosch, J; D'Ocon, P; Esplugues, JV; García-Zaragoza, E; Martínez-Cuesta, MA; Melin, P; Noguera, MA; Ramírez, MC | 1 |
Bone, HG; Meyer, J; Scharte, M; Van Aken, H | 1 |
Andreasen, RB; Ejlersen, E; Ingerslev, J; Melsen, T; Vilstrup, H | 1 |
Asselah, T; Bernard, B; Binn, M; Condat, B; de Kerguenec, C; Grangé, JD; Lebrec, D; Moreau, R; Pessione, F; Poynard, T; Valla, D | 1 |
Abergel, A; Bernard, B; Blanc, P; Bronowicki, JP; Butel, J; Cadranel, JF; Cervoni, JP; Coumaros, D; Ducloux, S; Duhamel, C; Durand, F; Fleurot, C; Giostra, E; Gurnot, D; Hadengue, A; Halimi, C; Ichaï, P; Lebrec, D; Levy, S; Moreau, R; Nouel, O; Pariente, A; Pauwels, M; Perarnau, JM; Platek, A; Poynard, T; Renard, P; Rivoal, M; Roche, J; Samuel, D; Scribe-Outtas, M; Valla, D | 1 |
Bertrand, M; Brun, L; Coriat, P; Gourdin, M; Meersschaert, K; Mouren, S; Riou, B | 1 |
Clapp, L; O'Brien, A; Singer, M | 1 |
Bernard, B; Bonnard, P; Cadranel, JF; Demontis, R; di Martino, V; Fievet, P; Halimi, C; Henry-Biabaud, E; Mathurin, P; Mofredj, A; Opolon, P; Poynard, T | 1 |
Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lee, WC; Lin, HC; Yang, YY | 1 |
Arroyo, V | 1 |
Calahorra, B; Ginès, P; Ortega, R | 1 |
Moreau, R | 1 |
Barrière, E; Bernuau, J; Colle, I; Durand, F; Lebrec, D; Moreau, R; Pessione, F; Rassiat, E; Valla, DC | 1 |
Arroyo, V; Bataller, R; Calahorra, B; Cárdenas, A; De Las Heras, D; Ginès, P; Guevara, M; Jiménez, W; Ortega, R; Rodés, J; Uriz, J | 1 |
Singh Ranger, G | 1 |
Barrière, E; Bernuau, D; Chauvelot-Moachon, L; Dargère, D; Guimont, MC; Lardeux, B; Lebrec, D; Moreau, R; Poirel, O; Tazi, KA; Urbanowicz, W | 1 |
Bone, HG; Sielenkämper, AW; Van Aken, H; Westphal, M | 1 |
Jalan, R; Mookerjee, RP; Sen, S | 1 |
Alessandria, C; Barletti, C; Fadda, M; Marzano, A; Rizzetto, M; Venon, WD | 1 |
Doust, J; Ioannou, GN; Rockey, DC | 1 |
Baik, SK; Choi, YJ; Jeong, PH; Kim, HS; Kim, MY; Kim, ND; Kim, YJ; Kwon, SO; Lee, DK; Park, DH; Park, JW | 1 |
Chawla, A; Garg, R; Gupta, R; Jain, M; Sarin, SK; Solanki, P | 1 |
Alquier, P; Asfar, P; Calès, P; Croquet, V; Douay, O; Gallois, Y; Moal, F; Oberti, F; Pierrot, M; Saumet, JL; Veal, N | 1 |
Landry, DW; Oliver, JA | 1 |
Ball, C; Bone, HG; Borgulya, R; Sielenkämper, AW; Stubbe, H; Van Aken, H; Westphal, M | 1 |
Baik, SK; Choi, YJ; Kim, HS; Kim, MY; Kim, YJ; Kwon, SO; Lee, DK; Park, DH; Park, JW | 1 |
De Keulenaer, BL; Stephens, DP | 1 |
Antoniades, C; Auzinger, G | 1 |
Asfar, P | 1 |
Rössle, M | 1 |
D'Amico, G; Pagliaro, L; Pietrosi, G; Tarantino, I | 2 |
Bertrand, M; Boccara, G; Coriat, P; Dufresne, E; Godet, G; Ouattara, A; Riou, B | 1 |
Hulek, P; Lata, J; Vanasek, T | 1 |
Broelsch, CE; Frühauf, NR; Lang, H; Malagó, M; Saner, FH; Schäfers, RF | 1 |
De Santis, A; Giorgi, A; Laviano, A; Riggio, O; Rossi-Fanelli, F; Vaccaro, F | 1 |
Ferguson, JW; Hayes, PC; Tripathi, D | 1 |
Bénard, P; Daccache, G; Fellahi, JL; Gérard, JL; Mourgeon, E | 1 |
Döhler, KD; Forssmann, K; Mentz, P; Staritz, M; Walker, S | 1 |
De Keulenaer, BL; Jolley, DH; Potter, A; Stephens, DP | 1 |
Alessandria, C; Arroyo, V; Garcia-Valdecasas, JC; Ginès, P; Guevara, M; Navasa, M; Ortega, R; Ozdogan, O; Restuccia, T; Rimola, A; Rodés, J | 1 |
Coluzzi, F; Conti, G; Cortese, G; De Gaetano, A; Morelli, A; Orecchioni, A; Pelaia, P; Pietropaoli, P; Rocco, M; Vernaglione, E | 1 |
Hayes, PC; Stanley, AJ; Therapondos, G | 1 |
Fernández-Sanmartín, M; González-Alonso, N; Martinón-Sánchez, JM; Martinón-Torres, F; Rodríguez-Núñez, A | 1 |
Davies, NA; Hayes, PC; Jalan, R; Lee, A; Mookerjee, RP; Shawcross, DL; Williams, R | 1 |
Booth, RA; Peters, MJ; Petros, AJ | 1 |
Adam, M; Barzilay, Z; Leibovitch, L; Matok, I; Paret, G; Rubinshtein, M; Vardi, A | 1 |
Abraldes, JG; Bosch, J; Dell'Era, A | 1 |
Bone, HG; Ertmer, C; Van Aken, H; Westphal, M | 3 |
Berg, RA | 1 |
Aberg, M; Jönsson, K; Mzezewa, S; Salemark, L; Sjöberg, T | 1 |
Biglarnia, R; Broelsch, CE; Frühauf, NR; Kavuk, I; Lang, H; Malagó, M; Saner, F; Schäfers, RF | 1 |
Factor, P; Mutlu, GM | 1 |
Allen, EK; Bradley, PG; Menon, DK | 1 |
Plessier, A | 1 |
Bendtsen, F; Hansen, EF; Henriksen, JH; Kiszka-Kanowitz, M; Møller, S | 1 |
Aksoy, N; Akyuz, F; Besisik, F; Boztas, G; Cakaloglu, Y; Danalioglu, A; Demir, K; Karaca, C; Kaymakoglu, S; Mungan, Z; Okten, A; Ozdil, S | 1 |
Akkus, N; Altintas, E; Gen, R; Helvaci, MR; Oguz, D; Sezgin, O | 1 |
Lubanda, H; Novák, F; Onderková, R; Zák, A | 1 |
Jørgensen, VL; Perner, A; Waldau, T | 1 |
Ginès, P; Guevara, M; Terra, C; Torre, A | 1 |
Bardet, S; Charbonnel, B; Coffin, C; Lecomte, P; Lefebvre, H; Mahoudeau, J; Reznik, Y; Rodien, P; Rohmer, V; Tabarin, A | 1 |
Chan, CC; Chang, FY; Chen, YC; Hou, MC; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Lu, RH; Wang, SS; Wu, SL | 1 |
Bambara, LM; Bassetto, AM; Corrocher, R; De Franceschi, L; Favalli, NM; Mansueto, G | 1 |
Albanèse, J; Chaabane, W; Delmas, A; Garnier, F; Leone, M; Martin, C | 1 |
Kam, PC; Williams, S; Yoong, FF | 1 |
Klebl, F | 1 |
Conti, G; De Gaetano, A; Morelli, A; Orecchioni, A; Pelaia, P; Picchini, U; Pietropaoli, P; Reale, C; Rocco, M; Tritapepe, L | 1 |
Boccara, G; Coriat, P; Landi, M; Le Manach, Y; Lecomte, P; Leguen, M; Ouattara, A; Riou, B | 1 |
Bihari, D; Boyle, M; Kurtovic, J; Riordan, SM | 1 |
Bone, HG; Ertmer, C; Sielenkämper, AW; van Aken, H; Westphal, M | 1 |
Cheng, KH; Chu, CS; Lai, WT; Lee, HC; Lee, KT; Lee, MY; Sheu, SH; Su, HM | 1 |
Albicini, M; Asfar, P; Bracht, H; Brückner, UB; Ehrmann, U; Hauser, B; Iványi, Z; Kick, J; Radermacher, P; Vogt, J; Wachter, U | 1 |
Traber, DL; Westphal, M | 1 |
Aracil, C; Balanzó, J; González, B; López-Balaguer, JM; Miñana, J; Planella, M; Villanueva, C | 1 |
Baik, SK; Chang, SJ; Jeong, PH; Ji, SW; Kim, HS; Kim, YJ; Kwon, SO; Lee, DK; Lee, SS; Park, JW; Yoo, BS | 1 |
Albanèse, J; Delmas, A; Leone, M; Martin, C; Rousseau, S | 1 |
Adam, M; Barzilay, Z; Efrati, O; Leibovitch, L; Matok, I; Paret, G; Rubinshtein, M; Vard, A; Vishne, T | 1 |
Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Yang, YY | 1 |
Aguilar Aguilar, G; Badenes Quiles, R; Belda Nacher, FJ; Lloréns Herrerías, J | 1 |
Boyd, R; Butler, J | 1 |
Economou, M; Kalambokis, G; Katsaraki, A; Konstantinos, P; Pappas, C; Paraskevi, K; Tsianos, EV | 1 |
Albanèse, J; Boyle, WA; Charvet, A; Delmas, A; Leone, M; Martin, C | 1 |
Boerma, EC; Ince, C; van der Voort, PH | 1 |
Albanèse, J; Delmas, A; Leone, M; Martin, C | 1 |
Bracco, D; Dubois, MJ | 1 |
Elisaf, M; Kalambokis, G; Milionis, H; Tsianos, EV | 1 |
Holmes, CL | 1 |
Brandstrup, KB; Fernández, C; López-Herce, J; Rodríguez-Núñez, A; Zeballos, G | 1 |
Angeli, P; Antona, C; Brollo, L; Cillo, U; Craighero, R; Fasolato, S; Franchin, M; Gatta, A; Guarda, S; Merkel, C; Miola, E; Piccolo, F | 1 |
Kumar, R; Nain, CK; Sharma, AK; Singh, B; Singh, V | 1 |
Gil-Antón, J; Hernández, A; López-Herce, J; Rey, C; Rodríguez-Núñez, A | 1 |
Arntz, RH; Dünser, MW; Krismer, AC; Lienhart, HG; Lindner, KH; Mayr, VD; Stadlbauer, KH; Wenzel, V | 1 |
Lebrec, D; Moreau, R | 2 |
McNamee, JJ; Michalek, P; Trainor, D | 1 |
Jaffer, U; McAuley, D | 1 |
Bello, G; de Talancé, N; Dewachter, P; Jouan-Hureaux, V; Lartaud, I; Longrois, D; Mertes, PM | 1 |
Borrego, R; Bustinza, A; Carrillo, A; López-Herce, J; Mencía, S; Sancho, L | 1 |
Leone, M; Martin, C | 2 |
May, G; Musa, D | 1 |
Calès, P; Dib, N; Oberti, F | 1 |
Akyuz, F; Besisik, F; Cakaloglu, Y; Ibrisim, D; Karadag, A; Mungan, Z; Okten, A; Ozdil, S | 1 |
Choi, JH; Han, WS; Hyun, JH; Jung, SW; Kim, CD; Kim, MJ; Lee, HS; Lee, JS; Lee, SW; Ryu, HS | 1 |
Halpern, EJ | 1 |
Baik, SK; Chang, SJ; Han, KH; Kim, HS; Kim, JW; Kim, SH; Kim, YJ; Kwon, SO; Lee, DK; Lee, SS; Park, JW; Um, SH | 1 |
Ellenberger, C; Giostra, E; Licker, M; Mentha, G | 1 |
Dixit, V; Fabrizi, F; Martin, P | 1 |
Choi, JH; Chun, HJ; Hyun, JJ; Jeen, YT; Keum, BR; Kim, CD; Kim, YH; Kim, YS; Lee, HS; Lee, SW; Park, S; Ryu, HS; Seo, YS; Um, SH | 1 |
Cho, SB; Choi, SK; Joo, YE; Kim, HS; Kim, SJ; Lee, JS; Lee, WS; Park, CH; Park, KJ; Rew, JS | 1 |
Gerbes, AL; Gülberg, V | 1 |
Christensen, E; Gluud, LL; Kjaer, MS | 1 |
de Jager, CP; Dünser, MW; Rozendaal, FW; Wenzel, V; Zuidema, X | 1 |
Borer, A; Gurman, GM; Kesslin, J; Klein, M; Koyfman, L; Weksler, N | 1 |
Badruddin, AH; Chaudhry, MA; Rasool, G | 1 |
Jennings, HR; Pesaturo, AB; Voils, SA | 1 |
Augarten, A; Efrati, O; Leibovitch, L; Matok, I; Paret, G; Rubinshtein, M; Vardi, A | 1 |
Almeida, JA; Bihari, D; Cranney, GB; Galhenage, S; Kim, R; Liu, J; Riordan, SM; Thomas, PS; Wegner, EA | 1 |
Araújo, LV; Freitas, GG; Martins, GA; Salluh, JI; Santino, MS; Verdeal, JC | 1 |
Arroyo, V; Gerbes, A; Ginès, P; Salerno, F; Wong, F | 1 |
Lange, M; Van Aken, H; Westphal, M | 2 |
Dunwoodie, E; Jowett, S | 1 |
Altorjay, I; Papp, M; Tornai, I; Udvardy, M; Vitális, Z | 1 |
Ertmer, C; Lange, M; Morelli, A; Westphal, M | 1 |
Bjerg, J; Gilsaa, T; Hansen, M | 1 |
Bhatt, A; Burroughs, A; Connolly, M; Currie, CJ; McEwan, P; Tetlow, A; Wechowski, J; Woehl, A | 1 |
Alessandria, C; Balzola, F; Cerenzia, MT; Debernardi-Venon, W; Martini, S; Marzano, A; Morgando, A; Ottobrelli, A; Rizzetto, M; Todros, L | 1 |
Favier, JC; Mertes, PM; Plancade, D; Rocq, N; Steiner, T | 1 |
Hayes, PC; Plevris, JN | 1 |
Bone, HG; Bröking, K; Ertmer, C; Hucklenbruch, C; Koehler, G; Lange, M; Morelli, A; Traber, DL; Van Aken, H; Westphal, M | 1 |
Dethloff, T; Eefsen, M; Frederiksen, HJ; Hansen, BA; Hauerberg, J; Larsen, FS | 1 |
Zuberi, BF | 1 |
Gortner, L; Gottschling, S; Meyer, S | 1 |
Aken, HV; Bone, HG; Böwering, N; Bröking, K; Ertmer, C; Lange, M; Luecke, M; Morelli, A; Rehberg, S; Traber, DL; Westphal, M | 1 |
Angus, PW; Gow, PJ; Testro, AG; Wongseelashote, S | 1 |
Cazzaniga, M; Gobbo, G; Salerno, F | 1 |
David, M; Di Marco, JN; Lagier, P; Martin, C; Michel, F; Nicaise, C; Thomachot, L; Vialet, R | 1 |
Cullen, G; Donnellan, F; Hegarty, JE; McCormick, PA | 1 |
de Jager, CP; Zuidema, X | 1 |
Huber, W; Reindl, W; Schmid, RM; Umgelter, A | 1 |
Bertino, G; Castellino, P; Cosimo, BM; Ignaccolo, L; Malaguarnera, M; Neri, S; Pulvirenti, D; Siringo, S | 1 |
Benhaim, A; Contesse, V; Joubert, M; Kong, LC; Lefebvre, H; Louiset, E; Mittre, H; Rego, JL; Reznik, Y | 1 |
Albanèse, J; Antonini, F; Blasco, V; Geissler, A; Leone, M; Martin, C | 1 |
Bendtsen, F; Henriksen, JH; Holstein-Rathlou, NH; Krag, A; Larsen, FS; Møller, S | 1 |
Ertmer, C; Lange, M; Westphal, M | 1 |
Baghai, A; Gortner, L; Gottschling, S; McGuire, W; Meyer, S | 1 |
Alhan, E; Celik, U; Sertdemir, Y; Yapicioglu, H; Yildizdas, D | 1 |
Bernardi, M; Bracci, E; Cappa, FM; Casadio, R; Di Micoli, A; Fontana, K; Trevisani, F; Zambruni, A | 1 |
Kalambokis, G; Korantzopoulos, P; Nikas, SA; Theodorou, A; Tsianos, EV | 1 |
Fabrizi, F; Martin, P; Messa, P | 1 |
Filippi, L; Fiorini, P; Poggi, C; Serafini, L | 1 |
Dünser, M; Ertmer, C; Lange, M; Morelli, A; Pietropaoli, P; Rehberg, S; Van Aken, H; Westphal, M | 1 |
Bai, Y; Gao, J; Li, ZS; Zou, DW | 1 |
Aracil, C; Colomo, A; Guarner, C; Villanueva, C | 1 |
de Franchis, R; Dell'Era, A; Iannuzzi, F | 1 |
Blaha, J; Cermak, T; Kotulak, T; Kunstyr, J; Lincova, D; Lips, M; Matias, M; Mourad, M; Rubes, D; Stritesky, M | 1 |
Kulicki, P; Matuszkiewicz-Rowińska, J; Niemczyk, L; Niemczyk, M; Niemczyk, S; Pyrza, M; Romejko-Ciepielewska, K | 1 |
Arroyo, V; Díaz, F; Fábrega, E; Ginès, P; Guevara, M; Martín-Llahí, M; Monescillo, A; Pépin, MN; Rodés, J; Soriano, G; Terra, C; Torre, A | 1 |
Appenrodt, B; Blei, A; Boyer, T; Garcia-Tsao, G; Gülberg, V; Regenstein, F; Rossaro, L; Sanyal, AJ; Sigal, S; Teuber, P | 1 |
Groszmann, RJ; Lim, JK | 1 |
Coleman, N; Miller, A | 1 |
Kumar, A; Sarin, SK; Sharma, P; Shrama, BC | 1 |
Cho, DH; Ha, JS; Oh, JE; Shim, SG; Yu, GJ | 1 |
Procházka, V; Sincl, F; Urbánek, K; Urge, J | 1 |
Chini, B; Durroux, T; Guillon, G; Manning, M; Mouillac, B; Stoev, S | 1 |
Kalambokis, GN; Tsianos, EV | 1 |
Ertmer, C; Morelli, A; Westphal, M | 1 |
Döhler, KD; Meyer, M | 1 |
Singer, M | 1 |
Ertmer, C; Rehberg, S; Westphal, M | 1 |
Bendtsen, F; Holstein-Rathlou, NH; Krag, A; Møller, S; Pedersen, EB | 1 |
Ahn, SH; Baik, SK; Cho, M; Cho, SH; Choi, SK; Hahn, T; Han, KH; Heo, J; Kim, BI; Kim, JH; Kim, YH; Lee, HW; Park, SH; Seo, YS; Um, SH; Yoo, TW; Yu, SK | 1 |
Bendtsen, F; Borup, T; Krag, A; Møller, S | 1 |
Broelsch, CE; Canbay, A; Gerken, G; Saner, FH | 1 |
Aractingi, S; Barete, S; Chosidow, O; Frances, C; Izzedine, H; Khosrotehrani, K; Mégarbané, H; Moguelet, P | 1 |
Denzer, UW; Geibler, M; Glowa, F; Lohse, AW; von Kalckreuth, V | 1 |
Alessandria, C; Carello, M; Ceretto, S; Debernardi-Venon, W; Marzano, A; Rizzetto, M | 1 |
Abbas, Z; Abid, S; Azam, Z; Hamid, S; Jafri, W; Mumtaz, K; Salih, M; Shah, HA | 1 |
Colson, PH; Fort, A; Guillon, G; Murat, B; Richard, S; Ryckwaert, F; Virsolvy, A | 1 |
Andrea, M; Ertmer, C; Morelli, A; Rehberg, S; Westphal, M | 1 |
Barzilay, Z; Leibovitch, L; Levy, A; Matok, I; Mishali, D; Paret, G; Rubinshtein, M; Vardi, A | 1 |
Chang, YH; Hsieh, MC; Hsin, SC; Lin, KD; Shin, SJ; Yen, FC | 1 |
Ertmer, C; Köhler, G; Lange, M; Moll, K; Morelli, A; Rehberg, S; Schlack, K; Spiegel, HU; Su, F; Van Aken, H; Vincent, JL; Westphal, M | 1 |
Chan, HH; Chen, WC; Cheng, LC; Lin, CK; Lo, GH; Tsai, WL; Tsay, FW; Wang, HM; Yu, HC | 1 |
Dixit, V; Fabrizi, F; Martin, P; Messa, P | 1 |
Meyer, S | 1 |
Lopez-Herce, J; Martínez, V; Rodriguez-Nunez, A | 1 |
Auler Júnior, JO; Carmona, MJ; D'Albuquerque, LA; Holms, CA; Machado, MC; Nani, RS; Rocha Filho, JA; Rocha, JP; Sá Malbouisson, LM | 1 |
David, A; Giardina, M; Lentini, S; Messina, R; Noto, A; Risitano, DC; Versaci, A | 1 |
Carrillo, A; Gil-Antón, J; López-Herce, J; Morteruel, E; Rodríguez-Núñez, A | 1 |
Caresta, E; Grossi, R; Midulla, F; Moretti, C; Papoff, P; Versacci, P | 1 |
Gerbes, AL; Gülberg, V; Huber, E | 1 |
Bachetoni, A; Cecchini, V; D'Alessandro, M; Ertmer, C; Lange, M; Morelli, A; Orecchioni, A; Pietropaoli, P; Rehberg, S; Van Aken, H; Westphal, M | 1 |
Cazzaniga, M; Salerno, F | 1 |
Atsukawa, M; Fukuda, T; Harimoto, H; Kanazawa, H; Katakura, T; Kidokoro, H; Kimura, Y; Matsushita, Y; Nakatsuka, K; Narahara, Y; Sakamoto, C; Taki, Y | 1 |
Alvarez, M; Alvarez, V; Cruces, MJ; Feal, C; García-Cruz, A; Posada, C | 1 |
Bendtsen, F; Krag, A | 1 |
Schepke, M | 1 |
Ertmer, C; Morelli, A; Pietropaoli, P; Westphal, M | 1 |
Leone, M | 1 |
Agarwal, AK; Puri, AS; Sachdeva, S; Tyagi, P | 1 |
Arroyo, V; Baccaro, ME; Ginès, P; Guevara, M; Marinelli, M; Martín-Llahi, M; Nazar, A; Pepin, MN; Pereira, GH; Solá, E; Terra, C | 1 |
Lo, GH | 1 |
Duan, ZJ; Liu, LN; Wang, YD; Yang, N; Zhang, ZF; Zhao, G | 1 |
Burroughs, AK; Cholongitas, E; Leandro, G; Marelli, L; Patch, D; Samonakis, D; Senzolo, M; Thalheimer, U; Triantos, CK | 1 |
Asfar, P; Calès, P; Oberti, F; Radermacher, P | 1 |
Kasturi, KS; Mittal, S; Sagi, SV; Sood, GK | 1 |
Angus, PW; Testro, AG | 1 |
Bendtsen, F; Hobolth, L; Krag, A; Møller, S | 1 |
Bellón, JM; del Castillo, J; Fernández, B; López-Herce, J; Mencía, S; Rodríguez-Núñez, A; Solana, MJ; Urbano, J | 1 |
Chun, HJ; Hyun, JJ; Jeen, YT; Keum, B; Kim, CD; Lee, KG; Ryu, HS; Seo, YS; Um, SH; Yim, HJ | 1 |
Demirjian, S; Dobre, M; Navaneethan, SD; Sehgal, AR | 1 |
Bendtsen, F; Henriksen, JH; Krag, A; Møller, S | 1 |
Bendtsen, F; Henriksen, JH; Krag, A; Mortensen, C; Møller, S | 1 |
Bouix, J | 1 |
Ahmed, E; El-Menyar, A; Elbadri, ME; Elzouki, AN; Gurbanna, BA; Imam, YZ | 1 |
Carneiro, AH; Póvoa, P | 1 |
Ackermann, O; Bernard, O; Durand, P; Habes, D; Jacquemin, E; Yousef, N | 1 |
Azpilicueta Idarreta, M; Frías Pérez, MA; Ibarra de la Rosa, I; Jaraba Caballero, S; Tejero Hernández, MA; Ulloa Santamaría, E | 1 |
Al-Naeeb, Y; Aravinthan, A; Richardson, P | 1 |
Herrlinger, K | 1 |
Abou Abbass, A; Fleming, JN | 1 |
Baltayiannis, G; Kalambokis, GN; Katsanou, A; Pappas, K; Tsianos, EV | 1 |
Baltayiannis, G; Fotopoulos, A; Kalambokis, G; Pakou, B; Tsianos, EV; Tsiouris, S | 1 |
Lammert, F; Zimmer, V | 1 |
Erkek, N; Hizli, S; Karacan, CD; Senel, S | 1 |
Bernardi, M; Bevilacqua, V; Caraceni, P; Mirici, F; Montanari, G; Pinna, AD; Santi, L | 1 |
Gaboli, M; Gil-Antón, J; López-Herce, J; Milano, G; Oulego-Erroz, I; Pérez-Caballero, C; Rodríguez-Núñez, A | 1 |
Kim, JW | 1 |
Arroyo, V; Bosch, J; Escorsell, A; Fagundes, C; Fernández, J; Ginès, P; González-Abraldes, J; Guevara, M; Lens, S; Martín-Llahí, M; Mas, A; Pavesi, M; Pereira, G; Solà, E | 1 |
Kampmeier, TG; Lange, M; Rehberg, S; Westphal, M | 1 |
Bruns, T; Fritzenwanger, M; Herrmann, A; Lehmann, M; Stallmach, A | 1 |
Ahmed, MH; Khalil, AA; Magan, AA | 1 |
Catarzi, S; Daniotti, M; Filippi, L; Fiorini, P; Gozzini, E; Pagliai, F | 1 |
Bendtsen, F; Krag, A; Møller, S; Pedersen, EB | 1 |
Bexon, AS; Blei, A; Boyer, TD; Carl, D; Garcia-Tsao, G; Sanyal, AJ; Teuber, P | 1 |
Ertmer, C; Kampmeier, TG; Köhler, G; Lange, M; Morelli, A; Rehberg, S; Van Aken, H; Westphal, M | 1 |
Chawla, Y; Rajekar, H | 1 |
Gortner, L; Gottschling, S; McGuire, W; Meyer, S; Mohammed Shamdeen, G | 1 |
Bendtsen, F; Krag, A; Møller, S | 1 |
Ell, C; May, A | 1 |
Sarin, SK; Sharma, P; Singh, S | 1 |
Maybauer, DM; Maybauer, MO | 1 |
Bastagli, L; Bernardi, M; Borghi, C; Buccione, D; Degli Esposti, D; Di Micoli, A; Santi, V; Trevisani, F | 1 |
Angeli, P; Boccagni, P; Boscato, N; Cavallin, M; Cillo, U; Fasolato, S; Gatta, A; Morando, F; Piano, S; Zanus, G | 1 |
Abdelaal, A; Aboulfetouh, F; Bahaa, M; El-Meteini, M; Fathy, M; Hassanien, A; Mostafa, I; Mukhtar, A; Obayah, G; Rady, M; Saeed, H; Salah, M; Samy, M | 1 |
Di Russo, A; Donati, A; Ertmer, C; Morelli, A; Orecchioni, A; Pelaia, P; Pietropaoli, P; Rehberg, S; Westphal, M | 1 |
Ginès, P | 3 |
Alahdab, Y; Ari, E; Arikan, H; Asicioglu, E; Atakan, A; Cakalagaoglu, F; Kahveci, A; Kedrah, AE; Kocak, H; Macunluoglu, B; Ozener, C; Tuglular, S; Yilmaz, Y | 1 |
Cooper, TB; Dasta, JF; Mazur, JE | 1 |
Biecker, E | 1 |
Kalambokis, GN; Mouzaki, A; Pappas, K; Rodi, M; Tsianos, EV | 1 |
Abid, S; Hamid, S; Jafri, W; Kamani, L; Mumtaz, K; Shah, HA | 1 |
Farber, E; Gershovich, M; Soboh, S; Yefet, E | 1 |
Herlenius, G; Oltean, M | 1 |
Aboulfetouh, F; Elmeteini, M; Hamza, A; Mukhtar, A; Salah, M | 1 |
Kalambokis, GN; Pappas, K; Tsianos, EV | 2 |
Sarin, SK; Sharma, P | 1 |
Chen, PH; Chiou, YY; Kao, WY; Wu, WC | 1 |
Hasper, D; Jörres, A | 1 |
Appenrodt, B; Bexon, AS; Boyer, TD; Garcia-Tsao, G; Gülberg, V; Regenstein, F; Rossaro, L; Sanyal, AJ; Sigal, S; Teuber, P | 1 |
Angeli, P; Cavallin, M; Morando, F; Piano, S | 1 |
Erdem, S; Horoz, OO; Yilidzdaş, D | 1 |
Botticelli, L; D'Egidio, A; Di Russo, A; Donati, A; Ertmer, C; Kampmeier, T; Landoni, G; Lombrano, MR; Morelli, A; Orecchioni, A; Pietropaoli, P; Rehberg, S; Valentini, A; Westphal, M; Zangrillo, A | 1 |
Fukui, H; Kanazawa, H; Kokubu, S; Maruyama, H; Masaki, N; Matsuzaki, Y; Mochida, S; Narahara, Y; Okita, K; Sakamoto, C; Sumino, Y; Uemura, M; Yokosuka, O | 1 |
Alexander, GJ; Srivastava, B | 1 |
Cioffi, O; D'Adamo, G; Fimiani, B; Guardia, DD; Izzi, A; Pagano, A; Puoti, C; Tagliamonte, MR | 1 |
Atilla, R; Bayram, B; Hocaoglu, N; Kalkan, S | 1 |
Abbas, Z; Abid, S; Azam, Z; Hamid, S; Jafri, W; Salih, M; Shah, H | 1 |
Aagaard, NK; Bendtsen, F; Grønbaek, H; Hansen, JB; Møller, S; Schmidt, L | 1 |
Chan, AC; Chan, SC; Cheung, TT; Chok, KS; Fan, ST; Fung, JY; Lo, CM; Sharr, WW | 1 |
Bhalla, A; Chawla, Y; Choudhary, NS; Ghosh, S; Kumar, P; Nain, CK; Sharma, AK; Sharma, N; Singh, B; Singh, V | 1 |
Bailey, M; Bellomo, R; Calzavacca, P; Ishikawa, K; May, CN; Wan, L | 1 |
Andrade, L; Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC | 1 |
Choi, JH; Chung, HS; Hong, SH; Lee, JM; Park, CS; Park, JH | 1 |
Fagundes, C; Ginès, P | 1 |
Adams, P; Beaton, M; Boyce, E; Chande, N; Levstik, M; Mrkobrada, M; Wells, M | 1 |
Doubek, J; Dudra, J; Kantorová, I; Radvan, M; Radvanova, J; Scheer, P; Svoboda, P | 1 |
Wong, F | 2 |
Lu, YY; Wei, KC; Wu, CS | 1 |
Dworzynski, K; Higgins, B; Kelsey, A; Palmer, K; Pollit, V | 1 |
Angeli, P; Gines, P | 1 |
Cardoso, SO; Damasceno, MC; Espósito, DC; Manetta, JA; Nassar, AP; Pereira, VG; Russell, JA; Serpa Neto, A | 1 |
Hua, F; Wang, X; Zhu, L | 1 |
Christensen, E; Christensen, K; Gluud, LL; Krag, A | 1 |
Davenport, A | 1 |
Camerini, PG; Radicioni, M; Troiani, S | 1 |
Bowen, D; Jones, C; Koorey, DJ; McCaughan, GW; Prakoso, E; Shackel, NA; Strasser, SI | 1 |
Bláha, V; Hrabovský, V; Hyšpler, R; Mendlová, A; Svagera, Z; Tichá, A; Zadák, Z | 1 |
Bai, CX; He, BM; Huang, YY; Sun, JY; Wang, JY | 1 |
Dimitrov, A; Georgiev, S; Sterev, A | 1 |
Chang, CY; Lin, HC; Lo, GH; Perng, DS; Tai, CM; Wang, HM | 1 |
Alegre, F; Banales, JM; Barbero, R; Carreño, N; Chang, HC; García, M; Herrero, I; Morán, A; Pérez-Vizcaíno, F; Prieto, J; Quiroga, J; Reboredo, M; Rodríguez-Ortigosa, CM; Sangro, B | 1 |
Corbett, C; Mangat, KS; Murphy, N; Olliff, S; Tripathi, D | 1 |
Biban, P; Gaffuri, M | 1 |
Ding, C; Fan, X; He, C; Li, J; Wu, X | 1 |
Hsu, SJ; Huang, HC | 1 |
Fernandes, CJ; Pammi, M; Rios, D; Rossano, J; Shivanna, B | 1 |
Agarwal, R; Bhalla, A; Chawla, YK; Choudhary, NS; Ghosh, S; Kumar, P; Sharma, AK; Sharma, N; Singh, B; Singh, V | 1 |
Bielawski, A; DeVito, SS; Devlin, JJ; Gutierrez, MA; Henao, J; Johnson, AS; Kotora, J; Littlejohn, LF; Nowak, G | 1 |
Alwaraqy, M; Fayed, N; Refaat, EK; Yassein, TE | 1 |
Cárdenas, A; Ginès, P; Solà, E | 1 |
Bendtsen, F; Egerod Israelsen, M; Gluud, LL; Krag, AA; Møller, S | 1 |
Ahmed, F; Ali, L; Haider, S; Hussain, Q; Liaquat, H; Shahbaz, S; Solangi, NM | 1 |
Lee, HJ; Oh, MJ | 1 |
Aytan, P; Erdemır, F; Kisacik, B; Köseoğlu, RD; Kutlutürk, F; Taşliyurt, T; Yelken, BM; Yilmaz, A | 1 |
Brito, J; Ferreira, AO; Rosa, L; Sousa, HT | 1 |
Kamble, U; Kumar, N; Patnaik, I; Sundriyal, D | 1 |
Das, D; Sidhu, SK | 1 |
Koike, MK; Martins, HS; Velasco, IT | 1 |
Krag, A; Poulsen, A | 1 |
Guntipalli, P; Rahimi, RS; Rockey, DC | 1 |
Chen, LT; Hwang, DY; Hwang, SJ; Kuo, MC; Wang, SS; Wang, YK | 1 |
Pasechnik, IN; Sal'nikov, PS | 1 |
Blokhina, NV; Pasechnik, IN | 1 |
An, H; Baik, SK; Cho, M; Hahn, T; Han, KH; Heo, J; Hwang, JS; Jang, BK; Kim, BI; Kim, HS; Kim, JH; Kim, MY; Park, JY; Park, SH; Park, SY; Seo, YS; Tak, WY; Um, SH; Yim, HJ | 1 |
Alessandria, C; Andrealli, A; Arroyo, V; Barreto, R; Elia, C; Fernández, J; Ginès, P; Graupera, I; Guevara, M; Pereira, G; Poca, M; Rodríguez, E; Sánchez, J; Solà, E; Soriano, G | 1 |
Choi, JH; Choung, RS; Hyun, JJ; Jung, SW; Kim, HR; Koo, JS; Lee, HJ; Lee, SJ; Lee, SW; Lee, YS; Ryu, JY; Yim, HJ; Yoon, EL | 1 |
Durand, F; Francoz, C | 1 |
Zamani, A | 1 |
Huang, Y; Qiu, H; Qiu, X; Xu, J; Yang, Y | 1 |
Beldi, G; Candinas, D; de Gottardi, A; Fahrner, R; Montani, M; Patsenker, E; Stickel, F; Stroka, D | 1 |
Lee, WC | 1 |
Huang, HC; Lee, FY; Lee, SD; Lin, HC; Tsai, MH; Wang, SS | 1 |
Berzigotti, A; Bosch, J | 1 |
Garrett, K; Gow, P; Majumdar, A; Robertson, M; Rumler, G; Testro, A | 1 |
Fortune, BE; Groszmann, RJ | 1 |
Botrán, M; Fernández, S; García, A; González, R; López, J; López-Herce, J; Solana, MJ; Urbano, J | 1 |
Chang, SS; Chen, SC; Huang, YC; Lee, CC; Lee, MT; Lee, SH; Yo, CH | 1 |
Herrera, I; Leiva-Salinas, M; Niveiro, M; Palazón, JM; Pascual, JC | 1 |
Baima, DC; Blefari, V; Carmo, LS; Rossi, MA; Troncon, LE; Zonta, V | 1 |
Cipollone, F; Efthymakis, K; Laterza, F; Massacesi, C; Milano, A; Neri, M; Tafuri, E | 1 |
Berg, RA; Meaney, PA; Nadkarni, VM | 1 |
Egerod Israelsen, M; Gluud, LL; Krag, A | 1 |
Peng, J; Wan, S; Wan, X; Zhu, Q | 1 |
Carrilho, FJ; D' Albuquerque, LA; Farias, AQ; Malbouisson, LM; Nassar Junior, AP | 1 |
An, H; Byun, KS; Chun, HJ; Jeen, YT; Jung, CH; Keum, B; Kim, CD; Kim, ES; Kim, JH; Kim, TH; Lee, HS; Ryu, HS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ; Yim, SY | 1 |
Cossu, AP; De Giudici, LM; Evangelista, M; Finco, G; Mura, P; Musu, M; Pasin, L; Puddu, D; Xanthos, T | 1 |
Elia, C; Ginès, P; Rodríguez, E; Solà Vergés, E | 1 |
Buğday, I; Gorkem, H; Karaman, A; Ozel Coskun, BD; Poyrazoğlu, OK; Senel, F | 1 |
Bailey, M; Bellomo, R; Eastwood, GM; Goodwin, MD; Schelleman, A; Schneider, AG | 1 |
Ahrens, J; Galle, PR; Götz, E; Marquardt, JU; Nguyen-Tat, M; Rey, JW; Schattenberg, J; Scholz-Kreisel, P; Sivanathan, V; Wörns, MA | 1 |
Abdelaal, A; Aboul-Fetouh, F; Bahaa, M; Dabous, H; El Meteini, M; Fathy, M; Hasanin, A; Mahmoud, I; Mukhtar, A; Obayah, G | 1 |
Angeli, P; Bernardi, M; Caraceni, P; Cavallin, M; Colletta, C; Di Giacomo, A; Fasolato, S; Fornasiere, E; Gatta, A; Kamath, PS; Merli, M; Morando, F; Piano, S; Ridola, L; Romanelli, RG; Salerno, F; Salinas, F; Toniutto, P | 1 |
Chen, XM; Li, T; Liu, L; Xiao, X; Yue, W; Zhen, D; Zhu, Y | 1 |
Han, J; Jin, CE; Li, DJ; Wang, C; Xiao, L; Yang, Z | 1 |
Bellón, JM; Botrán, M; Fernández, SN; García, A; González, R; López, J; López-Herce, J; Solana, MJ; Urbano, J | 1 |
Janicko, M; Jarcuska, P; Senajova, G; Veseliny, E | 1 |
Andrade, LC; Auler, JO; Borges, ES; Castro, LU; Dyson, A; Ida, KK; Malbouisson, LM; Otsuki, DA; Rocha Filho, JA; Sanches, TR; Sasaki, AT; Shimizu, MH; Smith, KJ | 1 |
Du, Y; Han, X; Liu, X; Ruan, X; Yang, J; Zhao, X | 1 |
Bhadoria, AS; Jindal, A; Maiwall, R; Sarin, SK | 1 |
Gupta, N; Kumar, A; Mittal, VV; Sarin, SK; Sharma, P | 1 |
Angeli, P; Cavallin, M; Fasolato, S; Marenco, S; Piano, S; Tonon, M | 1 |
Debernardi Venon, W; Marzano, A; Rizzetto, M; Sacco, M | 1 |
Arroyo, V; Barreto, R; Colmenero, J; Elia, C; Fernandez, J; Ginès, P; Henrique Pereira, G; Navasa, M; Pose, E; Rodriguez, E; Solà, E | 1 |
Avni, T; Grossman, A; Lador, A; Leibovici, L; Lev, S; Paul, M | 1 |
Jiang, D; Li, T; Liu, L; Wang, Y; Xiao, X; Zhang, J; Zhou, J; Zhu, Y | 1 |
Bharath, J; Ongley, D | 1 |
Celis, P; Rada, G | 1 |
Angus, P; Ardalan, Z; Gow, P; Testro, A; Vasudevan, A | 1 |
Belletti, A; Finco, G; Fominskiy, E; Hajjar, LA; Landoni, G; Monaco, F; Musu, M; Pasin, L; Saleh, O; Silvetti, S; Zangrillo, A | 1 |
Huang, Y; Wang, J; Wang, M | 1 |
Mattos, AA; Mattos, ÂZ; Ribeiro, RA | 1 |
Angeli, P; Benetti, G; Cavallin, M; Cillo, U; Fasolato, S; Frigo, AC; Gola, E; Morando, F; Piano, S; Romano, A; Rosi, S; Stanco, M; Sticca, A | 1 |
Ongley, D | 1 |
Boyer, TD; Frederick, RT; Ganger, D; Jamil, K; Lake, JR; O'Leary, JG; Pappas, SC; Sanyal, AJ; Wong, F | 1 |
Kumagai, T; Shibata, S; Tamura, Y; Taniguchi, K; Uchida, S | 1 |
Iskra, NI; Rudyk, DV; Shchur, IV; Trofimenko, SP; Tutchenko, MI | 1 |
Paďour, F; Pokorný, M; Šíma, M; Slanař, O | 1 |
Edrees, AM; El-Abd, OL; El-Azab, GI; El-Said, HH; Salman, TA | 1 |
de Mattos, AA; de Mattos, ÂZ | 1 |
Buder, R; Lenz, K; Lohr, G; Piringer, P; Voglmayr, M | 1 |
Bertino, G; Crisafulli, E; Demma, S; Koukias, N; Privitera, G; Purrello, F; Spadaro, L; Tsochatzis, EA | 1 |
Angus, PW; Ardalan, ZS; Gow, PJ; Testro, AG; Vasudevan, A; Ye, B | 1 |
Hsieh, YH; Hung, TH; Tsai, CC; Tseng, CW; Tseng, KC | 1 |
Bajaj, JS; Boyer, TD; Escalante, S; Jamil, K; Pappas, SC; Sanyal, AJ; Wong, F | 1 |
Jao, YTFN | 1 |
Charrabi, A; Colson, PH; Corbani, M; Gaudard, P; Guillon, G; Manière, MJ; Richard, S; Virsolvy, A | 1 |
Bhadoria, AS; Choudhury, A; Joshi, YK; Kedarisetty, CK; Kumar, G; Kumar, S; Maiwall, R; Saini, D; Sarin, SK; Sharma, MK; Vashishtha, C | 1 |
Goyal, O; Puri, S; Sehgal, N; Sidhu, SS | 1 |
Hofbeck, M; Kumpf, M; Michel, J; Neunhoeffer, F; Renk, H; Spiller, G | 1 |
Gupta, D; Haldar, R; Khandelwal, A; Rai, A | 1 |
Kim, SM; Song, IH | 1 |
Chung, D; Kim, H; Kong, MH; Lee, IO; Lim, BG; Park, E; Won, YJ | 1 |
Fallowfield, JA; Gifford, FJ; Morling, JR | 1 |
Masarwa, R; Matok, I; Paret, G; Perlman, A; Raccah, BH; Reif, S | 1 |
Badía Aranda, E; Bernad Cabredo, B; Corrales Cruz, D; Iglesias Julián, E; Romero Arauzo, MJ | 1 |
Boyer, A; Gerbaud, E; Ragot, C | 1 |
Appuswamy, E; Kaliamoorthy, I; Lakshmi, S; Malleeshwaran, S; Rajakumar, A; Reddy, MS; Rela, M; Varghese, J | 1 |
Araya, V; Boyer, TD; Escalante, S; Frederick, RT; Jamil, K; Pappas, SC; Reddy, KR; Rossaro, L; Sanyal, AJ; Teuber, P; Vargas, HE; Wong, F | 1 |
Chandar, AK; Facciorusso, A; Kamath, PS; Murad, MH; Muscatiello, N; Prokop, LJ; Singh, S | 1 |
Abouelenain, KM; Afifi, MH; Alsebaey, A; Kandil, MA; Mahmoud, MA; Rashed, HS; Yassen, KA | 1 |
Chawla, YK; Taneja, S | 1 |
Fallowfield, JA; Gifford, FJ | 1 |
Chen, Z; Lu, Y; Yang, C; Zhou, P | 1 |
Baiges, A; Berbel, C; García-Pagán, JC; Hernández-Gea, V | 1 |
Arlt, J; Dahmen, U; Dirsch, O; Homeyer, A; Settmacher, U; Wei, W; Xie, C | 1 |
Alam, A; Butt, AK; Haq, IU; Malik, K; Salim, A | 1 |
Braddock, M; Han, YJ; Sun, DQ; Zheng, JN; Zheng, MH; Zhong, JH; Zhou, YJ; Zou, TT | 1 |
Golestaneh, L; Neugarten, J | 1 |
Angeli, P; Piano, S; Tonon, M | 1 |
Allegretti, AS; Gluud, LL; Goldin, AH; Israelsen, M; Jovani, M; Krag, A; Winter, RW | 1 |
Gow, P; Papaluca, T | 1 |
Alizai, H; Andert, A; Heidenhain, C; Klink, C; Lurje, G; Neumann, U; Ulmer, TF; Weiland, A | 1 |
Durand, F; Nadim, MK; Olson, JC | 1 |
Baltayiannis, G; Christodoulou, D; Christou, L; Kalambokis, GN | 1 |
Bini, V; Camerini, PG; Campus, GM; Radicioni, M | 1 |
Colle, I; Laterre, PF | 1 |
Baltayiannis, G; Christaki, M; Christodoulou, D; Christou, L; Kalambokis, GN; Koustousi, C; Tsiakas, I | 1 |
Mindikoglu, AL; Pappas, SC | 1 |
Bo, W; Feng, X; Hu, Y; Liu, A; Wang, H | 1 |
Reiberger, T | 1 |
Chen, G; Han, MF; Jiang, QQ; Kilonzo, SB; Ma, K; Ning, Q; Wan, XY; Wang, YL; Wu, WY; You, J | 1 |
Satsangi, S | 1 |
Allegretti, AS; Gluud, LL; Goldin, AH; Israelsen, M; Jovani, M; Krag, A; Schulman, AR; Winter, RW | 1 |
Dayal, VM; Jha, A; Jha, SK; Mishra, M | 2 |
Agarwal, S; Gupta, S; Pandey, N; Singh, S; Verma, S | 1 |
Anand, A | 1 |
Ahamed, R; Augustine, P; Jose, A; Padsalgi, G; Philips, CA; Rajesh, S | 1 |
Borg, K; Lange, LB | 1 |
Gao, Y; Hou, B; Lin, S; Zhang, DD; Zhu, Y | 1 |
Karaaslan, P; Sevmis, S | 1 |
Mohanty, A | 1 |
Brown, RS; Ganger, D; Grewal, P; Moore, K; Sharma, P | 1 |
Chen, Q; Chen, Y; Huang, Z | 1 |
Aithal, GP; Palaniyappan, N | 1 |
Angus, PW; Chapman, B; Gow, PJ; Sinclair, M; Terbah, R; Testro, AG; Thwaites, PA | 1 |
Arab, JP; Benítez, C; Kulkarni, AV; Kumar, P; Premkumar, M; Rao, PN; Reddy, DN; Sharma, M; Simonetto, DA; Tirumalige Ravikumar, S | 1 |
Busta Nistal, MR; Fernández Salazar, L; Mora Cuadrado, N | 1 |
Biggins, SW; Evans, L; Paine, CH; Pichler, RH | 1 |
Alsaadi, AS; Bui, V; Razak, A; Samiee-Zafarghandy, S; Sushko, K; Van Den Anker, J | 1 |
Allegretti, AS; Jamil, K; Moore, K | 1 |
Weng, F | 1 |
Karasu, Z; Ustundag, Y; Yilmaz Urun, Y | 1 |
Allegretti, AS; Belcher, JM; Chung, RT; Garcia-Tsao, G; Juncos, LA; Karakala, N; Nadim, MK; Parada, XV; Parikh, SM; Regner, KR; Sharma, P; Simonetto, DA; Velez, JCQ; Wadei, HM | 1 |
Gonzalez, SA; Velez, JCQ | 1 |
Dębowski, D; Gitlin-Domagalska, A; Glavaš, M; Ptaszyńska, N; Rolka, K; Łęgowska, A | 1 |
Gupta, R; Kulkarni, AV; Kumar, K; Premkumar, M; Rao, PN; Ravikumar, ST; Reddy, DN; Sharma, M; Tevethia, H | 1 |
Song, L; Wang, C; Zeng, J; Zhou, Y | 1 |
Andraus, W; Arantes, RM; Carneiro-D'albuquerque, LA; Cunha, MR; De Moura, EG; Ducatti, L; Ernani, L; Fernandes, MR; Galvão, FH; Martino, RB; Nacif, LS; Pereira, PB; Pinheiro, RS; Rocha-Santos, V; Waisberg, DR | 1 |
Allegretti, AS; Cárdenas, A; Francoz, C; Olson, JC; Subramanian, RM | 1 |
Curry, MP; Jamil, K; Pappas, SC; Reddy, KR; Sanyal, A; Vargas, H; Wong, F | 1 |
Al-Saadi, A; Bui, V; Razak, A; Samiee-Zafarghandy, S; Sushko, K; van den Anker, J | 1 |
Arora, V; Choudhary, SP; Jindal, A; Kumar, G; Maiwall, R; Sarin, SK; Vijayaraghavan, R | 1 |
Jalan, R; Singal, AK | 1 |
Befeler, AS; Curry, MP; Jamil, K; Patwardhan, VR; Pyrsopoulos, NT; Vargas, HE | 1 |
Aschenbrenner, DS | 1 |
Frederick, RT; Jamil, K; Pappas, SC; Sanyal, AJ; Sigal, SH; Weinberg, EM | 1 |
Agrawal, D; Ariga, KK; Verma, G | 1 |
Curry, MP; Gonzalez, SA; Jamil, K; Pappas, SC; Reddy, KR; Sanyal, AJ; Vargas, HE; Velez, JCQ; Wong, F | 1 |
Cao, J; Gow, P; Lim, PCH; Sinclair, M; Terbah, R; Testro, A; Wong, D | 1 |
Liang, D; Lin, L; Mao, F; Tang, Z; Xu, Y | 1 |
160 review(s) available for terlipressin and lypressin
Article | Year |
---|---|
Management of variceal haemorrhage.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Sclerotherapy; Somatostatin; Terlipressin; Vasopressins | 1992 |
Acute management of bleeding oesophageal varices.
Topics: Acute Disease; Animals; Balloon Occlusion; Catheterization; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Lypressin; Nitroglycerin; Sclerotherapy; Somatostatin; Terlipressin; Vasopressins | 1992 |
The management of variceal bleeding.
Topics: Catheterization; Emergencies; Esophageal and Gastric Varices; Esophagus; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Lypressin; Resuscitation; Sclerosing Solutions; Sclerotherapy; Somatostatin; Terlipressin; Vasopressins | 1991 |
Medical and surgical treatment of acute bleeding from esophageal varices in patients with cirrhosis.
Topics: Catheterization; Clinical Trials as Topic; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Nitroglycerin; Portacaval Shunt, Surgical; Sclerotherapy; Somatostatin; Survival Rate; Terlipressin; Vasopressins | 1991 |
[Chemotherapy of portal hypertension].
Topics: Antihypertensive Agents; Drug Evaluation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Infusions, Intra-Arterial; Lypressin; Mesenteric Arteries; Propranolol; Terlipressin; Vasopressins | 1991 |
Vasoconstrictor therapy in bleeding esophageal varices.
Topics: Clinical Trials as Topic; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Metoclopramide; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 1990 |
Conservative and semi-invasive modalities for treating bleeding esophageal varices.
Topics: Balloon Occlusion; Catheterization; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Lypressin; Sclerotherapy; Terlipressin; Vasopressins | 1990 |
Advances in managing variceal bleeding in portal hypertension.
Topics: Catheterization; Embolization, Therapeutic; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ligation; Lypressin; Portacaval Shunt, Surgical; Portasystemic Shunt, Surgical; Propranolol; Resuscitation; Sclerosing Solutions; Somatostatin; Splenorenal Shunt, Surgical; Terlipressin; Vasopressins | 1986 |
[Drug treatment of bleeding esophageal varices. Acute therapy and prevention of recurrence].
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Lypressin; Nitroglycerin; Nitroprusside; Recurrence; Risk; Somatostatin; Terlipressin; Vasopressins | 1986 |
[Treatment of esophageal varices bleeding with vasoactive substances].
Topics: Clinical Trials as Topic; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Somatostatin; Terlipressin; Vasopressins | 1988 |
Vasopressin and glypressin in upper gastrointestinal bleeding.
Topics: Animals; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Somatostatin; Terlipressin; Vasopressins | 1987 |
[Therapy of bleeding esophageal varices. Attempt at a position statement].
Topics: Acute Disease; Clinical Trials as Topic; Embolization, Therapeutic; Emergencies; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Portasystemic Shunt, Surgical; Prospective Studies; Recurrence; Sclerosing Solutions; Terlipressin; Vasopressins | 1986 |
Nonsurgical treatment of variceal bleeding: new modalities.
Topics: Enbucrilate; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Hemostatics; Humans; Ligation; Lypressin; Octreotide; Portasystemic Shunt, Surgical; Sclerotherapy; Somatostatin; Stents; Terlipressin; Tissue Adhesives; Vasopressins | 1995 |
[Emergency medical treatment of portal hypertension].
Topics: Combined Modality Therapy; Emergency Medicine; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Octreotide; Sclerotherapy; Somatostatin; Terlipressin | 1995 |
[Drug therapy and prevention of hemorrhage in esophageal and gastric varices].
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Lypressin; Nitroprusside; Pituitary Hormones, Posterior; Recurrence; Somatostatin; Terlipressin; Vasopressins | 1995 |
Balloon tamponade technique and efficacy in variceal haemorrhage.
Topics: Balloon Occlusion; Catheterization; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Nitroglycerin; Recurrence; Sclerotherapy; Terlipressin; Vasopressins | 1994 |
[Efficacy and mode of action of vasopressin in the treatment of digestive hemorrhages caused by rupture of esophageal or gastric varices].
Topics: Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Lypressin; Nitro Compounds; Sclerotherapy; Terlipressin; Vasopressins | 1994 |
Terlipressin (glypressin) in the treatment of bleeding esophageal varices. State of the art.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Randomized Controlled Trials as Topic; Terlipressin | 1993 |
Pharmacological treatment of portal hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Catheterization; Clinical Trials as Topic; Diuretics; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Lypressin; Metoclopramide; Molsidomine; Octreotide; Portasystemic Shunt, Surgical; Sclerotherapy; Somatostatin; Terlipressin; Vasodilator Agents; Vasopressins | 1995 |
Terlipressin may influence the outcome of hepatorenal syndrome complicating alcoholic hepatitis.
Topics: Aged; Chronic Disease; Female; Hepatitis, Alcoholic; Hepatorenal Syndrome; Humans; Lypressin; Remission Induction; Terlipressin | 1997 |
[Esophageal varices].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Combined Modality Therapy; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Lypressin; Nitroglycerin; Octreotide; Recurrence; Risk Factors; Terlipressin | 1997 |
Development of analogues: successes and failures.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Octreotide; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 1998 |
Approach to the management of bleeding esophageal varices: role of somatostatin.
Topics: Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Lypressin; Randomized Controlled Trials as Topic; Sclerotherapy; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 1998 |
Pharmacological treatment of acute variceal bleeding.
Topics: Domperidone; Esophageal and Gastric Varices; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Lypressin; Metoclopramide; Octreotide; Randomized Controlled Trials as Topic; Sclerosing Solutions; Sclerotherapy; Somatostatin; Terlipressin; Vasopressins | 1998 |
[Terlipressin in the treatment of portal hypertension].
Topics: Antihypertensive Agents; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Lypressin; Terlipressin | 1998 |
Longer treatment with vasoactive drugs to prevent early variceal rebleeding in cirrhosis.
Topics: Acute Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatics; Humans; Liver Cirrhosis; Lypressin; Recurrence; Terlipressin | 1998 |
Pharmacologic intervention during the acute bleeding episode.
Topics: Acute Disease; Antihypertensive Agents; Blood Flow Velocity; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hormones; Humans; Liver Circulation; Lypressin; Nitroglycerin; Portal Pressure; Risk Factors; Somatostatin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 1999 |
Doppler evaluation of the effects of pharmacological treatment of portal hypertension.
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Domperidone; Humans; Hypertension, Portal; Lypressin; Metoclopramide; Nitrates; Octreotide; Portal System; Somatostatin; Terlipressin; Ultrasonography, Doppler; Ultrasonography, Doppler, Duplex; Vasopressins | 1999 |
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Transplantation; Lypressin; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Nitric Oxide Donors; Nitroglycerin; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Spironolactone; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients.
Topics: Disease Progression; Felypressin; Hepatitis, Alcoholic; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Octreotide; Renal Agents; Terlipressin; Vasoconstrictor Agents | 2000 |
Pretransplantation gastrointestinal bleeding.
Topics: Adrenergic beta-Antagonists; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Hypertension, Portal; Liver Transplantation; Lypressin; Risk Factors; Secondary Prevention; Survival Analysis; Terlipressin; Vasoconstrictor Agents | 2000 |
Hepatorenal syndrome.
Topics: Fibrosis; Hepatorenal Syndrome; Homeostasis; Humans; Liver Transplantation; Lypressin; Predictive Value of Tests; Terlipressin; Vasoconstrictor Agents | 2000 |
Octreotide for acute esophageal variceal bleeding: a meta-analysis.
Topics: Acute Disease; Esophageal and Gastric Varices; Hemorrhage; Hemostatics; Humans; Lypressin; Octreotide; Recurrence; Terlipressin; Vasopressins | 2001 |
Terlipressin for acute esophageal variceal hemorrhage.
Topics: Acute Disease; Catheterization; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Randomized Controlled Trials as Topic; Sclerotherapy; Terlipressin; Vasoconstrictor Agents | 2001 |
Management of acute variceal haemorrhage.
Topics: Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hormones; Humans; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Resuscitation; Sclerotherapy; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2001 |
Drug therapy for portal hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Hypertension, Portal; Lypressin; Research; Somatostatin; Terlipressin; Vasopressins | 2001 |
[Physiopathology of refractory ascites and the hepatorenal syndrome].
Topics: Ascites; Glomerular Filtration Rate; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hypotension; Kidney; Liver Cirrhosis; Lypressin; Ornipressin; Paracentesis; Peritoneovenous Shunt; Peritonitis; Plasma Substitutes; Renin-Angiotensin System; Splanchnic Circulation; Sympathetic Nervous System; Tachycardia; Terlipressin; Vasoconstriction | 2002 |
[Vasoconstrictors in the treatment of hepatorenal syndrome].
Topics: Adrenergic alpha-Agonists; Albumins; Drug Evaluation; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Midodrine; Octreotide; Ornipressin; Pilot Projects; Renal Circulation; Terlipressin; Vasoconstrictor Agents | 2002 |
Hepatorenal syndrome in patients with cirrhosis.
Topics: Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Primary Prevention; Prognosis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2002 |
Systematic review: terlipressin in acute oesophageal variceal haemorrhage.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Randomized Controlled Trials as Topic; Terlipressin; Vasoconstrictor Agents | 2003 |
Terlipressin for acute esophageal variceal hemorrhage.
Topics: Acute Disease; Catheterization; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Randomized Controlled Trials as Topic; Sclerotherapy; Terlipressin; Vasoconstrictor Agents | 2003 |
Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?
Topics: Animals; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hemodynamics; Lypressin; Oxygen Consumption; Safety; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2003 |
When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done? Immediate control of bleeding by TIPS?
Topics: Acute Disease; Cyanoacrylates; Embolization, Therapeutic; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Lypressin; Male; Middle Aged; Octreotide; Portasystemic Shunt, Transjugular Intrahepatic; Sclerotherapy; Terlipressin; Tissue Adhesives; Vasoconstrictor Agents | 2003 |
Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis.
Topics: Acute Disease; Emergency Medical Services; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatics; Hormones; Humans; Liver Cirrhosis; Lypressin; Octreotide; Randomized Controlled Trials as Topic; Sclerotherapy; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2003 |
Management of acute variceal bleeding.
Topics: Acute Disease; Algorithms; Balloon Occlusion; Catheterization; Endoscopy, Digestive System; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Hemostasis, Endoscopic; Humans; Liver Transplantation; Lypressin; Octreotide; Portasystemic Shunt, Transjugular Intrahepatic; Sclerotherapy; Somatostatin; Terlipressin; Vasoconstrictor Agents | 2003 |
Review article: the management of acute variceal bleeding.
Topics: Acute Disease; Catheterization; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatics; Hormones; Humans; Ligation; Lypressin; Octreotide; Portasystemic Shunt, Surgical; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2003 |
[Vasoconstrictive Therapies for Bleeding Esophageal Varices and their Mechanisms of Action].
Topics: Clinical Trials as Topic; Drug Approval; Emergencies; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Germany; Hemodynamics; Humans; Infusions, Intravenous; Injections, Intravenous; Lypressin; Octreotide; Somatostatin; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents | 2003 |
Medical management of variceal bleeding in patients with cirrhosis.
Topics: Algorithms; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hemostatics; Humans; Liver Cirrhosis; Lypressin; Octreotide; Practice Guidelines as Topic; Somatostatin; Terlipressin; Vasoconstrictor Agents | 2004 |
Somatostatin, somatostatin analogues and other vasoactive drugs in the treatment of bleeding oesophageal varices.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Octreotide; Sclerotherapy; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2004 |
Role of vasopressin in the management of septic shock.
Topics: Amino Acid Sequence; Blood Circulation; Blood Pressure; Dose-Response Relationship, Drug; Humans; Lypressin; Models, Biological; Osmolar Concentration; Pulmonary Circulation; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2004 |
[Acute upper gastrointestinal variceal bleeding: vasoactive agents].
Topics: Acute Disease; Esophageal and Gastric Varices; Esophageal Diseases; Gastrointestinal Hemorrhage; Humans; Lypressin; Rupture, Spontaneous; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2004 |
[Vasopressin and its analogues in the therapy of shock].
Topics: Animals; Humans; Lypressin; Shock; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasodilation; Vasopressins | 2004 |
Review article: a critical comparison of drug therapies in currently used therapeutic strategies for variceal haemorrhage.
Topics: Esophageal and Gastric Varices; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Lypressin; Octreotide; Somatostatin; Terlipressin; Vasoconstrictor Agents | 2004 |
Review article: pharmacological treatment of hepatorenal syndrome.
Topics: Adrenergic alpha-Agonists; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2004 |
Review article: future indications for terlipressin therapy.
Topics: Animals; Cardiopulmonary Resuscitation; Hepatorenal Syndrome; Humans; Lypressin; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Paracentesis; Rats; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Selective intra-arterial terlipressin infusion stops acute lower gastrointestinal bleeding: a case report and review of the literature.
Topics: Acute Disease; Adenocarcinoma; Female; Gastrointestinal Hemorrhage; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Lypressin; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2004 |
Vasopressin and terlipressin: pharmacology and its clinical relevance.
Topics: Animals; Esophageal and Gastric Varices; Heart Arrest; Humans; Lypressin; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2004 |
[Vasopressin and terlipressin in sepsis and systemic inflammatory response syndrome. Effects on microcirculation, oxygen transport, metabolism and organ function].
Topics: Animals; Humans; Lypressin; Microcirculation; Oxygen Consumption; Sepsis; Systemic Inflammatory Response Syndrome; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2005 |
Clinical review: Vasopressin and terlipressin in septic shock patients.
Topics: Adult; Animals; Antidiuretic Agents; Cardiac Output; Child; Diuresis; Drug Therapy, Combination; Epinephrine; Humans; Infusions, Parenteral; Intensive Care Units; Kidney; Lypressin; Multiple Organ Failure; Randomized Controlled Trials as Topic; Sheep; Shock, Septic; Swine; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2005 |
Best evidence topic report. Terlipressin or somatostatin for the treatment of bleeding oesophageal varices.
Topics: Acute Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hormones; Humans; Lypressin; Somatostatin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2005 |
Vasoactive drugs in the intensive care unit.
Topics: Dobutamine; Drug Therapy, Combination; Epinephrine; Hemodynamics; Humans; Intensive Care Units; Lypressin; Metaraminol; Norepinephrine; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2005 |
Vasopressin during cardiopulmonary resuscitation and different shock states: a review of the literature.
Topics: Animals; Cardiopulmonary Resuscitation; Clinical Trials as Topic; Combined Modality Therapy; Humans; Lypressin; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2006 |
The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
Topics: Adrenergic alpha-Agonists; Cardiovascular Diseases; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Paracentesis; Shock, Septic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2006 |
Best evidence topic report. Terlipressin or sclerotherapy for acute variceal bleeding?
Topics: Acute Disease; Emergencies; Esophageal and Gastric Varices; Evidence-Based Medicine; Gastrointestinal Hemorrhage; Humans; Lypressin; Middle Aged; Sclerotherapy; Terlipressin; Vasoconstrictor Agents | 2006 |
Rescue therapy in septic shock--is terlipressin the last frontier?
Topics: Animals; Humans; Lypressin; Shock, Septic; Terlipressin | 2006 |
Best evidence topic report. The use of intravenous terlipressin in non-variceal upper GI bleeds.
Topics: Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Lypressin; Terlipressin; Vasoconstrictor Agents | 2006 |
Current management of the complications of portal hypertension: variceal bleeding and ascites.
Topics: Algorithms; Anti-Bacterial Agents; Ascites; Collateral Circulation; Diuretics; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Hormones; Hypertension, Portal; Liver Cirrhosis; Lypressin; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Sclerotherapy; Secondary Prevention; Somatostatin; Spironolactone; Terlipressin; Vascular Resistance; Vasoconstrictor Agents; Vasodilation; Vasopressins | 2006 |
Meta-analysis: terlipressin therapy for the hepatorenal syndrome.
Topics: Clinical Trials as Topic; Hepatorenal Syndrome; Humans; Lypressin; Recurrence; Research Design; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2006 |
[Renal impairment in liver diseases].
Topics: Diagnosis, Differential; Hepatorenal Syndrome; Humans; Kidney Transplantation; Liver Cirrhosis; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Prognosis; Renal Insufficiency; Serum Albumin; Terlipressin | 2006 |
Terlipressin for hepatorenal syndrome.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Randomized Controlled Trials as Topic; Terlipressin; Vasoconstrictor Agents | 2006 |
Terlipressin: vasopressin analog and novel drug for septic shock.
Topics: Animals; Humans; Lypressin; Receptors, Vasopressin; Shock, Septic; Terlipressin; Vasopressins | 2006 |
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
Topics: Albumins; Hepatorenal Syndrome; Humans; Infusions, Parenteral; Liver Cirrhosis; Liver Transplantation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Renal Dialysis; Terlipressin; Vasoconstrictor Agents | 2007 |
[Gastroesophageal variceal haemorrhage--new advances in pathophysiology].
Topics: Antihypertensive Agents; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Risk Factors; Rupture, Spontaneous; Terlipressin; Vasoconstrictor Agents | 2006 |
Treating bleeding oesophageal varices with vasoactive agents: good value for money?
Topics: Antihypertensive Agents; Cost-Benefit Analysis; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2007 |
Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.
Topics: Arginine Vasopressin; Humans; Infusions, Intravenous; Lypressin; Metabolic Clearance Rate; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2008 |
Vasopressin in catecholamine-refractory shock in children.
Topics: Adolescent; Adult; Arginine Vasopressin; Blood Pressure; Catecholamines; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Lactic Acid; Lypressin; Shock; Terlipressin; Treatment Failure; Urine; Vasoconstrictor Agents | 2008 |
Recent advances in the management of hepato-renal syndrome (HRS).
Topics: Glomerular Filtration Rate; Hepatorenal Syndrome; Humans; Liver Transplantation; Lypressin; Meta-Analysis as Topic; Portasystemic Shunt, Transjugular Intrahepatic; Renal Dialysis; Terlipressin; Time Factors; Vasoconstrictor Agents | 2007 |
Current endoscopic therapy of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Hemostasis, Endoscopic; Humans; Isosorbide; Ligation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Recurrence; Somatostatin; Terlipressin; Tissue Adhesives | 2008 |
Acute variceal bleeding: pharmacological treatment and primary/secondary prophylaxis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Antibiotic Prophylaxis; Drug Therapy, Combination; Esophageal and Gastric Varices; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Octreotide; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2008 |
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Deamino Arginine Vasopressin; Female; Humans; Hyponatremia; Lypressin; Oligopeptides; Oxytocin; Peptides; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Structure-Activity Relationship; Terlipressin; Uterus; Vasodilator Agents; Vasopressins | 2008 |
"Terlipressin in the treatment of septic shock: the earlier the better"?
Topics: Animals; Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2008 |
Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.
Topics: Animals; Catecholamines; Drug Resistance; Humans; Infant; Infant, Newborn; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2008 |
Vasopressin analogues in the treatment of hepatorenal syndrome and gastrointestinal haemorrhage.
Topics: Animals; Blood Circulation; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Hypovolemia; Liver Cirrhosis; Lypressin; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2008 |
Arginine vasopressin vs. terlipressin in the treatment of shock states.
Topics: Animals; Arginine Vasopressin; Humans; Infusions, Intravenous; Injections, Intravenous; Lypressin; Shock; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2008 |
Vasopressin analogues in the treatment of shock states: potential pitfalls.
Topics: Animals; Chemical and Drug Induced Liver Injury; Humans; Ischemia; Kidney Diseases; Lypressin; Shock; Skin; Terlipressin; Thrombosis; Vasoconstrictor Agents; Vasopressins; Water-Electrolyte Imbalance | 2008 |
Acute kidney injury: new concepts. Hepatorenal syndrome: the role of vasopressors.
Topics: Acute Kidney Injury; Antihypertensive Agents; Humans; Hypertension, Portal; Lypressin; Terlipressin; Treatment Outcome; Vasopressins | 2008 |
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Failure, Acute; Lypressin; Midodrine; Norepinephrine; Octreotide; Paracentesis; Randomized Controlled Trials as Topic; Somatostatin; Terlipressin; Vasoconstrictor Agents | 2008 |
Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2007 |
Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials.
Topics: Albumins; Evidence-Based Medicine; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Odds Ratio; Plasma Substitutes; Randomized Controlled Trials as Topic; Survival Analysis; Terlipressin; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2009 |
[Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].
Topics: Adrenergic beta-Antagonists; Anti-Bacterial Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Hormones; Humans; Hypertension, Portal; Infection Control; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Lypressin; Portal Pressure; Secondary Prevention; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2009 |
Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
Topics: Animals; Cardiac Output; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
[Meta-analysis of terlipressin in treatment of hepatorenal syndrome: an update].
Topics: Hepatorenal Syndrome; Humans; Lypressin; Norepinephrine; Prognosis; Randomized Controlled Trials as Topic; Terlipressin; Treatment Outcome | 2009 |
The effects of vasopressin and its analogues on the liver and its disorders in the critically ill.
Topics: Critical Care; Critical Illness; Hemodynamics; Hepatorenal Syndrome; Humans; Intensive Care Units; Liver; Liver Cirrhosis; Lypressin; Risk Factors; Shock, Septic; Terlipressin; Varicose Veins; Vasoconstrictor Agents; Vasopressins | 2010 |
Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.
Topics: Biomarkers; Creatinine; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Risk Factors; Terlipressin; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2010 |
Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients.
Topics: Emergencies; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatics; Humans; Liver Cirrhosis; Lypressin; Octreotide; Sclerotherapy; Somatostatin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2010 |
Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis.
Topics: Antihypertensive Agents; Diagnosis, Differential; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Terlipressin; Treatment Outcome | 2011 |
Terlipressin-induced severe left and right ventricular dysfunction in patient presented with upper gastrointestinal bleeding: case report and literature review.
Topics: Electrocardiography; Emergency Service, Hospital; Endoscopy, Digestive System; Esophageal and Gastric Varices; Fingers; Gastrointestinal Hemorrhage; Humans; Ischemia; Lypressin; Male; Middle Aged; Terlipressin; Toes; Vasoconstrictor Agents; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2010 |
Adrenergic support in septic shock: a critical review.
Topics: Adrenergic Agents; Algorithms; Blood Flow Velocity; Blood Pressure; Cardiotonic Agents; Decision Trees; Dobutamine; Dopamine; Epinephrine; Fluid Therapy; Humans; Lypressin; Monitoring, Physiologic; Norepinephrine; Patient Selection; Practice Guidelines as Topic; Resuscitation; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2010 |
Relative adrenal insufficiency in a patient with liver disease.
Topics: Adrenal Insufficiency; Cefotaxime; Female; Humans; Hydrocortisone; Liver Cirrhosis, Alcoholic; Lypressin; Middle Aged; Multiple Organ Failure; Norepinephrine; Severity of Illness Index; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
[Classification and management of upper gastrointestinal bleeding].
Topics: Diagnosis, Differential; Emergencies; Endoscopy, Digestive System; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Prognosis; Risk Factors; Sclerotherapy; Terlipressin; Vasoconstrictor Agents | 2010 |
Hepatorenal syndrome: a comprehensive overview for the critical care nurse.
Topics: Critical Care; Disease Progression; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Risk Factors; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2010 |
Vasopressin in sepsis and septic shock.
Topics: Adrenal Cortex Hormones; Animals; Arginine Vasopressin; Catecholamines; Drug Administration Routes; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Humans; Hypotension; Ischemia; Lypressin; Molecular Structure; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Sepsis; Shock, Septic; Terlipressin; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists.
Topics: Antihypertensive Agents; Baroreflex; Cardiac Output; Hemodynamics; Hepatorenal Syndrome; Humans; Lypressin; Meta-Analysis as Topic; Renin-Angiotensin System; Sympathetic Nervous System; Terlipressin; Vasoconstrictor Agents | 2010 |
Terlipressin in hepatorenal syndrome: Evidence for present indications.
Topics: Evidence-Based Medicine; Hemodynamics; Hepatorenal Syndrome; Humans; Kidney; Liver Transplantation; Lypressin; Risk Assessment; Terlipressin; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2011 |
The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature.
Topics: Adolescent; Arginine Vasopressin; Cardiac Output, Low; Cardiopulmonary Resuscitation; Catecholamines; Child; Child, Preschool; Drug Resistance; Female; Heart Arrest; Hemodynamics; Hospital Mortality; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Lypressin; Male; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Shock, Septic; Survival Rate; Terlipressin; Young Adult | 2011 |
[Gastroenterological endoscopy].
Topics: Colonic Polyps; Double-Balloon Enteroscopy; Endoscopy, Gastrointestinal; Endosonography; Enteral Nutrition; Esophageal and Gastric Varices; Esophageal Neoplasms; Esophagitis, Peptic; Esophagogastric Junction; Foreign Bodies; Gallstones; Gastric Balloon; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Intestine, Small; Lypressin; Octreotide; Pancreatitis, Acute Necrotizing; Precancerous Conditions; Stomach; Terlipressin; Ultrasonography, Interventional | 2011 |
Terlipressin in hepatorenal syndrome.
Topics: Arginine Vasopressin; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2011 |
New insights into the management of hepato-renal syndrome.
Topics: Disease Management; Hepatorenal Syndrome; Humans; Lypressin; Midodrine; Norepinephrine; Renal Dialysis; Terlipressin | 2011 |
Hepatorenal syndrome.
Topics: Albumins; Hepatorenal Syndrome; Humans; Liver Transplantation; Lypressin; Terlipressin; Vasoconstrictor Agents | 2011 |
Renal failure in chronic liver disease and the hepatorenal syndrome.
Topics: Bilirubin; Chronic Disease; Evidence-Based Practice; Fluid Therapy; Hemodynamics; Hepatorenal Syndrome; Humans; Kidney; Liver; Liver Cirrhosis; Liver Transplantation; Lypressin; Monitoring, Physiologic; Patient Selection; Portasystemic Shunt, Surgical; Regional Blood Flow; Renal Insufficiency; Serum Albumin; Severity of Illness Index; Terlipressin; Vasoconstrictor Agents | 2011 |
Meta-analysis: vasoactive medications for the management of acute variceal bleeds.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatics; Humans; Lypressin; Octreotide; Randomized Controlled Trials as Topic; Somatostatin; Terlipressin; Vasopressins | 2012 |
Recent advances in our understanding of hepatorenal syndrome.
Topics: Comorbidity; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Norepinephrine; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2012 |
Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice.
Topics: Albumins; Antihypertensive Agents; Hepatorenal Syndrome; Humans; Liver Transplantation; Lypressin; Severity of Illness Index; Terlipressin; Waiting Lists | 2012 |
Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
Topics: Adult; Drug Therapy, Combination; Hemodynamics; Humans; Lypressin; Norepinephrine; Randomized Controlled Trials as Topic; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2012 |
Terlipressin for hepatorenal syndrome.
Topics: Albumins; Hepatorenal Syndrome; Humans; Lypressin; Randomized Controlled Trials as Topic; Terlipressin; Vasoconstrictor Agents | 2012 |
Vasopressin and terlipressin in neonates and children with refractory septic shock.
Topics: Child; Humans; Infant, Newborn; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2013 |
Management of ascites in patients with liver cirrhosis: recent evidence and controversies.
Topics: Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Midodrine; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Terlipressin | 2013 |
Vasopressin and its analogues for the treatment of refractory hypotension in neonates.
Topics: Humans; Hypotension; Infant, Newborn; Lypressin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2013 |
Results of pretransplant treatment of hepatorenal syndrome with terlipressin.
Topics: Hepatorenal Syndrome; Humans; Liver Transplantation; Lypressin; Preoperative Care; Terlipressin; Vasoconstrictor Agents | 2013 |
[Hepatorenal syndrome: diagnosis, treatment and prevention].
Topics: Albumins; Ascites; Drug Therapy, Combination; Evidence-Based Medicine; Hepatorenal Syndrome; Humans; Kidney; Liver Cirrhosis; Liver Transplantation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Terlipressin; Vasoconstrictor Agents | 2013 |
Ischemic skin necrosis following terlipressin therapy: report of two cases and review of the literature.
Topics: Aged; Hepatorenal Syndrome; Humans; Ischemia; Liver Cirrhosis; Lypressin; Male; Necrosis; Skin Diseases; Terlipressin; Vasoconstrictor Agents | 2012 |
[Bleeding from the esophageal and gastric varices in patients with liver cirrhosis].
Topics: Esophageal and Gastric Varices; Esophagus; Gastrointestinal Hemorrhage; Hemostasis, Surgical; Humans; Liver Cirrhosis; Lypressin; Outcome Assessment, Health Care; Patient Selection; Portacaval Shunt, Surgical; Portal System; Prognosis; Stomach; Terlipressin; Vasoconstrictor Agents | 2013 |
[The modern possibilities of the hepato-renal syndrome treatment].
Topics: Comparative Effectiveness Research; Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Nitric Oxide; Outcome Assessment, Health Care; Portasystemic Shunt, Transjugular Intrahepatic; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Terlipressin; Vasoconstrictor Agents | 2013 |
Pharmacologic management of portal hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antihypertensive Agents; Antioxidants; Carbazoles; Carvedilol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Portal; Liver Circulation; Lypressin; Portal Pressure; Propanolamines; Renin-Angiotensin System; Somatostatin; Splanchnic Circulation; Terlipressin; Vascular Resistance; Vasodilator Agents | 2014 |
Acute kidney injury and hepatorenal syndrome in cirrhosis.
Topics: Acute Kidney Injury; Albumins; Ascites; Disease Progression; Drug Therapy, Combination; Early Diagnosis; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Terlipressin | 2015 |
Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Middle Aged; Norepinephrine; Randomized Controlled Trials as Topic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2014 |
Vasopressin in hemorrhagic shock: a systematic review and meta-analysis of randomized animal trials.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Humans; Lypressin; Norepinephrine; Randomized Controlled Trials as Topic; Shock; Shock, Hemorrhagic; Terlipressin; Vasoconstrictor Agents | 2014 |
Efficacy of vasopressin/terlipressin and somatostatin/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding: a systematic review and meta-analysis.
Topics: Esophageal and Gastric Varices; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Lypressin; Octreotide; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Terlipressin; Vasoconstrictor Agents | 2015 |
The Treatment of Hepatorenal Syndrome.
Topics: Adrenergic alpha-Antagonists; Albumins; Antihypertensive Agents; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Terlipressin | 2015 |
Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
Topics: Epinephrine; Hemodynamics; Humans; Lypressin; Norepinephrine; Phenylephrine; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2015 |
Noradrenaline or terlipressin for hepatorenal syndrome?
Topics: Drug Costs; Hepatorenal Syndrome; Humans; Lypressin; Norepinephrine; Randomized Controlled Trials as Topic; Terlipressin; Vasoconstrictor Agents | 2015 |
Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials.
Topics: Databases, Factual; Humans; Lypressin; Methylene Blue; Randomized Controlled Trials as Topic; Sepsis; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2015 |
Hyponatraemia induced by terlipressin: a case report and literature review.
Topics: Adult; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hyponatremia; Lypressin; Male; Terlipressin | 2015 |
Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation.
Topics: Brazil; Chi-Square Distribution; Cost Savings; Cost-Benefit Analysis; Drug Costs; Hepatorenal Syndrome; Humans; Lypressin; Models, Economic; Norepinephrine; Odds Ratio; Randomized Controlled Trials as Topic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2016 |
Diagnosing and treating renal disease in cirrhotic patients.
Topics: Creatinine; Glomerular Filtration Rate; Humans; Kidney Diseases; Liver Cirrhosis; Liver Transplantation; Lypressin; Midodrine; Norepinephrine; Portasystemic Shunt, Surgical; Renal Replacement Therapy; Terlipressin; Vasoconstrictor Agents | 2016 |
[Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].
Topics: Critical Care; Fluid Therapy; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Cirrhosis; Liver Failure; Liver Transplantation; Lypressin; Prognosis; Serum Albumin; Terlipressin; Vasoconstrictor Agents | 2016 |
Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
Topics: Acute Kidney Injury; Adrenal Insufficiency; Ascites; Creatinine; Evidence-Based Medicine; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Transplantation; Lypressin; Midodrine; Norepinephrine; Octreotide; Plasma Substitutes; Portasystemic Shunt, Transjugular Intrahepatic; Serum Albumin; Terlipressin; Vasodilator Agents; Vasopressins | 2016 |
[Acute Kidney Injury in Cirrhotic Patients with Portal Hypertension].
Topics: Acute Kidney Injury; Biomarkers; Creatinine; Humans; Hypertension, Portal; Kidney Transplantation; Liver Cirrhosis; Lypressin; Serum Albumin; Terlipressin | 2016 |
Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1.
Topics: Albumins; Creatinine; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Prognosis; Randomized Controlled Trials as Topic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2017 |
Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysis.
Topics: Adolescent; Advanced Cardiac Life Support; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Length of Stay; Lypressin; Pediatrics; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2017 |
Cutaneous necrosis secondary to terlipressin therapy. A rare but serious side effect. Case report and literature review.
Topics: Aged, 80 and over; Female; Humans; Lypressin; Necrosis; Skin; Terlipressin; Vasoconstrictor Agents | 2017 |
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.
Topics: Adult; Albumins; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Randomized Controlled Trials as Topic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2017 |
Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis.
Topics: Dopamine; Drug Therapy, Combination; Gastrointestinal Agents; Hepatorenal Syndrome; Humans; Lypressin; Midodrine; Network Meta-Analysis; Norepinephrine; Octreotide; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2017 |
Acute variceal bleeding: risk stratification and management (including TIPS).
Topics: Acute Disease; Combined Modality Therapy; Endoscopy, Digestive System; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ligation; Liver Cirrhosis; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Risk Assessment; Terlipressin; Vasoconstrictor Agents | 2018 |
Comparative efficacy of vasoconstrictor therapies for type 1 hepatorenal syndrome: a network meta-analysis.
Topics: Albumins; Comparative Effectiveness Research; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Odds Ratio; Plasma Substitutes; Randomized Controlled Trials as Topic; Risk Factors; Terlipressin; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents | 2017 |
Dual Organ Duel: The Hepatorenal Axis.
Topics: Acute Kidney Injury; Animals; Antihypertensive Agents; Antiviral Agents; Cytochrome P-450 Enzyme System; Hepatitis C; Hepatorenal Syndrome; Humans; Liver Diseases; Lypressin; Renal Insufficiency, Chronic; Terlipressin | 2017 |
Management of ascites and hepatorenal syndrome.
Topics: Acute Kidney Injury; Albumins; Ascites; Bacterial Translocation; Diet, Sodium-Restricted; Diuretics; Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Lypressin; Paracentesis; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2018 |
Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
Topics: Antihypertensive Agents; Dopamine; Hepatorenal Syndrome; Humans; Lypressin; Midodrine; Norepinephrine; Octreotide; Randomized Controlled Trials as Topic; Terlipressin; Vasoconstrictor Agents | 2017 |
Terlipressin: Current and emerging indications in chronic liver disease.
Topics: Chronic Disease; Humans; Infusions, Intravenous; Liver Circulation; Liver Cirrhosis; Liver Diseases; Lypressin; Portal Pressure; Renal Circulation; Terlipressin | 2018 |
Renal dysfunction and cirrhosis.
Topics: Biomarkers; Creatinine; Early Diagnosis; Hepatorenal Syndrome; Humans; Interleukin-18; Kidney Transplantation; Lipocalin-2; Liver Transplantation; Lypressin; Renal Replacement Therapy; Terlipressin; Vasoconstrictor Agents | 2017 |
Hepatorenal syndrome: the clinical impact of vasoactive therapy.
Topics: Biomarkers; Creatinine; Hepatorenal Syndrome; Humans; Lypressin; Midodrine; Norepinephrine; Octreotide; Practice Guidelines as Topic; Predictive Value of Tests; Risk Factors; Terlipressin; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents | 2018 |
Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.
Topics: Hepatorenal Syndrome; Humans; Kidney; Lypressin; Recurrence; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2018 |
Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
Topics: Abdominal Pain; Albumins; Diarrhea; Hepatorenal Syndrome; Humans; Lypressin; Randomized Controlled Trials as Topic; Terlipressin; Vasoconstrictor Agents | 2017 |
Peptide-based therapy in portal hypertension.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Octreotide; Peptide Fragments; Somatostatin; Terlipressin | 2020 |
Role of Terlipressin and Albumin for Hepatorenal Syndrome in Liver Transplantation.
Topics: Albumins; Hepatorenal Syndrome; Humans; Liver Transplantation; Lypressin; Terlipressin; Vasoconstrictor Agents | 2020 |
Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives.
Topics: Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Terlipressin; Vasoconstrictor Agents | 2020 |
Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides.
Topics: Animals; Antidiuretic Agents; COVID-19; COVID-19 Drug Treatment; Deamino Arginine Vasopressin; Diabetes Insipidus; Hemostatics; Humans; Lypressin; Molecular Structure; Ornipressin; Pandemics; SARS-CoV-2; Terlipressin; Vasopressins | 2022 |
Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance.
Topics: Acute Kidney Injury; Albumins; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2022 |
Efficacy and Safety of Vasopressin and Terlipressin in Preterm Neonates: A Systematic Review.
Topics: Arginine Vasopressin; Humans; Hypotension; Infant, Newborn; Lypressin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2022 |
TERLIPRESSIN COMBINED WITH NOREPINEPHRINE IN THE TREATMENT OF SEPTIC SHOCK: A SYSTEMATIC REVIEW.
Topics: Adult; Combined Modality Therapy; Humans; Lypressin; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2023 |
129 trial(s) available for terlipressin and lypressin
Article | Year |
---|---|
Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study.
Topics: Acute Disease; Adult; Aged; Balloon Occlusion; Catheterization; Cause of Death; Combined Modality Therapy; Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Middle Aged; Somatostatin; Survival Rate; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 1992 |
[Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
Topics: Blood Pressure; Cardiac Output; Catecholamines; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Infusions, Intravenous; Injections, Intravenous; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Nitroglycerin; Terlipressin | 1992 |
Effect of triglycyl-lysin-vasopressin on quantitative liver function tests in patients with cirrhosis.
Topics: Adult; Aged; Female; Galactose; Humans; Indocyanine Green; Liver Cirrhosis; Liver Function Tests; Lypressin; Male; Middle Aged; Terlipressin | 1992 |
The hemodynamic effects of triglycyl-lysine-vasopressin (Glypressin) in patients with parkinsonism and orthostatic hypotension.
Topics: Aged; Blood Pressure; Cardiac Output; Female; Hemodynamics; Humans; Hypotension, Orthostatic; Levodopa; Lypressin; Male; Middle Aged; Parkinson Disease; Single-Blind Method; Terlipressin; Vascular Resistance | 1991 |
A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage.
Topics: Adult; Aged; Balloon Occlusion; Catheterization; Drug Therapy, Combination; Emergencies; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Middle Aged; Nitroglycerin; Randomized Controlled Trials as Topic; Terlipressin | 1990 |
Haemodynamic effect of triglycyl-lysine-vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Esophageal and Gastric Varices; Female; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Randomized Controlled Trials as Topic; Terlipressin | 1990 |
Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial.
Topics: Acute Disease; Aged; Double-Blind Method; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Terlipressin | 1990 |
The effect of pitressin and glypressin in variceal bleeding--a preliminary clinical trial.
Topics: Adult; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemostatics; Humans; Lypressin; Male; Middle Aged; Terlipressin; Vasopressins | 1990 |
[Haemodynamic effect of triglycyl-lysine vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial].
Topics: Drug Evaluation; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Placebos; Terlipressin | 1990 |
Endobronchial versus intravenous application of the vasopressin derivative glypressin during diagnostic bronchoscopy.
Topics: Adult; Aged; Blood Gas Analysis; Bronchi; Bronchoscopy; Carbon Dioxide; Female; Hemodynamics; Hemorrhage; Humans; Injections, Intravenous; Lung Diseases; Lypressin; Male; Middle Aged; Oxygen; Random Allocation; Terlipressin | 1989 |
Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding.
Topics: Acute Disease; Clinical Trials as Topic; Double-Blind Method; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Diseases, Alcoholic; Lypressin; Middle Aged; Random Allocation; Recurrence; Terlipressin | 1989 |
[Treatment of esophageal varices bleeding with vasoactive substances].
Topics: Clinical Trials as Topic; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Somatostatin; Terlipressin; Vasopressins | 1988 |
Comparison between lysine vasopressin and a long-acting analogue (N alpha-triglycyl-lysine vasopressin) used as local hemostatic agents for conization.
Topics: Cervix Uteri; Clinical Trials as Topic; Double-Blind Method; Female; Hemodynamics; Hemostatics; Humans; Lypressin; Postoperative Complications; Prospective Studies; Random Allocation; Terlipressin; Uterine Hemorrhage | 1988 |
[Therapy of bleeding esophageal varices. Attempt at a position statement].
Topics: Acute Disease; Clinical Trials as Topic; Embolization, Therapeutic; Emergencies; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Portasystemic Shunt, Surgical; Prospective Studies; Recurrence; Sclerosing Solutions; Terlipressin; Vasopressins | 1986 |
Hemostasis in cold-knife conization. Effects and side effects of Glypressin, a long-acting analogue of lysine-vasopressin.
Topics: Adult; Cervix Uteri; Clinical Trials as Topic; Double-Blind Method; Female; Hemostasis, Surgical; Humans; Lypressin; Middle Aged; Terlipressin; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1986 |
Effects of triglycyl-lysine-vasopressin on cardiovascular responses to orthostatic stress.
Topics: Adult; Blood Pressure; Hemodynamics; Humans; Lypressin; Male; Posture; Terlipressin; Vascular Resistance | 1987 |
Vasopressin therapy for upper gastrointestinal tract hemorrhage. Has its efficacy been proven?
Topics: Animals; Clinical Trials as Topic; Dogs; Double-Blind Method; Gastric Lavage; Gastrointestinal Hemorrhage; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Lypressin; Prognosis; Random Allocation; Research Design; Terlipressin; Vasopressins | 1985 |
Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices.
Topics: Adult; Aged; Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Infusions, Parenteral; Lypressin; Male; Middle Aged; Random Allocation; Terlipressin; Vasopressins | 1982 |
Uterine effects of N-alpha-triglycyl-(8-lysine)-vasopressin and 8-lysine-vasopressin in the first trimester of pregnancy.
Topics: Adult; Female; Humans; Lypressin; Myometrium; Pregnancy; Pregnancy Trimester, First; Terlipressin; Uterine Contraction; Uterus | 1980 |
Drug therapy for acute bleeding from portal hypertensive gastropathy.
Topics: Acute Disease; Double-Blind Method; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Perfusion; Stomach Diseases; Terlipressin; Vasoconstrictor Agents; Vasopressins | 1995 |
Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients.
Topics: Adult; Aged; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Liver Cirrhosis; Lypressin; Male; Middle Aged; Nitroglycerin; Prospective Studies; Survival Analysis; Terlipressin; Vasodilator Agents | 1995 |
Octreotide versus terlypressin in acute variceal hemorrhage in liver cirrhosis. Emergency control and prevention of early rebleeding.
Topics: Cost-Benefit Analysis; Diuretics; Endoscopy, Digestive System; Female; Hemorrhage; Humans; Liver Cirrhosis; Liver Function Tests; Lypressin; Male; Middle Aged; Octreotide; Single-Blind Method; Survival Analysis; Terlipressin | 1994 |
[Terlipressin and somatostatin in the treatment of hemorrhages from rupture of esophageal varices].
Topics: Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Somatostatin; Terlipressin | 1994 |
Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. Liver Study Group of V. Cervello Hospital.
Topics: Administration, Cutaneous; Adult; Aged; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Nitroglycerin; Terlipressin; Vasopressins | 1994 |
Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club.
Topics: Acute Disease; Deamino Arginine Vasopressin; Double-Blind Method; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Treatment Failure | 1993 |
A randomized double-blind trial of glypressin in the management of acute epistaxis.
Topics: Acute Disease; Adult; Aged; Double-Blind Method; Epistaxis; Female; Humans; Injections, Intravenous; Lypressin; Male; Middle Aged; Terlipressin | 1993 |
Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy.
Topics: Double-Blind Method; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Hyperemia; Hypertension, Portal; Laser-Doppler Flowmetry; Liver Cirrhosis; Lypressin; Male; Middle Aged; Oxygen; Regional Blood Flow; Spectrophotometry; Stomach Diseases; Terlipressin; Vasopressins | 1994 |
[Upper digestive hemorrhage. Comparison of terlipressin and octreotide].
Topics: Adult; Aged; Duodenal Diseases; Esophageal Diseases; Female; Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Middle Aged; Octreotide; Stomach Diseases; Terlipressin | 1993 |
Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial.
Topics: Administration, Cutaneous; Adult; Aged; Blood Pressure; Drug Therapy, Combination; Emergencies; Esophageal and Gastric Varices; Female; France; Gastrointestinal Hemorrhage; Hematocrit; Humans; Infusions, Intravenous; Liver Cirrhosis; Lypressin; Male; Middle Aged; Nitroglycerin; Octreotide; Recurrence; Terlipressin | 1993 |
Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide.
Topics: Adult; Aged; Blood Pressure Determination; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Middle Aged; Octreotide; Terlipressin; Vasoconstrictor Agents | 1996 |
Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Synergism; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Oxygen Consumption; Portal Pressure; Splanchnic Circulation; Terlipressin | 1996 |
Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group.
Topics: Acute Disease; Adult; Aged; Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Middle Aged; Recurrence; Sclerotherapy; Somatostatin; Terlipressin | 1996 |
Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices--final report of a placebo-controlled, double-blind study.
Topics: Adult; Aged; Antihypertensive Agents; Balloon Occlusion; Catheterization; Combined Modality Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Lypressin; Male; Middle Aged; Recurrence; Somatostatin; Survival Rate; Terlipressin; Treatment Failure; Treatment Outcome | 1996 |
Non-invasive variceal pressure measurements: validation and clinical implications.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure Determination; Double-Blind Method; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Propranolol; Reproducibility of Results; Spironolactone; Terlipressin; Venous Pressure | 1996 |
Time profile of the haemodynamic effects of terlipressin in portal hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Dose-Response Relationship, Drug; Double-Blind Method; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Infusions, Intravenous; Liver Cirrhosis; Lypressin; Male; Middle Aged; Recurrence; Splanchnic Circulation; Terlipressin | 1997 |
Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Catheterization; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Hemostatic Techniques; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Recurrence; Survival Rate; Terlipressin; Treatment Outcome | 1997 |
Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
Topics: Adult; Antihypertensive Agents; Ascites; Atrial Natriuretic Factor; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis, Alcoholic; Lypressin; Male; Natriuresis; p-Aminohippuric Acid; Regional Blood Flow; Renal Circulation; Splanchnic Circulation; Terlipressin | 1997 |
Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome.
Topics: Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Glomerular Filtration Rate; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Sodium; Terlipressin | 1998 |
Cost-effectiveness analysis of the terlipressin-glycerin trinitrate combination in the pre-hospital management of acute gastro-intestinal haemorrhage in cirrhotic patients.
Topics: Acute Disease; Antihypertensive Agents; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Emergency Treatment; Esophageal and Gastric Varices; Female; France; Gastrointestinal Hemorrhage; Humans; Intensive Care Units; Length of Stay; Liver Cirrhosis; Lypressin; Male; Nitroglycerin; Rupture, Spontaneous; Terlipressin | 1999 |
Use of color Doppler EUS in assessing azygos blood flow for patients with portal hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Azygos Vein; Endosonography; Female; Humans; Hypertension, Portal; Lypressin; Male; Middle Aged; Regional Blood Flow; Somatostatin; Statistics, Nonparametric; Terlipressin; Time Factors; Ultrasonography, Doppler, Color | 1999 |
[Local hemostasis in conization of the cervix].
Topics: Adult; Cervix Uteri; Conization; Female; Hemostasis, Surgical; Humans; Lypressin; Middle Aged; Terlipressin; Vasoconstrictor Agents | 1999 |
[The active management of the placental period with Remestyp].
Topics: Female; Humans; Labor Stage, Third; Lypressin; Methylergonovine; Oxytocics; Oxytocin; Pregnancy; Prospective Studies; Puerperal Disorders; Terlipressin; Time Factors; Uterine Hemorrhage; Vasoconstrictor Agents | 1999 |
Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2000 |
Terlipressin is more effective in decreasing variceal pressure than portal pressure in cirrhotic patients.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Portal System; Splanchnic Circulation; Terlipressin | 2000 |
Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.
Topics: Adult; Aged; Blood Pressure; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Injections, Intravenous; Lypressin; Male; Middle Aged; Norepinephrine; Pilot Projects; Renin; Serum Albumin; Terlipressin; Vasoconstrictor Agents | 2000 |
Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study.
Topics: Acute Disease; Aged; Female; Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Sclerotherapy; Terlipressin; Treatment Failure; Varicose Veins; Vasoconstrictor Agents | 2000 |
Adrenalin versus terlipressin: blood loss and cardiovascular side-effects in the vaginal part of laparoscopically-assisted vaginal hysterectomy or vaginal hysterectomy.
Topics: Adult; Blood Loss, Surgical; Cardiovascular Diseases; Diastole; Epinephrine; Female; Humans; Hypertension; Hysterectomy, Vaginal; Laparoscopy; Lypressin; Middle Aged; Prospective Studies; Systole; Terlipressin; Vasoconstrictor Agents | 2000 |
Endoscopic Doppler ultrasound for measurement of azygos blood flow. Validation against thermodilution and assessment of pharmacological effects of terlipressin in portal hypertension.
Topics: Adult; Aged; Azygos Vein; Blood Flow Velocity; Cross-Over Studies; Double-Blind Method; Endosonography; Female; Humans; Hypertension, Portal; Injections, Intravenous; Lypressin; Male; Middle Aged; Probability; Reference Values; Sensitivity and Specificity; Terlipressin; Thermodilution; Ultrasonography, Doppler | 2001 |
Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prazosin; Terlipressin | 2001 |
Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.
Topics: Albumins; Analysis of Variance; Blood Volume; Creatinine; Female; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Paracentesis; Pilot Projects; Renin; Sodium; Survival Analysis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2002 |
Terlipressin-ephedrine versus ephedrine to treat hypotension at the induction of anesthesia in patients chronically treated with angiotensin converting-enzyme inhibitors: a prospective, randomized, double-blinded, crossover study.
Topics: Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Ephedrine; Humans; Hypotension; Intraoperative Complications; Lypressin; Propofol; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2002 |
Terlipressin for norepinephrine-resistant septic shock.
Topics: Adult; Aged; APACHE; Half-Life; Hemodynamics; Humans; Lypressin; Middle Aged; Norepinephrine; Shock, Septic; Survival Rate; Terlipressin; Vasoconstrictor Agents | 2002 |
Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Topics: Aged; Cardiac Output; Drug Therapy, Combination; Female; Hemodynamics; Hepatitis B; Hepatitis C; Humans; Hypertension, Portal; Infusions, Intravenous; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Terlipressin; Vascular Resistance; Vasoconstrictor Agents; Venous Pressure | 2002 |
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.
Topics: Adult; Aged; Albumins; Antihypertensive Agents; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Recurrence; Survival Analysis; Terlipressin | 2002 |
Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2.
Topics: Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Portasystemic Shunt, Surgical; Prospective Studies; Terlipressin; Treatment Outcome; Urination; Vasoconstrictor Agents | 2002 |
Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial.
Topics: Blood Pressure; Creatinine; Female; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Function Tests; Lypressin; Male; Middle Aged; Prospective Studies; Single-Blind Method; Survival Analysis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2003 |
Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors.
Topics: Aged; Anesthesia, General; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Electrocardiography; Endarterectomy, Carotid; Female; Heart Rate; Humans; Hypotension; Lypressin; Male; Middle Aged; Norepinephrine; Postoperative Complications; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2003 |
Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock.
Topics: Aged; Catecholamines; Catheterization, Swan-Ganz; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Hemodynamics; Humans; Infant, Newborn; Intensive Care Units; Laser-Doppler Flowmetry; Lypressin; Male; Manometry; Middle Aged; Prospective Studies; Pulmonary Artery; Shock, Septic; Terlipressin; Urination; Vasoconstrictor Agents | 2004 |
Terlipressin for catecholamine-resistant septic shock in children.
Topics: Catecholamines; Child; Child, Preschool; Drug Resistance; Humans; Hypotension; Infant; Infusions, Intravenous; Lypressin; Male; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Output; Cerebrovascular Circulation; Female; Heart Rate; Hepatic Encephalopathy; Humans; Hyperemia; Intracranial Pressure; Liver Failure, Acute; Lypressin; Male; Middle Aged; Terlipressin; Vascular Resistance; Vasodilation | 2004 |
A prospective double blind randomized study comparing the need for blood transfusion with terlipressin or a placebo during early excision and grafting of burns.
Topics: Adolescent; Adult; Aged; Blood Loss, Surgical; Blood Transfusion; Burns; Child; Child, Preschool; Double-Blind Method; Female; Graft Survival; Humans; Lypressin; Male; Middle Aged; Prospective Studies; Skin Transplantation; Terlipressin; Vasoconstrictor Agents | 2004 |
Terlipressin and gelafundin: safe therapy of hepatorenal syndrome.
Topics: Antihypertensive Agents; Creatinine; Gelatin; Glomerular Filtration Rate; Hemodynamics; Hepatorenal Syndrome; Humans; Injections, Intravenous; Kidney; Kidney Function Tests; Lypressin; Pilot Projects; Plasma Substitutes; Terlipressin; Treatment Outcome | 2004 |
Effect of terlipressin on blood volume distribution in patients with cirrhosis.
Topics: Adult; Blood Volume; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2004 |
Effects of terlipressin on systolic pulmonary artery pressure of patients with liver cirrhosis: an echocardiographic assessment.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Echocardiography; Female; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Pulmonary Artery; Terlipressin | 2004 |
Terlipressin in catecholamine-resistant septic shock patients.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Platelets; Drug Resistance; Epinephrine; Female; France; Heart Rate; Hospital Mortality; Humans; Hypotension; Lactic Acid; Lypressin; Male; Middle Aged; Multiple Organ Failure; Norepinephrine; Oxygen Consumption; Prospective Studies; Shock, Septic; Terlipressin; Urodynamics; Vasoconstrictor Agents | 2004 |
Terlipressin versus norepinephrine to counteract anesthesia-induced hypotension in patients treated with renin-angiotensin system inhibitors: effects on systemic and regional hemodynamics.
Topics: Aged; Anesthesia; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Echocardiography; Electrocardiography; Female; Gastric Mucosa; Hemodynamics; Humans; Hypotension; Laser-Doppler Flowmetry; Lypressin; Male; Norepinephrine; Oxygen Consumption; Prospective Studies; Regional Blood Flow; Renin-Angiotensin System; Terlipressin; Vasoconstrictor Agents | 2005 |
Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose.
Topics: Aged; Blood Pressure; Double-Blind Method; Esophageal and Gastric Varices; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Somatostatin; Terlipressin; Vasoconstrictor Agents; Venous Pressure | 2005 |
Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
Topics: Blood Pressure; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Portal System; Terlipressin; Ultrasonography, Doppler, Duplex; Vasoconstrictor Agents; Venous Pressure | 2005 |
Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
Topics: Antihypertensive Agents; Female; Hemodynamics; Hormones; Humans; Infusions, Intravenous; Injections, Intravenous; Liver Cirrhosis; Lypressin; Male; Middle Aged; Portal Vein; Sodium; Somatostatin; Terlipressin; Ultrasonography, Doppler, Color | 2005 |
Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.
Topics: Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Lactates; Lypressin; Male; Middle Aged; Norepinephrine; Oxygen; Oxygen Consumption; Prospective Studies; Pulmonary Circulation; Shock, Septic; Stroke Volume; Terlipressin; Vascular Resistance; Vasoconstrictor Agents | 2005 |
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
Topics: Administration, Oral; Albumins; Anti-Bacterial Agents; Antihypertensive Agents; Ceftazidime; Ciprofloxacin; Female; Health Care Costs; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Length of Stay; Liver Cirrhosis; Lypressin; Male; Middle Aged; Peritonitis; Terlipressin | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Paracentesis; Plasma Substitutes; Renin; Terlipressin; Vasoconstrictor Agents | 2006 |
[A prospective study comparing the efficacy of early administration of terlipressin and somatostatin for the control of acute variceal bleeding in patients with cirrhosis].
Topics: Acute Disease; Aged; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hemostasis, Endoscopic; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Lypressin; Male; Middle Aged; Multivariate Analysis; Somatostatin; Terlipressin; Varicose Veins; Vasoconstrictor Agents | 2006 |
[Comparison of terlipressin and octreotide with variceal ligation for controlling acute esophageal variceal bleeding--a randomized prospective study].
Topics: Acute Disease; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Terlipressin; Vasoconstrictor Agents | 2006 |
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study.
Topics: Antihypertensive Agents; Female; Health Care Costs; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Pilot Projects; Prospective Studies; Recurrence; Survival Analysis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2007 |
Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors?
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Case-Control Studies; Cushing Syndrome; Female; Humans; Hydrocortisone; Lypressin; Male; Middle Aged; Receptors, Vasopressin; Severity of Illness Index; Terlipressin; Vasoconstrictor Agents | 2008 |
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.
Topics: Ascites; Double-Blind Method; Female; Glomerular Filtration Rate; Hepatorenal Syndrome; Humans; Kidney; Kidney Diseases; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Receptors, Vasopressin; Recovery of Function; Terlipressin; Vasoconstrictor Agents | 2007 |
Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children.
Topics: Adolescent; Blood Pressure; Catecholamines; Child; Child, Preschool; Drug Resistance; Female; Heart Rate; Humans; Hypotension; Intensive Care Units, Pediatric; Length of Stay; Lypressin; Male; Oxygen; Prospective Studies; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2008 |
Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.
Topics: Acid-Base Equilibrium; Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiac Output; Critical Care; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Oxygen; Oxygen Consumption; Partial Pressure; Pilot Projects; Prospective Studies; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2008 |
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
Topics: Adolescent; Adult; Aged; Albumins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Injections, Intravenous; Kidney Function Tests; Liver Cirrhosis; Lypressin; Male; Middle Aged; Retrospective Studies; Shock, Septic; Survival Rate; Terlipressin; Time Factors; Treatment Outcome; United States; Vasoconstrictor Agents | 2008 |
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Germany; Hepatorenal Syndrome; Humans; Injections, Intravenous; Kidney Function Tests; Lypressin; Male; Middle Aged; Prospective Studies; Russia; Severity of Illness Index; Shock, Septic; Survival Rate; Terlipressin; Treatment Outcome; United States; Vasoconstrictor Agents | 2008 |
An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
Topics: Antihypertensive Agents; Blood Pressure; Creatinine; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Pilot Projects; Renin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2008 |
Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects.
Topics: Adolescent; Adult; Aged; Antidiuretic Agents; Aquaporin 2; Arginine Vasopressin; Blood Pressure; Creatinine; Cyclic AMP; Drinking; Female; Hepatorenal Syndrome; Humans; Kidney; Lithium; Lypressin; Male; Middle Aged; Osmolar Concentration; Receptors, Vasopressin; Sodium; Terlipressin; Urine; Vasoconstrictor Agents; Water; Water-Electrolyte Balance; Young Adult | 2008 |
Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Length of Stay; Ligation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Terlipressin; Vasoconstrictor Agents; Young Adult | 2009 |
Low-dose terlipressin plus banding ligation versus low-dose terlipressin alone in the prevention of very early rebleeding of oesophageal varices.
Topics: Aged; Combined Modality Therapy; Drug Administration Schedule; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Ligation; Liver Cirrhosis; Lypressin; Proportional Hazards Models; Recurrence; Survival Rate; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2009 |
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Topics: Acid-Base Equilibrium; Aged; Dobutamine; Female; Hemodynamics; Homeostasis; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Oxygen; Pilot Projects; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2009 |
Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Topics: Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Neurotransmitter Agents; Placebo Effect; Renal Circulation; Terlipressin; Treatment Outcome; Ultrasonography, Doppler; Vascular Resistance; Vasoconstrictor Agents | 2009 |
Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis.
Topics: Aged; Ascites; Blood Pressure; Cardiac Output; Electrocardiography; Female; Heart Function Tests; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Stroke Volume; Terlipressin; Tomography, Emission-Computed, Single-Photon; Vasoconstrictor Agents; Ventricular Function, Left | 2010 |
Effects of terlipressin on water excretion after oral water load test in nonazotemic cirrhotic patients with ascites without hyponatremia.
Topics: Ascites; Diuresis; Drinking; Female; Humans; Hyponatremia; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2010 |
Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis.
Topics: Esophageal and Gastric Varices; Female; Gamma Cameras; Hemodynamics; Hormones; Humans; Hypertension, Portal; Infusions, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Technetium Tc 99m Sestamibi; Terlipressin; Thorax; Vasoconstrictor Agents | 2010 |
Effects of the vasopressin agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients with cirrhosis and water retention.
Topics: Antihypertensive Agents; Cyclic AMP; Demography; Epithelial Sodium Channels; Female; Humans; Kidney; Liver Cirrhosis; Lypressin; Male; Middle Aged; Receptors, Vasopressin; Sodium; Terlipressin; Vasopressins; Water-Electrolyte Balance | 2011 |
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.
Topics: Adult; Albumins; Blood Pressure; Creatinine; Double-Blind Method; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Lypressin; Male; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2011 |
The use of terlipressin during living donor liver transplantation: Effects on systemic and splanchnic hemodynamics and renal function.
Topics: Adult; Blood Pressure; Female; Humans; Intraoperative Care; Kidney; Kidney Function Tests; Liver Diseases; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Terlipressin; Vascular Resistance; Vasoconstrictor Agents | 2011 |
Differential effects of terlipressin on pulmonary and systemic hemodynamics in patients with cirrhosis and pulmonary hypertension: an echo study.
Topics: Aged; Antihypertensive Agents; Cardiac Output; Female; Humans; Hypertension, Pulmonary; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Terlipressin; Ultrasonography, Doppler, Duplex; Vascular Resistance | 2012 |
Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1.
Topics: Albumins; Cohort Studies; Hepatorenal Syndrome; Humans; Liver Failure; Liver Transplantation; Lypressin; Prognosis; Survival Rate; Terlipressin; Vasoconstrictor Agents | 2011 |
Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock.
Topics: Adrenergic alpha-Agonists; Aged; Arginine Vasopressin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lypressin; Male; Microcirculation; Middle Aged; Mouth Floor; Norepinephrine; Prospective Studies; Receptors, Vasopressin; Shock, Septic; Terlipressin | 2011 |
The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study.
Topics: Aged; Albumins; Antihypertensive Agents; Creatinine; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; Japan; Liver Cirrhosis; Lypressin; Male; Middle Aged; Norepinephrine; Prospective Studies; Renin; Survival Rate; Terlipressin; Treatment Outcome | 2012 |
The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.
Topics: Adult; Aged; Albumins; Ascites; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Kidney; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2011 |
Short course adjuvant terlipressin in acute variceal bleeding: a randomized double blind dummy controlled trial.
Topics: Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Double-Blind Method; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Hemorrhage; Humans; Ligation; Lypressin; Male; Middle Aged; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2012 |
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study.
Topics: Adult; Aged; Blood Pressure; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Terlipressin | 2012 |
Perioperative assessment of terlipressin infusion during living donor liver transplantation.
Topics: Body Fluids; Case-Control Studies; Demography; Female; Humans; Infusions, Intravenous; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Perioperative Care; Postoperative Care; Terlipressin; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2012 |
Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
Topics: Adult; Aged; Aged, 80 and over; Drug Resistance; Female; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2012 |
Terlipressin decreases vascular endothelial growth factor expression and improves oxygenation in patients with acute respiratory distress syndrome and shock.
Topics: Blood Pressure; Dopamine; Dopamine Agents; Female; Humans; Infusions, Intravenous; Lypressin; Male; Middle Aged; Prospective Studies; Respiratory Distress Syndrome; Shock, Septic; Terlipressin; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents | 2013 |
Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Combined Modality Therapy; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Hemostasis; Humans; Ligation; Lypressin; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Recurrence; Somatostatin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2013 |
Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Infusions, Intravenous; Injections, Intravenous; Lypressin; Male; Middle Aged; Monitoring, Physiologic; Portal Pressure; Portasystemic Shunt, Transjugular Intrahepatic; Terlipressin; Young Adult | 2013 |
Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study.
Topics: Adult; Biomarkers; Chi-Square Distribution; Creatinine; Female; Hemodynamics; Hepatorenal Syndrome; Humans; India; Kaplan-Meier Estimate; Logistic Models; Lypressin; Male; Middle Aged; Multivariate Analysis; Norepinephrine; Pilot Projects; Sodium; Terlipressin; Tertiary Care Centers; Time Factors; Treatment Outcome; Urination; Vasoconstrictor Agents | 2013 |
Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation.
Topics: Female; Hemodynamics; Humans; Liver Circulation; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Prospective Studies; Renal Circulation; Terlipressin; Vasoconstrictor Agents | 2013 |
Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage.
Topics: Acute Disease; Adult; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemostasis; Humans; Lypressin; Male; Middle Aged; Octreotide; Prospective Studies; Somatostatin; Terlipressin; Treatment Failure; Vasoconstrictor Agents | 2014 |
[A comparative study of high-or low-dose terlipressin therapy in patients with cirrhosis and type 1 hepatorenal syndrome].
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Retrospective Studies; Terlipressin; Treatment Outcome; Young Adult | 2014 |
[Response to Terlipressin and albumin is associated with improved outcome in patients with cirrhosis and hepatorenal syndrome].
Topics: Adult; Aged; Albumins; Antihypertensive Agents; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Treatment Outcome | 2015 |
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.
Topics: Aged; Albumins; Analysis of Variance; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Kidney Function Tests; Liver Function Tests; Lypressin; Male; Middle Aged; Midodrine; Octreotide; Predictive Value of Tests; Survival Analysis; Terlipressin; Treatment Outcome | 2015 |
Effects of terlipressin as early treatment for protection of brain in a model of haemorrhagic shock.
Topics: Animals; Cerebrovascular Circulation; Disease Models, Animal; Fluid Therapy; Hemodynamics; Hypotension; Lypressin; Shock, Hemorrhagic; Swine; Terlipressin; Vasoconstrictor Agents | 2015 |
Effects of terlipressin on patients with sepsis via improving tissue blood flow.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemodynamics; Humans; Infusions, Intravenous; Lypressin; Male; Middle Aged; Norepinephrine; Regional Blood Flow; Sepsis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Young Adult | 2016 |
Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.
Topics: Aged; Female; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Italy; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2016 |
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
Topics: Adult; Albumins; Canada; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; Kidney; Kidney Function Tests; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2016 |
Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis.
Topics: Adult; Bacterial Infections; Drug Therapy, Combination; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Midodrine; Peritonitis; Renal Circulation; Serum Albumin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2016 |
Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome.
Topics: Aged; Canada; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Placebos; Retrospective Studies; Survival Analysis; Systemic Inflammatory Response Syndrome; Terlipressin; Treatment Outcome; United States; Vasoconstrictor Agents | 2017 |
A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.
Topics: Adult; Female; Hemodynamics; Humans; India; Kaplan-Meier Estimate; Lactic Acid; Liver Cirrhosis; Logistic Models; Lypressin; Male; Microcirculation; Middle Aged; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2017 |
Noradrenaline is as Effective as Terlipressin in Hepatorenal Syndrome Type 1: A Prospective, Randomized Trial.
Topics: Adrenergic alpha-Agonists; Creatinine; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Norepinephrine; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2016 |
Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation.
Topics: Acute Kidney Injury; Adult; Ascites; Bradycardia; Double-Blind Method; Female; Humans; Incidence; Infusions, Intravenous; Kidney Failure, Chronic; Length of Stay; Liver Function Tests; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Perioperative Period; Portal Pressure; Postoperative Complications; Severity of Illness Index; Terlipressin; Vasoconstrictor Agents | 2017 |
Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: A randomized controlled trial.
Topics: Acute Kidney Injury; Adult; Aged; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Infusions, Intravenous; Lipocalin-2; Liver Transplantation; Living Donors; Logistic Models; Lypressin; Male; Middle Aged; Postoperative Complications; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2017 |
[Comparison of effect of norepinephrine and terlipressin on patients with ARDS combined with septic shock: a prospective single-blind randomized controlled trial].
Topics: Berlin; Hemodynamics; Humans; Lypressin; Norepinephrine; Prospective Studies; Respiratory Distress Syndrome; Shock, Septic; Single-Blind Method; Terlipressin | 2017 |
Comparison of 12-Hour with 72-Hour Terlipressin Therapy for Bleeding Esophageal Varices.
Topics: Adult; Aged; Combined Modality Therapy; Drug Administration Schedule; Endoscopy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Ligation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2017 |
Comparison of continuous versus intermittent infusions of terlipressin for the control of acute variceal bleeding in patients with portal hypertension: An open-label randomized controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Drug Administration Schedule; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Infusions, Intravenous; Injections, Intravenous; Lypressin; Male; Middle Aged; Portal Pressure; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Young Adult | 2018 |
Effect of terlipressin infusion therapy on recipient's hepatic and renal functions in living donor liver transplantations: Experience from a tertiary hospital.
Topics: Adult; Female; Hemodynamics; Humans; Kidney Function Tests; Liver Circulation; Liver Function Tests; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Postoperative Period; Renal Circulation; Retrospective Studies; Terlipressin; Vasoconstrictor Agents | 2019 |
Role of Terlipressin and Albumin for Hepatorenal Syndrome in Liver Transplantation.
Topics: Albumins; Hepatorenal Syndrome; Humans; Liver Transplantation; Lypressin; Terlipressin; Vasoconstrictor Agents | 2020 |
Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward.
Topics: Acute Kidney Injury; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2022 |
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Albumins; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Respiratory Insufficiency; Terlipressin; Vasoconstrictor Agents | 2022 |
Low-dose continuous terlipressin infusion is effective and safer than intravenous bolus injections in reducing portal pressure and control of acute variceal bleeding.
Topics: End Stage Liver Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Portal Pressure; Severity of Illness Index; Terlipressin | 2023 |
347 other study(ies) available for terlipressin and lypressin
Article | Year |
---|---|
Antidiuretic activity of terlipressin (triglycyl-lysine vasopressin)--role of pressure natriuresis.
Topics: Animals; Deamino Arginine Vasopressin; Diuretics; Dose-Response Relationship, Drug; Kidney; Lypressin; Male; Natriuresis; Rats; Rats, Wistar; Sodium; Terlipressin | 1992 |
Terlipressin-induced metabolic acidosis.
Topics: Acidosis; Acidosis, Lactic; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Middle Aged; Terlipressin | 1991 |
[The effect of the vasoconstrictor glycylpressin on the bioavailability of mitomycin C].
Topics: Aged; Biological Availability; Drug Interactions; Humans; Lypressin; Male; Middle Aged; Mitomycin; Mitomycins; Terlipressin; Vasoconstrictor Agents | 1991 |
[Pharmacokinetics and local availability of mitomycin. The influence of vasoconstriction and chemoembolization].
Topics: Biological Availability; Chemistry, Pharmaceutical; Diffusion; Embolization, Therapeutic; Half-Life; Hepatic Artery; Humans; Liver Neoplasms; Lypressin; Mitomycin; Mitomycins; Starch; Terlipressin; Vasoconstrictor Agents | 1991 |
Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers.
Topics: Adult; Dose-Response Relationship, Drug; Half-Life; Humans; Injections, Intravenous; Lypressin; Male; Middle Aged; Terlipressin | 1990 |
Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.
Topics: Adult; Aged; Drug Combinations; Hemodynamics; Hepatitis B; Humans; Injections, Intravenous; Liver; Liver Cirrhosis; Lypressin; Male; Middle Aged; Nitroglycerin; Terlipressin | 1990 |
Determination of a suitable dosage of lysine-vasopressin and triglycyl-lysine-vasopressin, given in a gel-solution locally in the rectum of rats for possible radioprotective purposes.
Topics: Administration, Rectal; Animals; Intestinal Mucosa; Lypressin; Radiation-Protective Agents; Rats; Rats, Inbred Strains; Terlipressin | 1990 |
[Epileptic crisis in hemoptysis treated with terlipressin].
Topics: Adult; Epilepsy, Tonic-Clonic; Female; Hemoptysis; Humans; Hypernatremia; Lypressin; Sodium; Terlipressin | 1989 |
Haemodynamic effects of triglycyl-lysine vasopressin plus nitroglycerin in patients with HBsAg-positive cirrhosis.
Topics: Drug Synergism; Hemodynamics; Hepatitis B Surface Antigens; Humans; Liver Cirrhosis; Lypressin; Nitroglycerin; Portal System; Terlipressin | 1989 |
[The effect of terlipressin (Remestyp Spofa) on hemodynamic parameters in patients with portal hypertension associated with liver cirrhosis].
Topics: Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Terlipressin | 1989 |
[Treatment of severe hemoptysis with terlipressin. Study of the efficacy and tolerance of this product].
Topics: Aged; Aged, 80 and over; Drug Evaluation; Drug Tolerance; Female; Hemoptysis; Humans; Injections, Intravenous; Lypressin; Male; Middle Aged; Terlipressin | 1989 |
[Drug therapy of bleeding esophageal varices].
Topics: Blood Transfusion; Brain Diseases; Critical Care; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; Lypressin; Sepsis; Somatostatin; Terlipressin; Vasopressins | 1986 |
[Changes in portal hemodynamics during pharmacologic stimulation: somatostatin vs glypressin].
Topics: Blood Pressure; Humans; Liver Cirrhosis; Lypressin; Portal System; Regional Blood Flow; Somatostatin; Terlipressin; Time Factors | 1986 |
Tryglycylvasopressin-reduced portal and systemic concentrations of serum bile acids after exogenous chenodeoxycholic acid load in rats as a reflection of reduced splanchnic blood flow.
Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Depression, Chemical; Lypressin; Male; Portal System; Rats; Rats, Inbred Strains; Splanchnic Circulation; Terlipressin | 1989 |
The effect of triglycyl-lysine-vasopressin (terlipressin INN, Glypressin) on skin blood flow, measured with laser Doppler flowmetry, thermography and plethysmography. A dose-response study.
Topics: Adult; Dose-Response Relationship, Drug; Humans; Lasers; Lypressin; Male; Middle Aged; Plethysmography; Regional Blood Flow; Rheology; Skin; Terlipressin; Thermography; Vasoconstriction | 1987 |
Haemodynamic responses to 1.25 and 2 mg of terlipressin intravenously in man.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Injections, Intravenous; Lypressin; Male; Middle Aged; Terlipressin | 1988 |
Development of an immunoassay for glypressin, an N-terminal extended vasopressin analogue.
Topics: Animals; Antibody Formation; Chromatography, High Pressure Liquid; Cross Reactions; Haptens; Humans; Lypressin; Rabbits; Radioimmunoassay; Terlipressin | 1988 |
Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis.
Topics: Adult; Aged; Blood Circulation; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Regional Blood Flow; Splanchnic Circulation; Spleen; Terlipressin | 1988 |
Ischaemic colitis in a patient treated with glypressin for bleeding oesophageal varices.
Topics: Adult; Colitis; Colon; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Ischemia; Lypressin; Male; Regional Blood Flow; Terlipressin | 1987 |
[Effect of glycylpressin on pressure in esophageal varices in patients with liver cirrhosis and previous hemorrhaging varices].
Topics: Adult; Aged; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Middle Aged; Pressure; Terlipressin | 1987 |
Cardiovascular effects of head-up tilt as affected by a vasopressin analogue.
Topics: Adult; Cardiac Output; Hemodynamics; Humans; Lypressin; Male; Middle Aged; Posture; Terlipressin; Vascular Resistance | 1987 |
[Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis].
Topics: Adult; Drug Evaluation; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Splanchnic Circulation; Terlipressin | 1985 |
Terlipressin (Glypressin)--a pro-drug variceal haemorrhage.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Terlipressin | 1985 |
[Ischemia of the cecum caused by glycylpressin].
Topics: Cecum; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ischemia; Lypressin; Male; Middle Aged; Necrosis; Stomach Ulcer; Terlipressin | 1985 |
Circulatory and renal effects of triglycyl-lysine-vasopressin and excision in experimental burns.
Topics: Animals; Blood Circulation; Blood Pressure; Burns; Cardiac Output; Diuresis; Female; Heart Rate; Kidney; Lypressin; Regional Blood Flow; Swine; Terlipressin | 1985 |
Early treatment of esophageal varices.
Topics: Acute Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Sclerosing Solutions; Terlipressin; Time Factors | 1982 |
[Recent developments in the medical treatment of emergency cirrhotic hemorrhage. Vasopressin and glipressin, prostaglandins, somatostatin, propranolol, cimetidine and ranitidine].
Topics: Cimetidine; Emergencies; Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Propranolol; Prostaglandins; Ranitidine; Somatostatin; Terlipressin; Vasopressins | 1983 |
[Treatment of hemorrhaging esophageal varices with triglycyl lysine vasopressin. Case reports].
Topics: Adult; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Middle Aged; Terlipressin | 1984 |
Triglycyl-lysine-vasopressin or lysine-vasopressin in early excision of burns. An experimental study comparing the effects on blood loss, hemodynamics and renal function.
Topics: Animals; Blood Pressure; Burns; Cardiac Output; Glomerular Filtration Rate; Heart Rate; Hemodynamics; Hemorrhage; Kidney; Lypressin; Swine; Terlipressin | 1984 |
Reduction of blood loss by triglycyl-lysine-vasopressin during early excision of burns in pigs.
Topics: Animals; Blood Gas Analysis; Burns; Cardiac Output; Hemodynamics; Hemorrhage; Hepatic Artery; Kidney; Lypressin; Skin; Swine; Terlipressin | 1984 |
[Therapy of acute esophageal varices hemorrhage. Animal-experiment and clinical results].
Topics: Acute Disease; Animals; Dogs; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Liver Circulation; Lypressin; Oxygen; Sclerosing Solutions; Terlipressin | 1983 |
Feline genitourinary and systemic circulatory changes due to a vasopressin hormonogen.
Topics: Adrenal Glands; Animals; Blood Pressure; Cardiac Output; Cats; Hemodynamics; Lypressin; Male; Pulse; Regional Blood Flow; Renal Circulation; Terlipressin; Testis; Tongue | 1984 |
Haemostatic effects of lysine vasopressin and triglycyl lysine vasopressin infusion in patients with cirrhosis.
Topics: Antigens; Blood Pressure; Esophageal and Gastric Varices; Factor VIII; Gastrointestinal Hemorrhage; Hemostasis; Humans; Liver Cirrhosis; Lypressin; Plasminogen Activators; Pulse; Terlipressin; Time Factors | 1980 |
The influence of a single dose of vasopressin analogs on human renal potassium excretion.
Topics: Adolescent; Adult; Aged; Arginine Vasopressin; Deamino Arginine Vasopressin; Female; Humans; Kidney; Lypressin; Male; Middle Aged; Potassium; Terlipressin; Urea | 1982 |
[The use of Remestyp in the paediatric gynecology treating juvenile metrorrhagia (author's transl)].
Topics: Adolescent; Child; Female; Humans; Lypressin; Metrorrhagia; Terlipressin; Vasoconstrictor Agents | 1980 |
Conversion of triglycylvasopressin to lysine-vasopressin in man.
Topics: Administration, Intranasal; Adult; Biological Assay; Blood Pressure; Female; Heart Rate; Humans; Injections, Intravenous; Lypressin; Male; Radioimmunoassay; Terlipressin | 1980 |
Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Dogs; Heart Rate; Hemodynamics; Liver Circulation; Lypressin; Splanchnic Circulation; Terlipressin | 1980 |
Effectiveness of triglycyl vasopressin in persistent hematuria associated with sickle cell hemoglobin.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Animals; Blood Pressure; Dogs; Erythrocyte Count; Female; Heart Rate; Hematuria; Hemoglobin, Sickle; Humans; Lypressin; Male; Pulse; Regional Blood Flow; Renal Artery; Terlipressin | 1980 |
Potentiometric and spectroscopic studies on the copper(II) complexes of peptide hormones containing disulfide bridges.
Topics: Amino Acid Sequence; Disulfides; Electron Spin Resonance Spectroscopy; Hormones; Lypressin; Molecular Sequence Data; Oxytocin; Potentiometry; Spectrophotometry; Terlipressin | 1995 |
Radioprotective effect of local administration of lysine-vasopressin and triglycyl-lysine-vasopressin on the rectal mucosa in rats.
Topics: Animals; Dose-Response Relationship, Drug; Intestinal Mucosa; Lypressin; Radiation Injuries, Experimental; Radiotherapy; Rats; Rats, Wistar; Rectum; Terlipressin | 1995 |
[Acute variceal hemorrhage: status of drug therapy].
Topics: Catheterization; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Survival Rate; Terlipressin | 1995 |
Octreotide infusion versus injection sclerotherapy.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Injections; Lypressin; Sclerotherapy; Terlipressin | 1993 |
[Pharmaceuticals plus endoscopic therapy for hemostasis. New therapeutic methods in esophageal varices].
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Hemostatics; Humans; Lypressin; Sclerotherapy; Somatostatin; Terlipressin | 1994 |
Control of hemorrhage during renal failure with triglycyl-lysine-vasopressin.
Topics: Adult; Bandages; Burns; Hemodynamics; Hemorrhage; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Lypressin; Male; Terlipressin | 1993 |
Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Topics: Animals; Blood Pressure; Carbon Dioxide; Heart Rate; Hemodynamics; Hydrogen-Ion Concentration; Hypertension, Portal; Liver Circulation; Liver Cirrhosis, Experimental; Lypressin; Male; Oxygen; Oxygen Consumption; Partial Pressure; Portal System; Portal Vein; Propranolol; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin; Vascular Resistance | 1993 |
Plasma ronidazole concentrations in sheep after intravenous, oral, intraruminal and intraabomasal administration.
Topics: Abomasum; Administration, Oral; Animals; Biological Availability; Deamino Arginine Vasopressin; Drinking; Gastrointestinal Motility; Injections, Intravenous; Lypressin; Ronidazole; Rumen; Sheep; Terlipressin | 1993 |
[Drug therapy of acute esophageal varices bleeding (vasopressin, terlipressin, somatostatin)].
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatics; Humans; Lypressin; Somatostatin; Terlipressin; Vasopressins | 1995 |
Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation.
Topics: Adult; Female; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Liver Transplantation; Lypressin; Terlipressin; Time Factors; Vasoconstrictor Agents | 1996 |
[Pharmacological therapy in bleeding esophageal varices: good results with glypressin].
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Neurotransmitter Agents; Terlipressin | 1996 |
Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance.
Topics: Adult; Body Water; Deamino Arginine Vasopressin; Diabetes Insipidus; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Proximal; Lypressin; Male; Metabolic Clearance Rate; Natriuresis; Receptors, Vasopressin; Sodium; Terlipressin; Uric Acid | 1996 |
Therapeutic benefit of vaso-active drugs for acute variceal bleeding: a real pharmacological effect, or a side-effect of definitions in trials?
Topics: Double-Blind Method; Drug Combinations; Gastrointestinal Hemorrhage; Humans; Lypressin; Nitroglycerin; Octreotide; Randomized Controlled Trials as Topic; Sclerotherapy; Terlipressin; Varicose Veins | 1996 |
Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Disease Models, Animal; Enzyme Inhibitors; Hypertension, Portal; In Vitro Techniques; Lypressin; Male; Mesenteric Arteries; Methoxamine; NG-Nitroarginine Methyl Ester; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Terlipressin; Vasodilation | 1996 |
[Myocardial infarction after injection of terlipressin for digestive hemorrhage].
Topics: Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Middle Aged; Myocardial Infarction; Terlipressin; Vasoconstrictor Agents | 1996 |
Terlipressin or somatostatin for acute variceal hemorrhage.
Topics: Acute Disease; Antihypertensive Agents; Hemorrhage; Humans; Lypressin; Somatostatin; Terlipressin; Varicose Veins | 1997 |
[Terlipressin acetate].
Topics: Antihypertensive Agents; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 1997 |
Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Drug Interactions; Drug Therapy, Combination; Hemodynamics; Hormones; Hypertension, Portal; Lypressin; Male; Octreotide; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin | 1997 |
Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.
Topics: Adult; Antihypertensive Agents; Deamino Arginine Vasopressin; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Diagnosis, Differential; Drinking; Female; Humans; Hypernatremia; Lypressin; Male; Medical Records; Renal Agents; Retrospective Studies; Sodium; Terlipressin; Uric Acid | 1997 |
[Hemostasis using vasopressin analogs during conization of the uterine cervix and minor vaginal operations].
Topics: Blood Loss, Surgical; Cervix Uteri; Conization; Female; Hemostasis, Surgical; Humans; Lypressin; Terlipressin; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vagina | 1997 |
Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diuresis; Dose-Response Relationship, Drug; Female; Hemodynamics; Hypertension, Portal; Lypressin; Male; Mesenteric Artery, Superior; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Splanchnic Circulation; Terlipressin; Time Factors; Vasoconstrictor Agents; Vasopressins | 1998 |
Terlipressin-exacerbated hypokalaemia.
Topics: Adult; Antihypertensive Agents; Female; Gastrointestinal Hemorrhage; Humans; Hypokalemia; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Terlipressin | 1998 |
Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Drug Therapy, Combination; Hemodynamics; Hypertension, Portal; Lypressin; Male; Octreotide; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin | 1998 |
Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension.
Topics: Animals; Drug Therapy, Combination; Guanidines; Hemodynamics; Hemorrhage; Hypertension, Portal; Lypressin; Male; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents | 1998 |
Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
Topics: Absorption; Acute Kidney Injury; Adult; Anti-Inflammatory Agents; Benzbromarone; Fludrocortisone; Gout; Humans; Kidney Tubules; Lypressin; Male; Probenecid; Pyrazinamide; Receptors, Vasopressin; Renal Agents; Terlipressin; Uric Acid; Uricosuric Agents | 1998 |
A discussion of how terlipressin limits mortality in cases of bleeding oesophageal varices.
Topics: Antihypertensive Agents; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Kidney; Liver; Lypressin; Portal System; Terlipressin | 1998 |
Splanchnic haemodynamics after intravenous terlipressin in anaesthetised healthy pigs.
Topics: Anesthesia; Animals; Antihypertensive Agents; Hemodynamics; Injections, Intravenous; Liver Circulation; Lypressin; Swine; Terlipressin | 1999 |
Portal hypotensive effects of combined terlipressin and DL-028, a synthetic alpha 1 adrenoceptor antagonist administration on anesthetized portal hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Antihypertensive Agents; Disease Models, Animal; Drug Therapy, Combination; Hypertension, Portal; Lypressin; Male; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Terlipressin; Venous Pressure | 1999 |
Endoscopic ultrasound duplex scanning for measurement of portal venous flow. Validation against transit time ultrasound flowmetry in pigs.
Topics: Animals; Blood Flow Velocity; Endosonography; Female; Lypressin; Male; Portal System; Portal Vein; Random Allocation; Swine; Terlipressin; Ultrasonography, Doppler, Duplex | 1999 |
Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system.
Topics: Aged; Anesthesia; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Electrocardiography; Female; Humans; Hypotension; Intraoperative Complications; Lypressin; Male; Receptors, Vasopressin; Terlipressin | 1999 |
The action of vasoconstrictive agents on human tubal arteries.
Topics: Arteries; Dinoprost; Drug Combinations; Epinephrine; Fallopian Tubes; Female; Humans; In Vitro Techniques; Lypressin; Terlipressin; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 1999 |
[Terlipressin in the treatment of portal hypertension].
Topics: Antihypertensive Agents; Humans; Hypertension, Portal; Lypressin; Meta-Analysis as Topic; Terlipressin | 1999 |
Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists.
Topics: Adrenergic Agents; Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Enalapril; Endarterectomy, Carotid; Ephedrine; Humans; Hypotension; Irbesartan; Lypressin; Male; Phenylephrine; Terlipressin; Tetrazoles; Vasoconstrictor Agents | 1999 |
Toxic rhabdomyolysis induced by terlipressin infusion in a uraemic patient suffering from AA-type amyloidosis.
Topics: Adult; Amyloidosis; Antihypertensive Agents; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Lypressin; Male; Nephrotic Syndrome; Rhabdomyolysis; Terlipressin; Uremia | 1999 |
Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Cholestasis; Disease Models, Animal; Drug Therapy, Combination; Hemodynamics; Hypertension, Portal; Lypressin; Male; Portal Vein; Pyrazines; Rats; Rats, Sprague-Dawley; Terlipressin; Vasodilator Agents | 1999 |
[Possibilities of reducing blood loss during gynecologic operations with drugs].
Topics: Blood Loss, Surgical; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Leiomyoma; Lypressin; Terlipressin; Triptorelin Pamoate; Uterine Neoplasms; Vasoconstrictor Agents | 1999 |
[The use of the vasoconstrictor hemostatic Remestyp in surgical obstetrics].
Topics: Female; Hemostatics; Humans; Lypressin; Obstetric Surgical Procedures; Placenta Previa; Postoperative Care; Postoperative Hemorrhage; Pregnancy; Terlipressin; Uterine Hemorrhage; Vasoconstrictor Agents | 1999 |
Effects of prostacyclin inhibition on splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Blood Transfusion; Cyclooxygenase Inhibitors; Gastrointestinal Hemorrhage; Hemodynamics; Hypertension, Portal; Indomethacin; Lypressin; Male; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin | 2000 |
Hepatorenal syndrome in cirrhotic patients: terlipressine is a safe and efficient treatment; propranolol and digitalic treatments: precipitating and preventing factors?
Topics: Adult; Aged; Digitoxin; Female; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Propranolol; Recurrence; Terlipressin; Vasoconstrictor Agents | 2000 |
Vascular hyporesponsiveness in cirrhosis - many facets of a common problem!
Topics: Animals; Biomechanical Phenomena; Epoprostenol; Hypertension, Portal; Liver Cirrhosis; Lypressin; Models, Biological; Rats; Terlipressin | 2001 |
Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hyposensitivity to glypressin in haemorrhage-transfused common bile duct-ligated rats.
Topics: Animals; Blood Transfusion; Common Bile Duct; Drug Interactions; Epoprostenol; Hemorrhage; Hypertension, Portal; Indomethacin; Ligation; Lypressin; Male; Rats; Rats, Wistar; Splanchnic Circulation; Terlipressin; Vasoconstriction | 2001 |
Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Topics: Animals; Antihypertensive Agents; Blood Transfusion; Drug Synergism; Enzyme Inhibitors; Hemodynamics; Hemorrhage; Hypertension, Portal; Lypressin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents | 2000 |
Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia?
Topics: Anesthesia, General; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Aortic Aneurysm, Abdominal; Coronary Angiography; Electrocardiography; Humans; Hypotension; Intraoperative Complications; Lypressin; Male; Middle Aged; Monitoring, Intraoperative; Myocardial Ischemia; Prodrugs; Terlipressin | 2001 |
New method of cardiac output measurement using ultrasound velocity dilution in rats.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Flow Velocity; Blood Pressure; Cardiac Output; Hypertension, Portal; Indicator Dilution Techniques; Losartan; Lypressin; Male; Microspheres; Observer Variation; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Terlipressin; Ultrasonography; Vasoconstrictor Agents | 2001 |
[Application of Remestip for genital hemorrhages in pubescent youth].
Topics: Adolescent; Female; Humans; Injections, Intravenous; Lypressin; Terlipressin; Time Factors; Uterine Hemorrhage; Vasoconstrictor Agents | 2000 |
Comparative effects of the novel vasotocin analogue F-180 vs. vasopressin and terlipressin on systemic and splanchnic isolated vessels from portal hypertensive rats.
Topics: Animals; Hypertension, Portal; Lypressin; Male; Mesenteric Arteries; Mesenteric Veins; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Terlipressin; Vasoconstriction; Vasoconstrictor Agents; Vasopressins | 2001 |
Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep.
Topics: Animals; Drug Interactions; Endotoxemia; Female; Hemodynamics; Lypressin; Norepinephrine; Sheep; Terlipressin; Vasoconstrictor Agents | 2001 |
Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices.
Topics: Adult; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemostasis; Humans; Injections, Intravenous; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Prothrombin Time; Recombinant Proteins; Terlipressin; Vasoconstrictor Agents | 2001 |
Life, death, and varices.
Topics: Antibiotic Prophylaxis; Antihypertensive Agents; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Sclerotherapy; Terlipressin; Treatment Outcome | 2001 |
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.
Topics: Aged; Antihypertensive Agents; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Multivariate Analysis; Renal Insufficiency; Retrospective Studies; Survival Analysis; Terlipressin | 2002 |
Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study.
Topics: Aged; Creatinine; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Function Tests; Lypressin; Male; Middle Aged; Pilot Projects; Retrospective Studies; Terlipressin; Vasoconstrictor Agents | 2002 |
Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.
Topics: Adult; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Retrospective Studies; Severity of Illness Index; Survival Rate; Terlipressin; Vasoconstrictor Agents | 2002 |
Terlipressin and arterial blood volume after paracentesis for tense ascites in cirrhosis.
Topics: Ascites; Humans; Hypovolemia; Liver Cirrhosis; Lypressin; Paracentesis; Terlipressin; Vasoconstrictor Agents | 2002 |
Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis.
Topics: Alanine Transaminase; Animals; Aorta, Thoracic; Blood Pressure; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Hypotension; Lipopolysaccharides; Liver Cirrhosis, Biliary; Lypressin; Lysine; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phenylephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Shock, Septic; Terlipressin; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2002 |
Terlipressin for haemodynamic support in septic patients: a double-edged sword?
Topics: Animals; Hemodynamics; Humans; Intestinal Mucosa; Ischemia; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2002 |
Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome?
Topics: Acetylcysteine; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstriction; Vasoconstrictor Agents | 2002 |
[Comparison of Doppler ultrasonography and hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis].
Topics: Antihypertensive Agents; Blood Flow Velocity; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Terlipressin; Ultrasonography, Doppler; Venous Pressure | 2002 |
Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats.
Topics: Animals; Hemodynamics; Lypressin; Male; Microcirculation; Random Allocation; Rats; Rats, Wistar; Shock, Septic; Splanchnic Circulation; Statistics, Nonparametric; Survival Analysis; Terlipressin; Vasoconstrictor Agents | 2003 |
Patient with a sudden drop in blood pressure.
Topics: Animals; Fluid Therapy; Humans; Hypotension; Lypressin; Rats; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2003 |
Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport.
Topics: Animals; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endotoxemia; Female; Hemodynamics; Infusions, Intravenous; Lypressin; Oxygen Consumption; Prospective Studies; Pulmonary Circulation; Respiratory Transport; Sheep; Shock, Septic; Terlipressin; Typhoid Fever; Vasoconstrictor Agents | 2003 |
Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis.
Topics: Adult; Aged; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Pulsatile Flow; Reproducibility of Results; Severity of Illness Index; Terlipressin; Ultrasonography, Doppler; Vascular Resistance | 2003 |
Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar.
Topics: Animals; Gastrointestinal Hemorrhage; Humans; Hypotension; Ischemia; Lypressin; Rats; Shock, Septic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents | 2003 |
Terlipressin and albumin for the hepatorenal syndrome.
Topics: Albumins; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2003 |
Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndrome.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Hydroxyethyl Starch Derivatives; Infusions, Intravenous; Lypressin; Male; Middle Aged; Plasma Substitutes; Postoperative Complications; Terlipressin; Vasoconstrictor Agents | 2003 |
Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? A case report.
Topics: Aged; Ascites; Bacterial Infections; Dose-Response Relationship, Drug; Fatal Outcome; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Ischemia; Liver Cirrhosis; Lypressin; Male; Peritonitis; Rectum; Serum Albumin; Terlipressin; Vasoconstrictor Agents | 2003 |
[Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin?].
Topics: Adrenergic beta-Agonists; Aged; Catecholamines; Dobutamine; Drug Resistance; Female; Hemodynamics; Humans; Infusions, Intravenous; Lypressin; Male; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2003 |
Terlipressin infusion in catecholamine-resistant shock.
Topics: Blood Pressure; Catecholamines; Drug Synergism; Hemodynamics; Humans; Infusions, Intravenous; Lypressin; Male; Middle Aged; Shock; Terlipressin; Time Factors; Vasoconstrictor Agents; Ventricular Fibrillation | 2003 |
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study.
Topics: Case-Control Studies; Female; Hepatorenal Syndrome; Humans; Kidney; Liver Failure; Liver Transplantation; Lypressin; Male; Middle Aged; Ornipressin; Postoperative Complications; Postoperative Period; Prognosis; Survival Analysis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2004 |
Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study.
Topics: Adult; Ascites; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Lypressin; Male; Middle Aged; Pilot Projects; Portal System; Statistics, Nonparametric; Terlipressin | 2004 |
Terlipressin bolus induces systemic vasoconstriction in septic shock.
Topics: Child; Escherichia coli Infections; Humans; Injections, Intravenous; Klebsiella Infections; Lypressin; Male; Norepinephrine; Shock, Septic; Terlipressin; Vascular Resistance; Vasoconstrictor Agents | 2004 |
Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock.
Topics: Blood Pressure; Catecholamines; Humans; Hypotension; Infant, Newborn; Injections, Intravenous; Klebsiella Infections; Lypressin; Male; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Terlipressin in patients with septic shock: friend or foe?
Topics: Humans; Lypressin; Oxygen Consumption; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
A long-acting vasopressin analog for septic shock: brilliant idea or dangerous folly?
Topics: Child; Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Terlipressin for cerebral perfusion pressure support in a patient with septic shock.
Topics: Cerebrovascular Circulation; Critical Care; Female; Humans; Intracranial Aneurysm; Lypressin; Middle Aged; Postoperative Complications; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Terlipressin and albumin combination treatment in hepatorenal syndrome.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Creatinine; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Retrospective Studies; Survival Rate; Terlipressin; Turkey; Vasoconstrictor Agents | 2003 |
Pressure or flow?
Topics: Hemodynamics; Humans; Infusions, Intravenous; Lypressin; Shock; Terlipressin; Vasoconstrictor Agents | 2004 |
Terlipressin increased the concentration of L-lactate in the rectal lumen in a patient with septic shock.
Topics: Aged; Cardiac Output; Dialysis; Hemodynamics; Humans; Lactic Acid; Lypressin; Male; Norepinephrine; Rectum; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2004 |
Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aged; Angiotensin II; Case-Control Studies; Cisapride; Eating; Female; Glucagon; Humans; Hydrocortisone; Hypothalamic Hormones; Incidental Findings; Lypressin; Male; Middle Aged; Posture; Prospective Studies; Serotonin Receptor Agonists; Stimulation, Chemical; Terlipressin; Vasoconstrictor Agents | 2004 |
Nitric oxide synthase expression in the splanchnic hyposensitivity to glypressin of a hemorrhage-transfused rat model with portal hypertension.
Topics: Animals; Antihypertensive Agents; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Hemorrhage; Hypertension, Portal; Lypressin; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Terlipressin | 2004 |
[Hematemesis].
Topics: Diagnosis, Differential; Emergencies; Endoscopy, Digestive System; Gastrointestinal Hemorrhage; Germany; Hematemesis; Humans; Lypressin; Octreotide; Somatostatin; Survival Rate; Terlipressin | 2004 |
Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart.
Topics: Animals; Arginine Vasopressin; Blood Gas Analysis; Blood Pressure; Buffers; Cardiac Output; Electrolytes; Erythrocytes; Female; Heart; In Vitro Techniques; Lypressin; Norepinephrine; Oxygen Consumption; Perfusion; Rabbits; Stroke Volume; Terlipressin; Vasoconstrictor Agents; Vasopressins; Ventricular Function, Left | 2005 |
Nitric-oxide-lowering effect of terlipressin in decompensated cirrhosis: comparison to the molecular adsorbent recirculating system and correlation with clinical status.
Topics: Aged; Endotoxemia; Humans; Hypotension; Liver Cirrhosis; Liver, Artificial; Lypressin; Male; Nitric Oxide; Sorption Detoxification; Terlipressin; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents; Vasodilation | 2004 |
Terlipressin-related acute myocardial infarction: a case report and literature review.
Topics: Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Lypressin; Myocardial Infarction; Terlipressin | 2004 |
Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism.
Topics: Animals; Blood Pressure; Cardiac Output; Endotoxemia; Endotoxins; Escherichia coli; Female; Glucose; Hemodynamics; Hydrogen-Ion Concentration; Lactic Acid; Lipopolysaccharides; Liver Circulation; Lypressin; Male; Oxygen; Oxygen Consumption; Pyruvic Acid; Splanchnic Circulation; Swine; Terlipressin; Vascular Resistance; Vasoconstrictor Agents | 2005 |
Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art's sake or state of the art?
Topics: Animals; Hemodynamics; Humans; Liver Circulation; Lypressin; Sepsis; Splanchnic Circulation; Systemic Inflammatory Response Syndrome; Terlipressin; Vasoconstrictor Agents | 2005 |
Terlipressin as rescue therapy for intractable hypotension due to septic shock in children.
Topics: Adolescent; Antihypertensive Agents; Blood Pressure; Catecholamines; Child; Child, Preschool; Creatinine; Epinephrine; Female; Heart Rate; Humans; Hypotension; Infant; Infant, Newborn; Lypressin; Male; Oxygen; Prognosis; Shock, Septic; Terlipressin; Time Factors | 2005 |
Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen.
Topics: Animals; Antibodies; Blood; Drug Synergism; Gastric Lavage; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Glucagon; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Octreotide; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Stomach; Terlipressin; Vasoconstrictor Agents | 2005 |
[Vasopressin and terlipressin in anesthesia and postoperative recovery care: limits on use in Spain].
Topics: Anesthesia; Anesthesia Recovery Period; Drug Utilization; Humans; Lypressin; Spain; Terlipressin; Vasopressins | 2005 |
Terlipressin: a new therapeutic for calcium-channel blockers overdose.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Drug Overdose; Humans; Lypressin; Male; Middle Aged; Terlipressin | 2005 |
Sublingual microcirculatory flow is impaired by the vasopressin-analogue terlipressin in a patient with catecholamine-resistant septic shock.
Topics: Acid-Base Equilibrium; Aged, 80 and over; Blood Pressure; Catecholamines; Drug Resistance; Fatal Outcome; Female; Hemodynamics; Humans; Lypressin; Meningitis, Meningococcal; Microcirculation; Mouth Floor; Regional Blood Flow; Respiration, Artificial; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2005 |
Hemodynamic support in septic shock: is restoring a normal blood pressure the right target?
Topics: Blood Pressure; Humans; Lypressin; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2005 |
Terlipressin avoids hemodialysis in the treatment of refractory hyperkalemia associated with renal dysfunction in cirrhosis.
Topics: Hepatorenal Syndrome; Humans; Hyperkalemia; Liver Cirrhosis; Lypressin; Male; Middle Aged; Renal Agents; Terlipressin | 2005 |
Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock.
Topics: Blood Pressure; Catecholamines; Fatal Outcome; Female; Humans; Hypotension; Infant; Infusions, Intravenous; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2006 |
Rescue treatment with terlipressin in children with refractory septic shock: a clinical study.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Hypotension; Infant; Infant, Newborn; Lypressin; Male; Meningitis, Meningococcal; Prospective Studies; Shock, Septic; Staphylococcal Infections; Terlipressin | 2006 |
Terlipressin for refractory hypotension following angiotensin-II receptor antagonist overdose.
Topics: Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Drug Overdose; Female; Humans; Hypotension; Irbesartan; Lypressin; Middle Aged; Terlipressin; Tetrazoles; Vasoconstrictor Agents | 2006 |
Comparison of arginine vasopressin, terlipressin, or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized brown Norway rats.
Topics: Anaphylaxis; Anesthesia; Animals; Arginine Vasopressin; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Epinephrine; Hypotension; Lypressin; Oxygen; Rats; Rats, Inbred BN; Terlipressin | 2006 |
Severe ischemia of the lower limb and of the intestine associated with systemic vasoconstrictor therapy and femoral arterial catheterization.
Topics: Cardiac Output; Catheterization, Peripheral; Fatal Outcome; Female; Femoral Artery; Humans; Infant; Intestines; Ischemia; Leg; Lypressin; Terlipressin; Vasoconstrictor Agents | 2006 |
Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient.
Topics: Albumins; Hepatitis B; Hepatitis D; Humans; Hydrothorax; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2006 |
[A case of peripheral ischemic complication after terlipressin therapy].
Topics: Adult; Hand; Hepatorenal Syndrome; Humans; Ischemia; Lypressin; Male; Terlipressin; Toes; Vasoconstrictor Agents | 2006 |
Terlipressin for haemodynamic support in septic shock: less may be more.
Topics: Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2006 |
Science to practice: Noninvasive assessment of portal hypertension--can US aid in the prediction of portal pressure and monitoring of therapy?
Topics: Antihypertensive Agents; Humans; Hypertension, Portal; Lypressin; Monitoring, Physiologic; Portal Pressure; Prognosis; Terlipressin; Ultrasonography, Doppler | 2006 |
Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response.
Topics: Antihypertensive Agents; Esophageal and Gastric Varices; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Logistic Models; Lypressin; Male; Middle Aged; Monitoring, Physiologic; Portal Pressure; Prognosis; Prospective Studies; Sensitivity and Specificity; Terlipressin; Ultrasonography, Doppler | 2006 |
Cardiovascular collapse due to massive pulmonary thromboembolism during orthotopic liver transplantation.
Topics: Aprotinin; Blood Pressure; Bronchodilator Agents; Cardiotonic Agents; Catheterization, Swan-Ganz; Echocardiography, Transesophageal; Female; Heart Ventricles; Hemostatics; Humans; Intraoperative Complications; Liver Transplantation; Lypressin; Middle Aged; Milrinone; Nitric Oxide; Platelet Aggregation Inhibitors; Platelet Transfusion; Pulmonary Embolism; Terlipressin; Ventricular Dysfunction, Right | 2006 |
Terlipressin as an adjunct vasopressor in refractory hypotension after tricyclic antidepressant intoxication.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Blood Pressure Determination; Catecholamines; Drug Overdose; Female; Humans; Hypotension; Lypressin; Terlipressin; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2007 |
Terlipressin facilitates transport of septic patients treated with norepinephrine.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Female; Humans; Lypressin; Male; Middle Aged; Norepinephrine; Retrospective Studies; Shock, Septic; Terlipressin; Transportation of Patients; Vasoconstrictor Agents | 2006 |
Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Pulse; Terlipressin; Vasoconstrictor Agents | 2006 |
Beneficial effects of terlipressin in prolonged pediatric cardiopulmonary resuscitation: a case series.
Topics: Cardiopulmonary Resuscitation; Child; Child, Preschool; Drug Therapy, Combination; Epinephrine; Female; Heart Arrest; Hospitals, University; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Lypressin; Male; Retrospective Studies; Terlipressin; Vasoconstrictor Agents | 2007 |
Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome.
Topics: Antihypertensive Agents; Blood Pressure; Chronic Disease; Curcumin; Cyclic GMP; Echocardiography; Female; Hepatopulmonary Syndrome; Humans; Lypressin; Methylene Blue; Middle Aged; Nitric Oxide; Terlipressin; Treatment Failure; Vascular Resistance | 2007 |
Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury.
Topics: Accidents, Traffic; Adolescent; Blood Pressure; Brain Injuries; Catecholamines; Cerebrovascular Circulation; Drug Resistance; Fatal Outcome; Humans; Lypressin; Male; Motorcycles; Multiple Organ Failure; Norepinephrine; Oxygen; Respiratory Distress Syndrome; Severity of Illness Index; Shock; Systemic Inflammatory Response Syndrome; Terlipressin; Time Factors; Vasoconstrictor Agents | 2007 |
Impact of terlipressin on hepatosplanchnic perfusion: "only the dose makes a thing not a poison" (paracelsus).
Topics: Humans; Hypotension; Lypressin; Microcirculation; Sepsis; Splanchnic Circulation; Terlipressin | 2007 |
Terlipressin causing a hyponatraemic seizure.
Topics: Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hyponatremia; Ligation; Lypressin; Middle Aged; Seizures; Shock, Septic; Sodium; Terlipressin; Vasoconstrictor Agents | 2007 |
Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better?
Topics: Adult; Aged; Critical Care; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lypressin; Male; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2007 |
[Terlipressin and reversible intestinal ischaemia].
Topics: Colon; Humans; Intestine, Small; Ischemia; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2007 |
An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis.
Topics: Cost-Benefit Analysis; Drug Costs; Esophageal and Gastric Varices; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Octreotide; Terlipressin; United Kingdom; Vasoconstrictor Agents | 2007 |
Successful use of terlipressin in post-cardiac arrest resuscitation after an epinephrine-resistant anaphylactic shock to suxamethonium.
Topics: Anaphylaxis; Anesthesia, General; Cardiopulmonary Resuscitation; Drug Resistance; Epinephrine; Heart Arrest; Hernia, Inguinal; Humans; Lypressin; Male; Middle Aged; Neuromuscular Depolarizing Agents; Succinylcholine; Terlipressin; Vasoconstrictor Agents | 2007 |
Continuous versus bolus infusion of terlipressin in ovine endotoxemia.
Topics: Animals; Catecholamines; Disease Models, Animal; Endotoxemia; Endotoxins; Female; Heart Rate; Hemodynamics; Humans; Hypotension; Lypressin; Myocardium; Random Allocation; Salmonella typhi; Sheep; Tachyphylaxis; Terlipressin; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support.
Topics: Adolescent; Adult; Brain; Cerebrovascular Circulation; Extracellular Fluid; Female; Humans; Intracranial Pressure; Lactic Acid; Liver Failure, Acute; Lypressin; Male; Microdialysis; Middle Aged; Norepinephrine; Osmolar Concentration; Pyruvic Acid; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2007 |
Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver.
Topics: Blood Pressure; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2007 |
The use of terlipressin in a 14-year-old adolescent with catecholamine-resistant shock after severe traumatic brain injury.
Topics: Adult; Arginine Vasopressin; Blood Pressure; Brain Injuries; Catecholamines; Cerebrovascular Circulation; Drug Resistance; Humans; Lypressin; Male; Shock; Terlipressin; Vasoconstrictor Agents | 2007 |
Employing dobutamine as a useful agent to reverse the terlipressin-linked impairments in cardiopulmonary hemodynamics and global oxygen transport in healthy and endotoxemic sheep.
Topics: Animals; Blood Pressure; Dobutamine; Endotoxemia; Female; Hemodynamics; Infusions, Intravenous; Lypressin; Oxygen; Sheep; Terlipressin; Vascular Resistance | 2008 |
Long-term outcome of patients treated with terlipressin for types 1 and 2 hepatorenal syndrome.
Topics: Adult; Aged; Cardiovascular Agents; Female; Hepatorenal Syndrome; Humans; Kaplan-Meier Estimate; Kidney; Liver Transplantation; Lypressin; Male; Middle Aged; Patient Selection; Retrospective Studies; Risk Assessment; Severity of Illness Index; Terlipressin; Time Factors; Treatment Outcome | 2008 |
Pharmacological treatment of hepatorenal syndrome: a note of optimism.
Topics: Albumins; Baroreflex; Blood Pressure; Central Venous Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hypovolemia; Kidney; Lypressin; Norepinephrine; Portacaval Shunt, Surgical; Regional Blood Flow; Renal Artery; Terlipressin; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Continuous low-dose infusion of terlipressin as a rescue therapy in meningococcal septic shock.
Topics: Child, Preschool; Female; Humans; Infusions, Parenteral; Lypressin; Meningococcal Infections; Neisseria meningitidis, Serogroup B; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2007 |
Ischaemic complications of Glypressin in liver disease: a case series.
Topics: Female; Humans; Ischemia; Liver Cirrhosis; Lypressin; Male; Middle Aged; Necrosis; Skin; Terlipressin; Vasoconstrictor Agents | 2007 |
Terlipressin and tricyclic antidepressant intoxication.
Topics: Aged; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Drug Interactions; Drug Overdose; Female; Humans; Lypressin; Sodium Bicarbonate; Terlipressin | 2007 |
Prevention and treatment of major blood loss.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hemorrhage; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2007 |
Continuous terlipressin infusion in patients with persistent septic shock and cirrhosis of the liver.
Topics: Adult; Aged; Critical Care; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lypressin; Male; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2008 |
Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
Topics: Albumins; Female; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Time Factors; Vasoconstrictor Agents | 2008 |
Impact of terlipressin on renal graft function.
Topics: Adult; Aged; Antihypertensive Agents; Brain Death; Creatinine; Female; Graft Survival; Humans; Hypotension; Kidney; Kidney Transplantation; Liver; Lypressin; Male; Middle Aged; Norepinephrine; Recovery of Function; Retrospective Studies; Shock; Terlipressin; Transplantation, Homologous | 2008 |
Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome.
Topics: Aged; Breast; Cyanosis; Female; Hepatorenal Syndrome; Humans; Infusions, Intra-Arterial; Ischemia; Liver Cirrhosis; Lypressin; Skin; Terlipressin; Vasoconstrictor Agents | 2008 |
Significant improvement of portopulmonary hypertension after 1-week terlipressin treatment.
Topics: Adult; Antihypertensive Agents; Follow-Up Studies; Humans; Hypertension, Portal; Hypertension, Pulmonary; Injections, Intravenous; Lypressin; Male; Shock, Septic; Terlipressin; Time Factors | 2008 |
Terlipressin as rescue treatment of refractory shock in a neonate.
Topics: Abdominal Neoplasms; Fatal Outcome; Humans; Infant, Newborn; Lypressin; Male; Neuroblastoma; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2008 |
Somatostatin or its analogs and terlipressin: Different evidence levels, Same recommendations?
Topics: Antihypertensive Agents; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hormones; Humans; Lypressin; Somatostatin; Terlipressin | 2008 |
A retrospective analysis of Terlipressin infusion in patients with refractory hypotension after cardiac surgery.
Topics: Aged; Analysis of Variance; Cardiac Surgical Procedures; Chi-Square Distribution; Female; Humans; Hypotension; Infusions, Intravenous; Lypressin; Male; Retrospective Studies; Statistics, Nonparametric; Survivors; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2008 |
[The results of treatment patients with hepatorenal syndrome. The analysis of 65 cases].
Topics: Adult; Albumins; Diuretics; Dopamine; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Paracentesis; Renal Dialysis; Terlipressin; Treatment Outcome | 2006 |
Vasoconstrictor therapy for the hepatorenal syndrome.
Topics: Dose-Response Relationship, Drug; Hepatorenal Syndrome; Humans; Injections, Intravenous; Lypressin; Severity of Illness Index; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2008 |
Dobutamine and terlipressin in patients with septic shock.
Topics: Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2008 |
[A case of ischemic skin necrosis after glypressin therapy in liver cirrhosis].
Topics: Aged; Fatal Outcome; Hematemesis; Hemorrhage; Humans; Ischemia; Liver Cirrhosis; Lypressin; Male; Melena; Necrosis; Skin; Terlipressin; Vasoconstrictor Agents | 2008 |
Terlipressin-induced ventricular arrhythmia.
Topics: Adult; Electric Countershock; Electrocardiography; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Long QT Syndrome; Lypressin; Male; Risk Assessment; Severity of Illness Index; Terlipressin; Torsades de Pointes; Treatment Outcome; Vasoconstrictor Agents | 2008 |
Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome.
Topics: Adrenergic alpha-Agonists; Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Midodrine; Terlipressin; Vasoconstrictor Agents | 2008 |
Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis.
Topics: Adult; Aged; Cohort Studies; Female; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; Infections; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Treatment Outcome | 2008 |
Two observations raising questions about risk factors of cutaneous necrosis induced by terlipressin (Glypressin).
Topics: Aged; Humans; Ischemia; Lypressin; Male; Necrosis; Risk Factors; Skin; Skin Diseases; Terlipressin; Vasoconstrictor Agents | 2009 |
Terlipressin in 30 patients with hepatorenal syndrome: results of a retrospective study.
Topics: Adult; Aged; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Male; Middle Aged; Prognosis; Renal Dialysis; Retrospective Studies; Terlipressin; Vasoconstrictor Agents | 2009 |
Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study.
Topics: Case-Control Studies; Drug Administration Schedule; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Midodrine; Prospective Studies; Secondary Prevention; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2009 |
Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performance.
Topics: Animals; Coronary Circulation; Heart; Lypressin; Male; Rats; Rats, Wistar; Terlipressin; Vasoconstrictor Agents | 2009 |
Terlipressin--more than just a prodrug of lysine vasopressin?
Topics: Animals; Humans; Lypressin; Prodrugs; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
Terlipressin for children with extremely low cardiac output after open heart surgery.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Child; Child, Preschool; Drug Evaluation; Female; Heart Rate; Hemodynamics; Humans; Infant; Infant, Newborn; Kidney Function Tests; Lypressin; Male; Respiratory Function Tests; Retrospective Studies; Terlipressin; Vasoconstrictor Agents | 2009 |
Diabetic muscle infarction in association with terlipressin therapy: a case report.
Topics: Diabetes Mellitus, Type 2; Humans; Infarction; Lypressin; Male; Middle Aged; Muscles; Radiography; Terlipressin | 2009 |
Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.
Topics: Animals; Arginine Vasopressin; Drug Therapy, Combination; Female; Hemodynamics; Lypressin; Random Allocation; Sheep; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
Comment: Terlipressin for children with extremely low cardiac output after open heart surgery.
Topics: Arginine Vasopressin; Cardiac Output, Low; Child; Hemodynamics; Humans; Infant, Newborn; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
Terlipressin continuous infusion: please mind the solvent!
Topics: Drug Stability; Glucose; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Lypressin; Shock, Septic; Sodium Chloride; Solutions; Solvents; Terlipressin; Vasoconstrictor Agents | 2009 |
Hyperkalemia accompanies hemorrhagic shock and correlates with mortality.
Topics: Animals; Disease Models, Animal; Fluid Therapy; Heart Arrest; Hemostatics; Hyperkalemia; Lypressin; Male; Resuscitation; Shock, Hemorrhagic; Survival Rate; Swine; Terlipressin | 2009 |
A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.
Topics: Aged; Aged, 80 and over; Blood Pressure; Cardiac Output; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Central Venous Pressure; Drug Resistance; Female; Humans; Hypotension; Injections; Lactic Acid; Lypressin; Male; Middle Aged; Norepinephrine; Retrospective Studies; Terlipressin; Time Factors; Treatment Outcome; Urination; Vascular Resistance; Vasoconstrictor Agents; Vasoplegia | 2009 |
Pediatric cardiac arrest refractory to advanced life support: is there a role for terlipressin?
Topics: Advanced Cardiac Life Support; Child; Child, Preschool; Compassionate Use Trials; Dose-Response Relationship, Drug; Female; Hospitals, Pediatric; Humans; Infant; Intensive Care Units, Pediatric; Lypressin; Male; Prospective Studies; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2010 |
The role of terlipressin in the management of severe pulmonary hypertension in congenital diaphragmatic hernia.
Topics: Antihypertensive Agents; Blood Pressure; Female; Hernias, Diaphragmatic, Congenital; Humans; Hypertension, Pulmonary; Infant; Lypressin; Oxygen; Terlipressin; Treatment Outcome | 2009 |
Terlipressin for hepatorenal syndrome: continuous infusion as an alternative to i.v. bolus administration.
Topics: Creatinine; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Injections, Intravenous; Lypressin; Terlipressin; Vasoconstrictor Agents | 2009 |
Prevention of early variceal rebleeding adding banding to terlipressin therapy.
Topics: Aged; Combined Modality Therapy; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Ligation; Liver Cirrhosis; Lypressin; Recurrence; Terlipressin; Vasoconstrictor Agents | 2009 |
Cutaneous necrosis secondary to terlipressin therapy.
Topics: Adult; Fatal Outcome; Hepatorenal Syndrome; Humans; Ischemia; Lypressin; Male; Necrosis; Skin; Terlipressin | 2009 |
Terlipressin vs. octreotide in bleeding esophageal varices.
Topics: Esophageal and Gastric Varices; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Lypressin; Octreotide; Terlipressin; Vasoconstrictor Agents | 2009 |
Terlipressin or europressin?
Topics: Humans; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
Terlipressin in control of acute hemobilia during therapeutic ERCP in patient with portal biliopathy.
Topics: Acute Disease; Adult; Bile Ducts; Cholangiopancreatography, Endoscopic Retrograde; Female; Hemobilia; Humans; Jaundice, Obstructive; Lypressin; Male; Middle Aged; Portal Vein; Retrospective Studies; Sphincterotomy, Transduodenal; Terlipressin; Vasoconstrictor Agents; Young Adult | 2009 |
Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.
Topics: Aged; Albumins; Antihypertensive Agents; Blood Pressure; Creatinine; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Predictive Value of Tests; Terlipressin | 2010 |
Combination of endoscopic band ligation with terlipressin is better than that with octreotide in shortening hospital stay?
Topics: Acute Disease; Combined Modality Therapy; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; Length of Stay; Ligation; Lypressin; Male; Octreotide; Prognosis; Risk Assessment; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2009 |
Terlipressin therapy for renal failure in cirrhosis.
Topics: Adult; Aged; Creatinine; Electrolytes; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Multivariate Analysis; Renal Insufficiency; Retrospective Studies; Serum Albumin; Terlipressin; Treatment Outcome; Urea; Vasoconstrictor Agents; Young Adult | 2010 |
Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
Topics: Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Lypressin; Renal Circulation; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2009 |
Hyponatraemia during terlipressin therapy.
Topics: Esophageal and Gastric Varices; Humans; Hyponatremia; Lypressin; Terlipressin; Vasoconstrictor Agents | 2010 |
Terlipressin versus adrenaline in an infant animal model of asphyxial cardiac arrest.
Topics: Animals; Asphyxia; Cardiopulmonary Resuscitation; Disease Models, Animal; Drug Therapy, Combination; Epinephrine; Heart Failure; Lypressin; Prospective Studies; Swine; Terlipressin; Vasoconstrictor Agents | 2010 |
Terlipressin-induced hyponatremic seizure.
Topics: Humans; Hyponatremia; Lypressin; Male; Middle Aged; Seizures; Terlipressin; Vasoconstrictor Agents | 2010 |
Effects of a single dose of terlipressin on transcutaneous oxygen pressures.
Topics: Adult; Blood Gas Monitoring, Transcutaneous; Female; Humans; Hypoxia; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2010 |
[Management of digestive system hemorrhages].
Topics: Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hematemesis; Humans; Hypertension, Portal; Lypressin; Octreotide; Somatostatin; Terlipressin | 2010 |
Hepatorenal syndrome: diagnosis and effect of terlipressin therapy in 4 pediatric patients.
Topics: Adolescent; Child, Preschool; Female; Hepatorenal Syndrome; Humans; Infant; Lypressin; Male; Terlipressin; Treatment Outcome | 2010 |
[Terlipressin as rescue therapy in hypercyanotic spells of Fallot tetralogy].
Topics: Cyanosis; Humans; Hypoxia; Infant; Lypressin; Male; Terlipressin; Tetralogy of Fallot; Vasoconstrictor Agents | 2010 |
Terlipressin-induced skin necrosis and rhabdomyolysis.
Topics: Humans; Lypressin; Male; Middle Aged; Necrosis; Rhabdomyolysis; Skin; Terlipressin; Vasoconstrictor Agents | 2010 |
Terlipressin saved the life of a child with severe nonvariceal upper gastrointestinal bleeding.
Topics: Duodenal Diseases; Emergency Service, Hospital; Gastrointestinal Hemorrhage; Humans; Infant; Lypressin; Male; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2011 |
Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation.
Topics: Adult; Aged; Albumins; Creatinine; Drug Administration Schedule; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Liver Transplantation; Lypressin; Male; Middle Aged; Terlipressin; Time Factors; Vasoconstrictor Agents | 2011 |
Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock.
Topics: Adolescent; Blood Pressure; Catecholamines; Child; Child, Preschool; Drug Resistance; Female; Hemodynamics; Hospitals, University; Humans; Hypotension; Infant; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Pediatric; Ischemia; Lypressin; Male; Prospective Studies; Shock, Septic; Spain; Survival Rate; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2010 |
[Type 2 hepatorenal syndrome in a cirrhotic patient who underwent gastric cancer surgery].
Topics: Adult; Hepatitis C; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Portasystemic Shunt, Transjugular Intrahepatic; Stomach Neoplasms; Terlipressin; Tomography, X-Ray Computed; Vasoconstrictor Agents | 2010 |
Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.
Topics: Adult; Aged; Bilirubin; Creatinine; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Hyponatremia; International Normalized Ratio; Liver Cirrhosis; Lypressin; Male; Middle Aged; Serum Albumin; Sodium; Terlipressin | 2010 |
[54-year-old male with hepatic cirrhosis and therapy-associated torsade de pointes tachycardia].
Topics: Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Torsades de Pointes; Vasoconstrictor Agents | 2011 |
Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants.
Topics: Catecholamines; Female; Humans; Hypotension; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Italy; Lypressin; Male; Medical Audit; Retrospective Studies; Shock, Septic; Terlipressin; Ultrasonography; Vasoconstrictor Agents | 2011 |
Effects of two different dosing regimens of terlipressin on organ functions in ovine endotoxemia.
Topics: Animals; Blood Proteins; Disease Models, Animal; Endotoxemia; Endotoxins; Female; Hemodynamics; Inflammation; Lypressin; Permeability; Random Allocation; Salmonella typhi; Sheep; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2011 |
Hyponatremia in patients treated with terlipressin: mechanisms and implications for clinical practice.
Topics: Contraindications; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Hyponatremia; Hypotonic Solutions; Lypressin; Receptors, Vasopressin; Sodium; Terlipressin | 2011 |
Hyponatremia in patients with acute variceal bleeding treated with terlipressin.
Topics: Esophageal and Gastric Varices; Hemorrhage; Humans; Hyponatremia; Lypressin; Prevalence; Risk Factors; Sodium; Terlipressin; Vasoconstrictor Agents | 2011 |
Vasopressin analogues and V1a receptor agonists in septic shock.
Topics: Arginine Vasopressin; Catecholamines; Clinical Trials as Topic; Humans; Lypressin; Microcirculation; Perfusion; Receptors, Vasopressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2011 |
Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndrome.
Topics: Aged; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Takotsubo Cardiomyopathy; Terlipressin | 2011 |
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?
Topics: Albumins; End Stage Liver Disease; Hepatorenal Syndrome; Humans; Liver Cirrhosis, Alcoholic; Liver Transplantation; Lypressin; Male; Middle Aged; Recurrence; Terlipressin; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2011 |
Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Hospitals, University; Humans; Intensive Care Units; Lypressin; Male; Microcirculation; Middle Aged; Mouth Floor; Prospective Studies; Shock, Septic; Terlipressin; Vascular Resistance; Vasoconstrictor Agents; Young Adult | 2011 |
Pharmacological management of hepatorenal syndrome: lessons from non-responders.
Topics: Albumins; Creatinine; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Terlipressin | 2011 |
Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy.
Topics: Acute Kidney Injury; Animals; Contrast Media; Disease Models, Animal; Kidney Function Tests; Lypressin; Rats; Rats, Inbred BB; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2011 |
Diagnosis and therapy of ascites in liver cirrhosis.
Topics: Albumins; Ascites; Ascitic Fluid; Bacterial Infections; Clinical Trials as Topic; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Paracentesis; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Renin-Angiotensin System; Terlipressin | 2011 |
Bacterial translocation attenuates the systemic hemodynamic improvement produced by terlipressin in patients with cirrhosis.
Topics: Bacterial Translocation; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2011 |
Impact of a bleeding care pathway in the management of acute upper gastrointestinal bleeding.
Topics: Acute Disease; Adult; Aged; Case-Control Studies; Critical Pathways; Endoscopy; Female; Gastrointestinal Hemorrhage; Humans; Intensive Care Units; Length of Stay; Lypressin; Male; Middle Aged; Octreotide; Omeprazole; Prospective Studies; Retrospective Studies; Survival Rate; Terlipressin; Time Factors; Treatment Outcome; Upper Gastrointestinal Tract | 2011 |
Extensive epidermal necrosis due to terlipressin.
Topics: Aged; Epidermis; Esophageal and Gastric Varices; Fatal Outcome; Humans; Hypertension, Portal; Ischemia; Lypressin; Male; Necrosis; Skin; Terlipressin; Vasoconstrictor Agents | 2011 |
Renal protection during liver transplantation: an ounce of prevention is worth a pound of cure.
Topics: Humans; Kidney Diseases; Liver Diseases; Liver Transplantation; Lypressin; Terlipressin; Vasoconstrictor Agents | 2011 |
The use of terlipressin for management of dynamic left ventricular outflow tract obstruction complicating orthotropic liver transplantation: a case report.
Topics: Adult; Heart Ventricles; Humans; Liver Transplantation; Lypressin; Male; Terlipressin | 2011 |
Terlipressin: an asset for hepatologists!
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2011 |
Duodenal variceal bleeding caused by chronic pancreatitis.
Topics: Aged; Duodenal Diseases; Duodenum; Endoscopy, Digestive System; Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Pancreatitis, Chronic; Radiography; Recurrence; Sclerotherapy; Terlipressin; Varicose Veins; Vasoconstrictor Agents | 2012 |
Beneficial effects of terlipressin in pediatric cardiac arrest.
Topics: Adolescent; Advanced Cardiac Life Support; Cardiopulmonary Resuscitation; Child; Child, Preschool; Comorbidity; Dopamine; Drug Evaluation; Epinephrine; Female; Heart Arrest; Humans; Infant; Intensive Care Units, Pediatric; Lypressin; Male; Recovery of Function; Retrospective Studies; Survival Rate; Terlipressin; Turkey; Vasoconstrictor Agents | 2011 |
Effects of terlipressin in a rat model of severe uncontrolled hemorrhage via liver injury.
Topics: Animals; Blood Pressure; Disease Models, Animal; Hemorrhage; Liver; Lypressin; Male; Rats; Rats, Wistar; Resuscitation; Terlipressin; Vasoconstrictor Agents | 2012 |
Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
Topics: Acute Kidney Injury; Clinical Protocols; Contraindications; Diuretics; Evidence-Based Medicine; Fluid Therapy; Hepatorenal Syndrome; Humans; Hyponatremia; Liver Cirrhosis; Lypressin; Renal Insufficiency, Chronic; Terlipressin; Vasoconstrictor Agents; Water-Electrolyte Imbalance | 2012 |
Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation.
Topics: Adult; Albumins; Comorbidity; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Renal Dialysis; Risk Factors; Terlipressin; Treatment Outcome | 2012 |
The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis.
Topics: Animals; Escherichia coli; Escherichia coli Infections; Female; Hemodynamics; Kidney; Lypressin; Regional Blood Flow; Sheep; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2012 |
Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding.
Topics: Adult; Aged; Aged, 80 and over; Erythrocyte Transfusion; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hospital Mortality; Hospitalization; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Platelet Count; Portugal; Risk Factors; Severity of Illness Index; Terlipressin; Vasoconstrictor Agents | 2012 |
Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.
Topics: Albumins; Combined Modality Therapy; Follow-Up Studies; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Lypressin; Male; Middle Aged; Renal Insufficiency; Risk Assessment; Severity of Illness Index; Terlipressin; Treatment Outcome | 2012 |
Terlipressin-induced extensive skin necrosis: a case report and published work review.
Topics: Aged; Antihypertensive Agents; Fatal Outcome; Female; Fungemia; Humans; Lypressin; Multiple Organ Failure; Necrosis; Purpura; Skin; Terlipressin; Treatment Outcome | 2012 |
Management of acute upper gastrointestinal bleeding: summary of NICE guidance.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Component Transfusion; Clopidogrel; Contraindications; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Resuscitation; Risk Assessment; Secondary Prevention; Terlipressin; Ticlopidine; United Kingdom; Vasoconstrictor Agents; Warfarin | 2012 |
Terlipressin improves pulmonary pressures in cirrhotic patients with pulmonary hypertension and variceal bleeding or hepatorenal syndrome.
Topics: Antihypertensive Agents; Arterial Pressure; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Greece; Hepatorenal Syndrome; Humans; Hypertension, Pulmonary; Liver Cirrhosis; Lypressin; Male; Terlipressin; Treatment Outcome; Vascular Resistance; Vasoconstrictor Agents | 2012 |
AKI in a patient with cirrhosis and ascites.
Topics: Acute Kidney Injury; Adult; Ascites; Creatinine; Female; Fluid Therapy; Glomerular Filtration Rate; Humans; Hypotension; Hypovolemia; Liver Cirrhosis; Lypressin; Oliguria; Paracentesis; Terlipressin; Vasoconstrictor Agents | 2012 |
Effects of terlipressin on pulmonary artery pressure in a septic cooled infant: an echocardiographic assessment.
Topics: Antihypertensive Agents; Asphyxia Neonatorum; Disease Progression; Epinephrine; Humans; Hypertension, Pulmonary; Hypothermia, Induced; Infant, Newborn; Lypressin; Male; Norepinephrine; Pulmonary Circulation; Shock; Terlipressin; Tricuspid Valve Insufficiency; Troponin; Ultrasonography; Vascular Resistance; Vasoconstrictor Agents | 2012 |
Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure.
Topics: Adult; Aged; Cohort Studies; Female; Humans; Hyponatremia; Liver Failure; Lypressin; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Terlipressin | 2013 |
Cholesterol metabolism in acute upper gastrointestinal bleeding, preliminary observations.
Topics: Acute Disease; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Combined Modality Therapy; Endoscopy, Gastrointestinal; Erythrocyte Transfusion; Esophageal and Gastric Varices; Female; Fluid Therapy; Follow-Up Studies; Gastrointestinal Hemorrhage; Hematemesis; Hemodilution; Humans; Hypercholesterolemia; Infusions, Intravenous; Intensive Care Units; Liver Cirrhosis; Lypressin; Male; Melena; Middle Aged; Omeprazole; Parenteral Nutrition, Total; Proton Pump Inhibitors; Terlipressin | 2012 |
Terlipressin resolves ascites of cirrhotic rats through downregulation of aquaporin 2.
Topics: Alanine Transaminase; Animals; Aquaporin 1; Aquaporin 2; Arginine Vasopressin; Ascites; Bilirubin; Blood Pressure; Blood Urea Nitrogen; Down-Regulation; Kidney; Liver Cirrhosis; Lypressin; Male; Rats; Rats, Sprague-Dawley; Serum Albumin; Terlipressin; Vasoconstrictor Agents | 2012 |
[Guideline for life-threatening peripartal haemorrhage].
Topics: Blood Coagulation Tests; Blood Volume; Bulgaria; Female; Humans; Lypressin; Methylergonovine; Misoprostol; Oxytocics; Oxytocin; Postpartum Hemorrhage; Pregnancy; Risk Factors; Terlipressin; Uterus | 2012 |
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Body Weight; Carbon Tetrachloride; Catecholamines; Common Bile Duct; Cyclic AMP; Drug Synergism; Drug Therapy, Combination; Hypertension, Portal; Infusions, Intravenous; Ligation; Liver Cirrhosis, Experimental; Lypressin; Mesenteric Artery, Superior; Oxazolidinones; Perfusion; Portal Pressure; Propranolol; Rats; Regional Blood Flow; Renal Artery; Splanchnic Circulation; Sympathectomy; Terlipressin; Tryptamines; Vasodilation | 2013 |
A case-control study of transjugular intrahepatic portosystemic stent shunts for patients admitted to intensive care following variceal bleeding.
Topics: Aged; Anti-Bacterial Agents; Chi-Square Distribution; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Lypressin; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Patient Admission; Polytetrafluoroethylene; Portasystemic Shunt, Transjugular Intrahepatic; Proportional Hazards Models; Prosthesis Design; Retrospective Studies; Risk Factors; Stents; Terlipressin; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2013 |
Terlipressin with limited fluid resuscitation in a swine model of hemorrhage.
Topics: Animals; Arterial Pressure; Disease Models, Animal; Fluid Therapy; Heart Rate; Hemorrhage; Lactic Acid; Lypressin; Swine; Terlipressin; Vasoconstrictor Agents | 2013 |
Estimating effect of terlipressin on portal pressure in cirrhosis by observing hepatic vein Doppler waveform.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure Determination; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Ultrasonography, Doppler | 2013 |
A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease.
Topics: Aged; Creatinine; Foot; Gangrene; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Lypressin; Male; Osteomyelitis; Radiography; Severity of Illness Index; Terlipressin; Toe Phalanges; Vasoconstrictor Agents | 2013 |
Upper gastrointestinal bleeding in cirrhosis: varix or no varix?
Topics: Duodenum; Gastrointestinal Hemorrhage; Hepatitis C, Chronic; Humans; Ligation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Tomography, X-Ray Computed; Varicose Veins; Vasoconstrictor Agents | 2013 |
Terlipressin induced ischaemia of skin.
Topics: Humans; Ischemia; Lypressin; Male; Middle Aged; Skin; Terlipressin; Vasoconstrictor Agents | 2013 |
Terlipressin-induced QT prolongation.
Topics: Female; Humans; Long QT Syndrome; Lypressin; Middle Aged; Terlipressin | 2013 |
Effects of terlipressin and naloxone compared with epinephrine in a rat model of asphyxia-induced cardiac arrest.
Topics: Animals; Arterial Pressure; Asphyxia; Cardiopulmonary Resuscitation; Epinephrine; Heart Arrest; Hemodynamics; Lypressin; Male; Models, Animal; Naloxone; Random Allocation; Rats; Rats, Wistar; Reference Values; Reproducibility of Results; Terlipressin; Time Factors; Vasoconstrictor Agents | 2013 |
[Severe hyponatraemia to terlipressin treatment].
Topics: Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hyponatremia; Lypressin; Middle Aged; Sodium; Terlipressin; Vasoconstrictor Agents | 2013 |
Worldwide practices for pharmacologic therapy in esophageal variceal hemorrhage.
Topics: Attitude of Health Personnel; Combined Modality Therapy; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Health Care Surveys; Hemostasis, Endoscopic; Hospitals, Community; Hospitals, University; Humans; Internationality; Liver Cirrhosis; Lypressin; Male; Octreotide; Professional Practice Location; Terlipressin; Vasoconstrictor Agents | 2014 |
Terlipressin-induced hyponatremic encephalopathy in a noncirrhotic patient.
Topics: Adult; Brain Diseases; Female; Humans; Hyponatremia; Liver Cirrhosis; Lypressin; Terlipressin | 2013 |
Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis.
Topics: Aged; Albumins; Blood Pressure; Creatinine; Female; Heart Rate; Hepatorenal Syndrome; Humans; Kidney; Liver Failure; Lypressin; Male; Middle Aged; Prospective Studies; Sepsis; Terlipressin; Treatment Outcome | 2014 |
Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
Topics: Bilirubin; Creatinine; Electrocardiography; Fatal Outcome; Hepatorenal Syndrome; Humans; Intestinal Mucosa; Intestines; Liver Cirrhosis; Lypressin; Male; Middle Aged; Necrosis; Terlipressin; Tomography, X-Ray Computed; Vasoconstrictor Agents | 2013 |
Type-1 hepatorenal syndrome in patients with cirrhosis and infection vs. sepsis-induced acute kidney injury: what matters?
Topics: Albumins; Female; Hepatorenal Syndrome; Humans; Lypressin; Male; Sepsis; Terlipressin | 2014 |
Bronchoscopic intratumoral injection of tranexamic acid to prevent excessive bleeding during multiple forceps biopsies of lesions with a high risk of bleeding: a prospective case series.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bronchoscopy; Epinephrine; Female; Hemorrhage; Humans; Injections, Intralesional; Lung Neoplasms; Lypressin; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Terlipressin; Tranexamic Acid | 2014 |
Effects of terlipressin on microcirculation of small bowel mesentery in rats with endotoxic shock.
Topics: Acid-Base Equilibrium; Animals; Drug Evaluation, Preclinical; Hemodynamics; Lypressin; Male; Microcirculation; Norepinephrine; Oxygen; Random Allocation; Rats, Wistar; Shock, Septic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents | 2014 |
Elevated liver regeneration in response to pharmacological reduction of elevated portal venous pressure by terlipressin after partial hepatectomy.
Topics: Animals; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p21; Fatty Liver; Hepatectomy; Interleukin-6; Ki-67 Antigen; Liver; Liver Regeneration; Lypressin; Mice; Mice, Inbred C57BL; Nuclear Proteins; Portal Pressure; Portal Vein; Regeneration; Terlipressin; Vasoconstrictor Agents | 2014 |
Pharmacotherapy of Small-for-Size of the Liver.
Topics: Animals; Liver; Liver Regeneration; Lypressin; Portal Pressure; Terlipressin | 2014 |
Adrenal dysfunction in portal hypertensive rats with acute hemorrhage.
Topics: Adrenal Glands; Animals; Aorta, Abdominal; Body Weight; Corticosterone; Dexamethasone; Gene Expression Regulation, Enzymologic; Hemodynamics; Hemorrhage; Hypertension, Portal; Hypothalamo-Hypophyseal System; Lypressin; Male; Mesenteric Artery, Superior; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Terlipressin; Tumor Necrosis Factor-alpha | 2014 |
Continuous outpatient terlipressin infusion for hepatorenal syndrome as a bridge to successful liver transplantation.
Topics: Hepatorenal Syndrome; Home Infusion Therapy; Humans; Infusions, Intravenous; Liver Transplantation; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2014 |
Combination of splanchnic vasoconstrictors and endoscopic band ligation is an effective treatment strategy for acute variceal hemorrhage; but how do we get those drugs approved by the FDA?
Topics: Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Octreotide; Somatostatin; Terlipressin; Vasoconstrictor Agents | 2014 |
Adrenaline, terlipressin, and corticoids versus adrenaline in the treatment of experimental pediatric asphyxial cardiac arrest.
Topics: Adrenal Cortex Hormones; Animals; Asphyxia; Blood Circulation; Blood Pressure; Carbon Dioxide; Cardiopulmonary Resuscitation; Disease Models, Animal; Drug Therapy, Combination; Epinephrine; Heart Arrest; Lypressin; Partial Pressure; Prospective Studies; Random Allocation; Swine; Terlipressin; Time Factors; Vasoconstrictor Agents | 2014 |
A comparison of vasopressin, terlipressin, and lactated ringers for resuscitation of uncontrolled hemorrhagic shock in an animal model.
Topics: Animals; Disease Models, Animal; Isotonic Solutions; Lypressin; Male; Rats; Rats, Wistar; Ringer's Lactate; Shock, Hemorrhagic; Terlipressin; Vasopressins | 2014 |
[Extensive cutaneous necrosis due to terlipressin use].
Topics: Aneurysm, Ruptured; Brain Ischemia; Drug Eruptions; Fatal Outcome; Humans; Hypotension; Intracranial Aneurysm; Ischemia; Liver Cirrhosis, Alcoholic; Liver Failure; Lypressin; Male; Middle Aged; Necrosis; Purpura; Skin; Subarachnoid Hemorrhage; Terlipressin; Vasoconstrictor Agents | 2015 |
Involvement of the microvasculature in the pathogenesis of terlipressin-related myocardial infarction.
Topics: Antihypertensive Agents; Autopsy; Humans; Liver Cirrhosis, Alcoholic; Lypressin; Male; Microvessels; Myocardial Infarction; Terlipressin; Young Adult | 2016 |
Acute esophageal necrosis: possible association with terlipressin.
Topics: Aged; Esophageal Diseases; Esophagoscopy; Esophagus; Hematemesis; Humans; Lypressin; Male; Melena; Necrosis; Terlipressin; Ulcer; Vasoconstrictor Agents | 2014 |
Does a resuscitation pharmacologic bundle of epinephrine, terlipressin, and corticosteroids improve outcome from asphyxial cardiac arrest?
Topics: Adrenal Cortex Hormones; Animals; Epinephrine; Heart Arrest; Lypressin; Terlipressin; Vasoconstrictor Agents | 2014 |
Risk Factors for Developing Hyponatremia During Terlipressin Treatment: A Retrospective Analyses in Variceal Bleeding.
Topics: Adult; Age Factors; Aged; Body Mass Index; Creatinine; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hyponatremia; Lypressin; Male; Middle Aged; Retrospective Studies; Risk Factors; Sodium; Terlipressin; Time Factors; Vasoconstrictor Agents | 2015 |
Transient increase in urine protein excretion during treatment with terlipressin and albumin for type-1 hepatorenal syndrome.
Topics: Albumins; Antihypertensive Agents; Biomarkers; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin | 2015 |
Terlipressin-induced ischemic skin necrosis: a rare association.
Topics: Aged; Biopsy; Diagnosis, Differential; Forearm; Gastrointestinal Hemorrhage; Humans; Lypressin; Male; Necrosis; Skin Diseases; Terlipressin; Vasoconstrictor Agents | 2014 |
Contrast-enhanced ultrasound evaluation of the renal microcirculation response to terlipressin in hepato-renal syndrome: a preliminary report.
Topics: Administration, Intravenous; Antihypertensive Agents; Hepatorenal Syndrome; Humans; Image Enhancement; Kidney Cortex; Lypressin; Male; Microcirculation; Middle Aged; Perfusion Imaging; Severity of Illness Index; Terlipressin; Treatment Outcome; Ultrasonography | 2015 |
Intraoperative terlipressin therapy reduces the incidence of postoperative acute kidney injury after living donor liver transplantation.
Topics: Acute Kidney Injury; Adult; Aged; Case-Control Studies; Female; Humans; Incidence; Intraoperative Care; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Terlipressin; Treatment Outcome | 2015 |
Beneficial and side effects of arginine vasopressin and terlipressin for septic shock.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Calcium; Dose-Response Relationship, Drug; Female; Lypressin; Male; Norepinephrine; Rabbits; Rats; Rats, Sprague-Dawley; Sex Characteristics; Shock, Septic; Terlipressin | 2015 |
Comparison of normal saline, hypertonic saline albumin and terlipressin plus hypertonic saline albumin in an infant animal model of hypovolemic shock.
Topics: Albumins; Animals; Animals, Newborn; Blood Pressure; Carbon Dioxide; Disease Models, Animal; Heart Rate; Hemodynamics; Hemorrhage; Hypovolemia; Lypressin; Oxygen; Saline Solution, Hypertonic; Sodium Chloride; Stroke Volume; Sus scrofa; Terlipressin | 2015 |
Predictors of hepatorenal syndrome in alcoholic liver cirrhosis.
Topics: Acute Kidney Injury; Albumins; Analysis of Variance; Antihypertensive Agents; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Risk Factors; Terlipressin | 2015 |
Cortical laminar necrosis following the rapid correction of drug-induced hyponatremia.
Topics: Adult; Antihypertensive Agents; Brain; Brain Diseases; Female; Humans; Hyponatremia; Lypressin; Magnetic Resonance Imaging; Necrosis; Terlipressin | 2015 |
Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; India; Lypressin; Male; Middle Aged; Peritonitis; Retrospective Studies; Severity of Illness Index; Survival Analysis; Terlipressin; Vasoconstrictor Agents | 2016 |
Cirrhotic patients with large esophageal varices and older age have poor hemodynamic response to terlipressin.
Topics: Adult; Age Factors; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Time Factors; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents | 2015 |
Hepatorenal syndrome after treatment of visceral leishmaniasis requiring terlipressin therapy.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Hepatorenal Syndrome; Humans; Leishmaniasis, Visceral; Lypressin; Male; Terlipressin; Vasoconstrictor Agents | 2015 |
Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes.
Topics: Albumins; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Hepatorenal Syndrome; Humans; Injections, Intravenous; Kidney Function Tests; Liver Transplantation; Lypressin; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Spain; Survival Rate; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Waiting Lists; Watchful Waiting | 2015 |
Is there a place for bolus terlipressin use on the ward in postoperative hypotension not responding to fluid resuscitation?
Topics: Aged; Aged, 80 and over; Female; Fluid Therapy; Humans; Hypotension; Lypressin; Postoperative Complications; Resuscitation; Terlipressin; Vasoconstrictor Agents | 2015 |
Efficacy of outpatient continuous terlipressin infusions for hepatorenal syndrome.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Outpatients; Terlipressin; Vasoconstrictor Agents | 2016 |
Serendipitous use of terlipressin.
Topics: Antihypertensive Agents; Humans; Hypertension, Pulmonary; Lypressin; Terlipressin | 2016 |
Stimulation of V1a receptor increases renal uric acid clearance via urate transporters: insight into pathogenesis of hypouricemia in SIADH.
Topics: Animals; Aquaporin 2; ATP Binding Cassette Transporter, Subfamily G, Member 2; Inappropriate ADH Syndrome; Lypressin; Male; Metabolic Clearance Rate; Monosaccharide Transport Proteins; Organic Anion Transporters; Rats; Rats, Wistar; Receptors, Vasopressin; Renal Tubular Transport, Inborn Errors; Sodium-Phosphate Cotransporter Proteins, Type III; Terlipressin; Uric Acid; Urinary Calculi | 2016 |
[MODERN VIEW ON INTENSIVE THERAPY OF GASTRO-INTESTINAL HEMORRHAGE].
Topics: Adolescent; Adult; Aged; Antifibrinolytic Agents; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Laparoscopy; Lypressin; Male; Middle Aged; Octreotide; Recurrence; Terlipressin; Tranexamic Acid; Vitamin B Complex | 2015 |
Terlipressin Induced Severe Hyponatremia.
Topics: Adult; Esophageal and Gastric Varices; Female; Hematemesis; Humans; Hyponatremia; Liver Cirrhosis; Lypressin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Water-Electrolyte Imbalance | 2016 |
Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Terlipressin and Beyond.
Topics: Acute-On-Chronic Liver Failure; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Terlipressin; Vasoconstrictor Agents | 2016 |
Terlipressin given by continuous intravenous infusion or by intravenous boluses: Is there already an answer?
Topics: Humans; Infusions, Intravenous; Injections, Intravenous; Lypressin; Terlipressin; Vasoconstrictor Agents | 2016 |
Outpatient Terlipressin Infusion for the Treatment of Refractory Ascites.
Topics: Ambulatory Care; Ascites; Catheterization, Peripheral; Humans; Infusions, Intravenous; Lypressin; Male; Middle Aged; Paracentesis; Terlipressin; Vasoconstrictor Agents | 2016 |
No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment.
Topics: Adult; Aged; Databases, Factual; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Kaplan-Meier Estimate; Kidney Diseases; Liver Cirrhosis; Lypressin; Male; Middle Aged; Retrospective Studies; Somatostatin; Taiwan; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2016 |
Refractory torsade de pointes induced by terlipressin (Glypressin).
Topics: Aged; Anti-Arrhythmia Agents; Coma; Electric Countershock; Electrocardiography; Esophageal and Gastric Varices; Esophagoscopy; Fatal Outcome; Gastrointestinal Hemorrhage; Heart Arrest; Humans; Lypressin; Male; Pacemaker, Artificial; Recurrence; Romano-Ward Syndrome; Terlipressin; Torsades de Pointes; Vasoconstrictor Agents | 2016 |
Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile.
Topics: Animals; Cell Line; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Hepatorenal Syndrome; Humans; Inositol Phosphates; Liver Cirrhosis; Lypressin; Male; Prodrugs; Rats; Rats, Wistar; Receptors, Vasopressin; Terlipressin; Transfection; Vasopressins | 2016 |
Safety and Efficacy of Terlipressin in Pediatric Distributive Shock: A Retrospective Analysis in 20 Children.
Topics: Adolescent; Catecholamines; Child; Child, Preschool; Female; Heart Rate; Hemodynamics; Humans; Hypotension; Infant; Infant, Newborn; Lypressin; Male; Retrospective Studies; Shock; Systemic Inflammatory Response Syndrome; Terlipressin; Treatment Failure; Vasoconstrictor Agents; Young Adult | 2017 |
Isolated lower limb gangrene: a caveat of terlipressin therapy.
Topics: Aged; Gangrene; Humans; Lower Extremity; Lypressin; Male; Terlipressin; Vasoconstrictor Agents | 2016 |
Use of Terlipressin in an Elderly Patient With Moderate Aortic Valve Stenosis Accompanied by Episodic Atrial Fibrillation During Liver Transplantation: A Case Report.
Topics: Aged; Anesthetics; Aortic Valve Stenosis; Atrial Fibrillation; Female; Humans; Liver Transplantation; Lypressin; Male; Terlipressin | 2016 |
Terlipressin in refractory shock induced by diltiazem poisoning.
Topics: Calcium Channel Blockers; Critical Care; Diltiazem; Drug Overdose; Female; Humans; Lypressin; Middle Aged; Multiple Organ Failure; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2017 |
Terlipressin for hepatorenal syndrome: ready for prime time.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2017 |
Perioperative use of terlipressin in adult liver transplant.
Topics: Adult; Humans; Liver Cirrhosis; Liver Transplantation; Living Donors; Lypressin; Terlipressin; Vasoconstrictor Agents | 2017 |
Editorial: tackling hepatorenal syndrome-terlipressin for all, or time for a stratified approach?
Topics: Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2017 |
Modulation of hepatic perfusion did not improve recovery from hepatic outflow obstruction.
Topics: Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Hepatectomy; Isosorbide Dinitrate; Liver; Lypressin; Male; Octreotide; Portal Pressure; Propanolamines; Rats, Inbred Lew; Sildenafil Citrate; Splenectomy; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2017 |
Comparative study of the effects of terlipressin versus splenectomy on liver regeneration after partial hepatectomy in rats.
Topics: Animals; Body Weight; Hepatectomy; Ki-67 Antigen; Liver Regeneration; Lypressin; Male; Portal Pressure; Rats; Rats, Wistar; Splenectomy; Terlipressin | 2017 |
Terlipressin is superior to midodrine/octreotide for hepatorenal syndrome type 1.
Topics: Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Lypressin; Midodrine; Octreotide; Retrospective Studies; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2017 |
Terlipressin-induced modifications of Doppler ultrasound signals of systemic arteries in preterm infants with vasoactive-resistant patent ductus arteriosus: A pilot study.
Topics: Blood Flow Velocity; Cerebral Arteries; Cohort Studies; Ductus Arteriosus, Patent; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lypressin; Male; Mesenteric Artery, Superior; Pilot Projects; Prospective Studies; Renal Artery; Terlipressin; Ultrasonography, Doppler, Pulsed; Vasoconstrictor Agents | 2018 |
Systemic hemodynamic response to terlipressin predicts development of hepatorenal syndrome and survival in advanced cirrhosis.
Topics: Aged; Area Under Curve; Arterial Pressure; Ascites; Cardiac Output; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Linear Models; Liver Cirrhosis; Logistic Models; Lypressin; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Reproducibility of Results; Retrospective Studies; Risk Factors; ROC Curve; Terlipressin; Time Factors; Vascular Resistance; Vasoconstrictor Agents | 2018 |
Predictors of Response to Terlipressin in Hepatorenal Syndrome.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2018 |
When Should We Stop Treatment With Terlipressin and Albumin for Patients With Hepatorenal Syndrome?
Topics: Acute-On-Chronic Liver Failure; Albumins; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin | 2018 |
Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Biomarkers; Disease Progression; Female; Hepatitis B virus; Humans; Kidney Tubules; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Risk Factors; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2018 |
Response to Terlipressin in Hepatorenal Syndrome: Predict to Prognosticate!
Topics: Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2018 |
Letter To Editor: Terlipressin is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute On Chronic Liver Failure.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Humans; Lypressin; Norepinephrine; Terlipressin | 2018 |
Is Terlipressin Superior to Noradrenaline in the Treatment of Acute Kidney Injury in Acute-on-Chronic Liver Failure?
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Humans; Lypressin; Norepinephrine; Terlipressin | 2019 |
Intermittent or continuous infusion of terlipressin for acute variceal bleeding-"cherry picking" to make it simpler.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Terlipressin; Varicose Veins | 2018 |
[Severe reversible penile ischaemia after terlipressin treatment of hepatorenal syndrome].
Topics: Acute Kidney Injury; Aged; Hepatorenal Syndrome; Humans; Ischemia; Liver Cirrhosis, Alcoholic; Lypressin; Male; Penis; Terlipressin; Vasoconstrictor Agents | 2018 |
Reply to the letter to Editor on comparison of continuous versus intermittent infusions of terlipressin for the control of acute variceal bleeding in patients with portal hypertension: An open-label randomized controlled trial.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Terlipressin; Varicose Veins | 2018 |
Letter to Editor: The Synergistic Effect of Albumin on Terlipressin in Acute-on-Chronic Liver Failure With Acute Kidney Injury.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Albumins; Humans; Lypressin; Norepinephrine; Terlipressin | 2019 |
Terlipressin in the treatment of neonatal refractory hypotension caused by septic shock: a case report.
Topics: Adult; Child; Humans; Hypotension; Infant, Newborn; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2020 |
Editorial: treating hepatorenal syndrome-a window and the views.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2020 |
Safety and efficacy of outpatient continuous terlipressin infusion for the treatment of portal hypertensive complications in cirrhosis.
Topics: Ascites; End Stage Liver Disease; Hepatorenal Syndrome; Humans; Hydrothorax; Liver Cirrhosis; Lypressin; Outpatients; Severity of Illness Index; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2022 |
Ischemic skin necrosis secondary to the use of terlipressin.
Topics: Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Necrosis; Terlipressin; Vasoconstrictor Agents | 2021 |
Toward Norepinephrine as a First-Line Treatment for All Hospitalized Patients With Hepatorenal Syndrome.
Topics: Hepatorenal Syndrome; Humans; Liver Transplantation; Lypressin; Norepinephrine; Terlipressin | 2021 |
Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review.
Topics: Humans; Infant, Newborn; Lypressin; Shock; Systematic Reviews as Topic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2021 |
Letter: real-world use of terlipressin in patients with the hepatorenal syndrome-authors' reply.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2021 |
Letter: real-world use of terlipressin in patients with hepatorenal syndrome.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2021 |
Standardized versus nonstandardized pharmacologic treatment for hepatorenal syndrome.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Terlipressin | 2021 |
Board Review Vignette: Lessons Learned in the Management of Hepatorenal Syndrome Type 1 With Terlipressin.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2022 |
Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Hepatorenal Syndrome; Humans; Lypressin; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2022 |
Clinical characteristics and treatment of terlipressin-induced ischemic skin necrosis: A synthesis of 35 literature reported cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Humans; Infant; Ischemia; Lypressin; Male; Middle Aged; Necrosis; Retrospective Studies; Terlipressin; Vasoconstrictor Agents; Young Adult | 2022 |
Duodenal Necrosis and Nonvariceal Digestive Bleeding After Terlipressin Administration for Treatment of Hepatorenal Syndrome: a Case Report of a Novel Side Effect of a Commonly Used Drug.
Topics: Creatinine; End Stage Liver Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Ischemia; Liver Cirrhosis; Lypressin; Male; Middle Aged; Necrosis; Severity of Illness Index; Terlipressin; Vasoconstrictor Agents | 2022 |
[Practice guidance for the use of terlipressin for liver cirrhosis-related complications (2021)].
Topics: Electrolytes; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Terlipressin; Vasoconstrictor Agents | 2022 |
Terlipressin for hepatorenal syndrome: opportunities and challenges.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2023 |
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies.
Topics: Creatinine; Hepatorenal Syndrome; Humans; Lypressin; North America; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2023 |
First Drug for Treating Hepatorenal Syndrome.
Topics: Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2023 |
Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis.
Topics: Albumins; Hepatitis, Alcoholic; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2023 |
Higher Respiratory Complications in Alcoholic Hepatitis Patients With Hepatorenal Syndrome When Treated With Terlipressin: Is it Safe?
Topics: Hepatitis, Alcoholic; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2023 |
The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome.
Topics: Continuous Renal Replacement Therapy; Hepatorenal Syndrome; Humans; Lypressin; Terlipressin; Vasoconstrictor Agents | 2023 |
Outcomes of patients with hepatorenal syndrome undergoing liver transplantation in the era of terlipressin.
Topics: Creatinine; Hepatorenal Syndrome; Humans; Liver Transplantation; Lypressin; Retrospective Studies; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2023 |